FN Thomson Reuters Web of Knowledge
VR 1.0
PT J
AU Yoon, J
   Kim, K
AF Yoon, Janghyeok
   Kim, Kwangsoo
TI An automated method for identifying TRIZ evolution trends from patents
SO EXPERT SYSTEMS WITH APPLICATIONS
LA English
DT Article
DE System evolution pattern; TRIZ; Evolutionary potential; Automation;
   Patent analysis; Technology forecasting; Natural language processing;
   Semantic similarity measurement
ID MORPHOLOGY ANALYSIS; ALGORITHM
AB Trend analysis of the Theory of Inventive Problem Solving (Russian
   acronym: TRIZ) identifies the evolutionary status of systems to seek
   directions for further improvement of technology by relating properties
   and functions obtained from patents to TRIZ trends. The property, which
   is a specific characteristic of a system, is usually described using
   adjectives; the function, which is an action that changes a feature of
   an object, is usually described using verbs. Methods exist to facilitate
   identification of TRIZ trends, but they rely heavily on human
   intervention to identify specific trends and trend phases. Therefore,
   this paper proposes a method that automates identification of TRIZ
   trends. The proposed method consists of (1) extracting binary relations
   of the 'adjective + noun' or 'verb + noun' forms from patents using
   natural language processing, (2) defining a 'reasons for jumps' rule
   base that arranges trend-specific binary relations for trend
   identification, and (3) determining specific trends and trend phases by
   measuring semantic sentence similarity between the binary relations from
   patents and the binary relations in the rule base. The final output of
   the method depicts the evolutionary potential as a normalized radar
   plot, which can be used as input for technology forecasting based on
   TRIZ trends. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Yoon, Janghyeok; Kim, Kwangsoo] Pohang Univ Sci & Technol, Dept Ind & Management Engn, Pohang 790784, Kyungbuk, South Korea.
RP Kim, K (reprint author), Pohang Univ Sci & Technol, Dept Ind & Management Engn, San 31, Pohang 790784, Kyungbuk, South Korea
EM janghyoon@postech.ac.kr
   kskim@postech.ac.kr
FU National Research Foundation of Korea (NRF); Korea government
   (MEST)[2009-0088379]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MEST) (No. 2009-0088379).
CR 2010, GOOGLE CHART TOOLS
   *STANF NLP GROUP, 2010, STANF PARS STAT PARS
   2010, WORDNET LEXICAL DATA
   VERHAEGEN PA, 2009, CIRP J MANUFACTURING, V1, P126, DOI DOI 10.1016/J.CIRPJ.2008.09.010
   Cong H, 2008, EXPERT SYST APPL, V34, P788, DOI 10.1016/j.eswa.2006.10.015
   DEMARNEFFE M, 2008, STANFORD TYPED DEPEN
   CASCINI G, 2008, INT FED INFO PROC, V277, P31
   Yoon B, 2007, IEEE T ENG MANAGE, V54, P588, DOI 10.1109/TEM.2007.900796
   CASCINI G, 2007, INT J PRODUCT DEV, V4, P52, DOI 10.1504/IJPD.2007.011533
   LIANG YH, 2007, INT FED INFO PROC, V250, P89
   TONG LH, 2006, WORLD PATENT INFORM, V28, P6
   DEWULF S, 2006, ETRIA TRIZ FUT
   Yoon B, 2005, TECHNOL FORECAST SOC, V72, P145, DOI 10.1016/j.techfore.2004.08.011
   SIMPSON T, 2005, WORDNET BASED SEMANT
   *TECHN FUT AN METH, 2004, TECHNOLOGICAL FORECA, V71, P287
   BANERJEE S, 2003, P 18 INT JOINT C ART, P805
   KLEIN D, 2003, ADV NEURAL INFORM PR, P3
   CHEN LE, 2003, PLANTS WUTONG MOUNTA, P1
   MANN D, 2002, HANDS ON SYSTEMATIC
   MANN D, 2002, TRIZ J
   PETROV VM, 2002, TRIZ J
   Cavallucci D, 2001, CIRP ANN-MANUF TECHN, V50, P115
   SAVRANSKY SD, 2000, ENG CREATIVITY INTRO
   BRANTS T, 2000, P 6 C APPL NAT LANG, P224
   RESNIK P, 1998, WORDNET ELECT LEXICA, P239
   RATNAPARKHI A, 1996, C EMP METH NAT LANG
   MILLER GA, 1995, COMMUN ACM, V38, P39
   BRILL E, 1992, P 3 C APPL NAT LANG, P152
   LESK M, 1986, P 5 ANN INT C SYST D, P24
   ALTSCHULLER G, 1984, CREATIVITY EXACT SCI
   PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130
NR 31
TC 1
Z9 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0957-4174
J9 EXPERT SYST APPL
JI Expert Syst. Appl.
PD NOV-DEC
PY 2011
VL 38
IS 12
BP 15540
EP 15548
DI 10.1016/j.eswa.2011.06.005
PG 9
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic; Operations Research & Management Science
SC Computer Science; Engineering; Operations Research & Management Science
GA 824HQ
UT WOS:000295193400124
ER
PT J
AU Martin, S
   Diaz, G
   Sancristobal, E
   Gil, R
   Castro, M
   Peire, J
AF Martin, Sergio
   Diaz, Gabriel
   Sancristobal, Elio
   Gil, Rosario
   Castro, Manuel
   Peire, Juan
TI New technology trends in education: Seven years of forecasts and
   convergence
SO COMPUTERS & EDUCATION
LA English
DT Article
DE Technology trends; Education; Forecasts; Social web; Mobile and
   ubiquitous devices; Augmented reality; Semantic web; Immersive
   environments; Learning objects
ID PATENT ANALYSIS; DESIGN; SYSTEM; GAME; BIBLIOMETRICS; TEACH
AB Each year since 2004, a new Horizon Report has been released. Each
   edition attempts to forecast the most promising technologies likely to
   impact on education along three horizons: the short term (the year of
   the report), the mid-term (the next 2 years) and the long term (the next
   4 years). This paper analyzes the evolution of technology trends from
   2004 to 2014 that correspond to the long-term predictions of the most
   recent Horizon Report. The study analyzes through bibliometric analysis
   which technologies were successful and became a regular part of
   education systems, which ones failed to have the predicted impact and
   why, and the shape of technology flows in recent years. The study also
   shows how the evolution and maturity of some technologies allowed the
   revival of expectations for others. The analysis here, which focuses on
   educational applications, offers guidelines that may be helpful to those
   seeking to invest in new research areas. (C) 2011 Elsevier Ltd. All
   rights reserved.
C1 [Martin, Sergio; Diaz, Gabriel; Sancristobal, Elio; Gil, Rosario; Castro, Manuel; Peire, Juan] Spanish Univ Distance Educ UNED, Elect & Comp Engn Dept, Madrid 28040, Spain.
RP Martin, S (reprint author), Spanish Univ Distance Educ UNED, Elect & Comp Engn Dept, 12 Juan del Rosal, Madrid 28040, Spain
EM smartin@ieec.uned.es
FU Spanish Science and Innovation Ministry[TIN2008-06083-C03/TSI,
   CYTED-508AC0341]; e-Madrid Project[S2009/TIC-1650]
FX The authors acknowledge the Spanish Science and Innovation Ministry for
   support of the projects TIN2008-06083-C03/TSI "s-Labs - Integracion de
   Servicios Abiertos para Laboratorios Remotos y Virtuales Distribuidos"
   and CYTED-508AC0341 "SOLITESOFTWARE LIBRE EN TELEFORMACION." Finally,
   the authors acknowledge the support provided by e-Madrid Project,
   S2009/TIC-1650, "Investigacion y Desarrollo de tecnologias para el
   e-learning en la Comunidad de Madrid".
CR Hainey T, 2011, COMPUT EDUC, V56, P21, DOI 10.1016/j.compedu.2010.09.008
   Kwok RCW, 2011, COMPUT EDUC, V56, P101, DOI 10.1016/j.compedu.2010.08.015
   Liu Y, 2010, COMPUT EDUC, V55, P1211, DOI 10.1016/j.compedu.2010.05.018
   Traphagan TW, 2010, COMPUT EDUC, V55, P923, DOI 10.1016/j.compedu.2010.04.003
   Wang QY, 2010, COMPUT EDUC, V55, P1270, DOI 10.1016/j.compedu.2010.05.023
   Yang JC, 2010, COMPUT EDUC, V55, P1346, DOI 10.1016/j.compedu.2010.06.005
   Girvan C, 2010, COMPUT EDUC, V55, P342, DOI 10.1016/j.compedu.2010.01.020
   JOHNSON L, 2010, 2010 HORIZON REPORT
   Huang SL, 2009, COMPUT EDUC, V53, P701, DOI 10.1016/j.compedu.2009.04.011
   Coller BD, 2009, COMPUT EDUC, V53, P900, DOI 10.1016/j.compedu.2009.05.012
   Jarmon L, 2009, COMPUT EDUC, V53, P169, DOI 10.1016/j.compedu.2009.01.010
   JARVIS J, 2009, WHAT WOULD GOOGLE DO
   JOHNSON L, 2009, 2009 HORIZON REPORT
   De Lucia A, 2009, COMPUT EDUC, V52, P220, DOI 10.1016/j.compedu.2008.08.001
   REEVES B, 2009, TOTAL ENGAGEMENT USI
   SANDI M, 2009, BRIT EDUC RES J, V35, P243
   OKUOKA T, 2009, 11 IEEE INT S MULT 2, V14, P501
   PAPASTERGIOU M, 2009, COMPUTERS ED
   MARTIN S, 2009, P 4 INT MULT COMP GL
   PATTERSON D, 2009, UK E LEARNING MARKET
   Monahan T, 2008, COMPUT EDUC, V50, P1339, DOI 10.1016/j.compedu.2006.12.008
   JOHNSON L, 2008, 2008 HORIZON REPORT
   SUE B, 2008, BRIT J EDUC TECHNOL, V39, P775
   NAKAYAMA K, 2008, 22 INT C ADV INF NET, V25, P1150
   ZHOU F, 2008, P ISMAR 2008 CAMBR U
   Moreno-Ger P, 2007, SCI COMPUT PROGRAM, V67, P3, DOI 10.1016/j.scico.2006.07.003
   JOHNSON L, 2007, 2007 HORIZON REPORT
   Daim TU, 2006, TECHNOL FORECAST SOC, V73, P981, DOI 10.1016/j.techfore.2006.04.004
   Wang HC, 2006, COMPUT EDUC, V46, P458, DOI 10.1016/j.compedu.2005.09.005
   JOHNSON L, 2006, 2006 HORIZON REPORT
   JOHNSON L, 2005, 2005 HORIZON REPORT
   VANSTON LK, 2004, TELEKTRONIKK, V4, P32
   NAISMITH L, 2004, NESTA FUTURELAB SERI, V11
   SMITH R, 2004, GUIDELINES AUTHORS L
   JOHNSON L, 2004, 2004 HORIZON REPORT
   PILKINGTON A, 2003, PORTL INT C MAN ENG
   Morris S, 2002, COMPUT IND ENG, V43, P841
   Crosier JK, 2002, COMPUT EDUC, V38, P77
   Kostoff RN, 2001, TECHNOL FORECAST SOC, V68, P223
   Abraham BP, 2001, TECHNOVATION, V21, P245
   PRENSKY M, 2001, HORIZON, V9, P1
   NORTON MJ, 2001, INFORM PROCESSING MA, V37, P764
   Wang PM, 1998, J BUS ECON STAT, V16, P27
   Watts RJ, 1997, TECHNOL FORECAST SOC, V56, P25
   Liu SJ, 1997, INT J TECHNOL MANAGE, V13, P661
   WEISER M, 1991, SCI AM, V265, P94
   WISHART J, 1990, COMPUTERS ED
NR 47
TC 0
Z9 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-1315
J9 COMPUT EDUC
JI Comput. Educ.
PD NOV
PY 2011
VL 57
IS 3
BP 1893
EP 1906
DI 10.1016/j.compedu.2011.04.003
PG 14
WC Computer Science, Interdisciplinary Applications; Education &
   Educational Research
SC Computer Science; Education & Educational Research
GA 810AY
UT WOS:000294099000005
ER
PT J
AU Brown, NC
   Kimbrough, MD
AF Brown, Nerissa C.
   Kimbrough, Michael D.
TI Intangible investment and the importance of firm-specific factors in the
   determination of earnings
SO REVIEW OF ACCOUNTING STUDIES
LA English
DT Article
DE Earnings noncommonality; Intangible assets; Appropriability
ID RESEARCH-AND-DEVELOPMENT; COMPETITIVE ADVANTAGE; DEVELOPMENT SPILLOVERS;
   RETURN VARIATION; STOCK MARKETS; INDUSTRY; PATENTS; INFORMATION;
   INNOVATION; RESOURCES
AB We examine the effect of intangible investment on earnings
   noncommonality, defined as the extent to which a firm's earnings
   performance is determined by firm-specific factors versus market and
   industry factors. Such insight is important in determining the
   appropriate weighting of these factors when forecasting a firm's
   earnings. For a sample of US firms over the 1980-2006 period, we find
   that earnings noncommonality is positively associated with intangible
   asset intensity. This finding is consistent with the resource-based view
   of the firm, which posits that intangible investments allow firms to
   differentiate themselves economically from their rivals. We also find
   that separable recognized intangibles contribute more to earnings
   noncommonality than do either goodwill or R&D, perhaps because separable
   recognized intangibles are more likely to arise from contractual or
   legal rights and thus are less susceptible to expropriation by rival
   firms. Finally, we find that the positive impact of R&D on earnings
   noncommonality is significantly greater for those industries where
   patents and other legal mechanisms are most effective in protecting R&D.
   This result suggests that the success of intangible investment as a
   differentiation strategy depends largely on the effectiveness of
   mechanisms used to protect intangible investments from expropriation.
C1 [Kimbrough, Michael D.] Univ Maryland, Robert H Smith Sch Business, College Pk, MD 20742 USA.
   [Brown, Nerissa C.] Georgia State Univ, J Mack Robinson Coll Business, Atlanta, GA 30303 USA.
RP Kimbrough, MD (reprint author), Univ Maryland, Robert H Smith Sch Business, College Pk, MD 20742 USA
EM nbrown@gsu.edu
   mkimbrough@rhsmith.umd.edu
CR DEFRANCO G, 2011, J ACCOUNTIN IN PRESS
   LITOV L, 2010, CORPORATE STRATEGY A
   KIMBROUGH M, 2010, EVIDENCE INVESTORS A
   ERKENS D, 2010, INFLUENCE PROPERTY R
   Ball R, 2009, J ACCOUNT RES, V47, P1097, DOI 10.1111/j.1475-679X.2009.00351.x
   Kini O, 2009, J ACCOUNT RES, V47, P867, DOI 10.1111/j.1475-679X.2009.00338.x
   Marx M, 2009, MANAGE SCI, V55, P875, DOI 10.1287/mnsc.1080.0985
   Fairfield PM, 2009, J ACCOUNT RES, V47, P147, DOI 10.1111/j.1475-679X.2008.00313.x
   Petersen MA, 2009, REV FINANC STUD, V22, P435, DOI 10.1093/rfs/hhn053
   GONG G, 2009, EARNINGS NONSYNCHRON
   ENGELBERG J, 2009, KNOW THY NEIGHBOR IN
   Matolcsy ZR, 2008, ACCOUNT REV, V83, P479
   Basu S, 2008, ACCOUNT BUS RES, V38, P171
   Skinner DJ, 2008, ACCOUNT BUS RES, V38, P191
   PALEPU KG, 2007, BUSINESS ANAL VALUAT
   Jin L, 2006, J FINANC ECON, V79, P257, DOI 10.1016/j.jfineco.2004.11.003
   Moen J, 2005, J LABOR ECON, V23, P81
   Piotroski JD, 2004, ACCOUNT REV, V79, P1119
   Villalonga B, 2004, J ECON BEHAV ORGAN, V54, P205, DOI 10.1016/j.jebo.2003.07.001
   Durnev A, 2004, J FINANC, V59, P65
   ELGERS P, 2004, BIRDS FEATHER DO COM
   Durnev A, 2003, J ACCOUNTING RES, V41, P797, DOI 10.1046/j.1475-679X.2003.00124.x
   MAINES LA, 2003, ACCOUNT HORIZ, V17, P175
   Cohen WM, 2002, RES POLICY, V31, P1349
   McGahan AM, 2002, MANAGE SCI, V48, P834
   Hall BH, 2002, OXFORD REV ECON POL, V18, P35
   WOOLDRIDGE J, 2002, INTRO ECONOMETRICS M
   KOTHARI SP, 2002, REV ACCOUNT STUD, V7, P355
   Davis LN, 2001, TECHNOL ANAL STRATEG, V13, P325
   Barth ME, 2001, J ACCOUNTING RES, V39, P1
   LEV B, 2001, INTANGIBLES MANAGEME
   LAVELLE L, 2001, BUSINESS WEEK   1126
   Morck R, 2000, J FINANC ECON, V58, P215
   COHEN WM, 2000, 7552 NBER
   BHIDE A, 2000, ORIGIN EVOLUTION NEW
   Barth ME, 1999, J ACCOUNT ECON, V28, P211
   Gilson RJ, 1999, NEW YORK U LAW REV, V74, P575
   VONHOFFMAN C, 1999, HARVARD MANAGEM 0903
   Mauri AJ, 1998, STRATEGIC MANAGE J, V19, P211
   KAHANER L, 1997, COMPETITIVE INTELLIG
   MCGAHAN A, 1997, STRATEGIC MANAGE SUM, P18
   Lev B, 1996, J ACCOUNT ECON, V21, P107
   PRESCOTT JE, 1995, COMPETITIVE INTELLIG, V6, P4
   HALL R, 1993, STRATEGIC MANAGE J, V14, P607
   NELSON RR, 1991, STRATEGIC MANAGE J, V12, P61
   BARNEY J, 1991, J MANAGE, V17, P99
   RUMELT RP, 1991, STRATEGIC MANAGE J, V12, P167
   ROMER PM, 1990, J POLIT ECON, V98, pS71
   DIERICKX I, 1989, MANAGE SCI, V35, P1504
   COHEN WM, 1989, ECON J, V99, P569
   SHILLER RJ, 1989, J FINANC, V44, P719
   COHEN WM, 1989, HDB IND ORG
   DOSI G, 1988, J ECON LIT, V26, P1120
   COCKBURN I, 1988, AM ECON REV, V78, P419
   CUBBIN J, 1987, J IND ECON, V35, P427
   ITAMI H, 1987, MOBILIZING INVISIBLE
   LEVIN R, 1987, BROOKINGS PAPERS EC, V1987, P783
   JAFFE AB, 1986, AM ECON REV, V76, P984
   TEECE DJ, 1986, RES POLICY, V15, P285
   MANSFIELD E, 1986, MANAGE SCI, V32, P173
   SCHMALENSEE R, 1985, AM ECON REV, V75, P341
   HORSTMANN I, 1985, J POLIT ECON, V93, P837
   MANSFIELD E, 1985, J IND ECON, V34, P217
   LONG M, 1985, CORPORATE CAPITAL ST, P325
   BRADLEY M, 1984, J FINANC, V39, P857
   RUMELT RP, 1984, COMPETITIVE STRATEGI
   LIPPMAN SA, 1982, BELL J ECON, V13, P418
   MAGEE RP, 1974, J ACCOUNTING RES, V12, P270
   GONEDES NJ, 1973, J ACCOUNT RES, V11, P212
   PELES Y, 1970, J ACCOUNTING RES, V8, P128
   BEAVER W, 1970, ACCOUNT REV, V45, P654
   BALL R, 1967, J ACCOUNT RES, V5, P55
   WILLIAMS T, 1967, J ACCOUNT RES, V5, P81
   CYERT R, 1967, J ACCOUNTING RES S, V5, P78
   ARROW KJ, 1962, RATE DIRECTION INVEN
   *FASB, STAT FIN ACC CONC 6
NR 76
TC 0
Z9 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-6653
J9 REV ACCOUNT STUD
JI Rev. Account. Stud.
PD SEP
PY 2011
VL 16
IS 3
BP 539
EP 573
DI 10.1007/s11142-011-9151-x
PG 35
WC Business, Finance
SC Business & Economics
GA 808YW
UT WOS:000294018900008
ER
PT J
AU Lee, HJ
   Lee, S
   Yoon, B
AF Lee, Hyoung-joo
   Lee, Sungjoo
   Yoon, Byungun
TI Technology clustering based on evolutionary patterns: The case of
   information and communications technologies
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE Technology clustering; Patent analysis; Trend analysis; Evolutionary
   patterns; Information and communications technology
ID PATENT ANALYSIS; BUSINESS VALUE; IMPACT; PERFORMANCE; INNOVATION;
   ALGORITHM; FIRM; VISUALIZATION; CITATIONS; PORTFOLIO
AB Technology trend analysis anticipates the direction and rate of
   technology changes, and thus supports strategic decision-making for
   innovation. As technological convergence and diversification are
   regarded as emerging trends, it is important to compare the growth
   patterns of various technologies in a particular industry to help
   understand the industry characteristics and analyse the technology
   innovation process. However, despite the potential value of this
   approach, conventional approaches have focused on individual
   technologies and paid little attention to synthesising and comparing
   multiple technologies. We therefore propose a new approach for
   clustering technologies based on their growth patterns. After
   technologies with similar patterns are identified, the underlying
   factors that lead to the patterns can be analysed. For that purpose, we
   analysed patent data using a Hidden Markov model, followed by clustering
   analysis, and tested the validity of the proposed approach by applying
   it to the ICT industry. Our approach provides insights into the basic
   nature of technologies in an industry, and facilitates the analysis and
   forecasting of their evolution. (C) 2011 Elsevier Inc. All rights
   reserved.
C1 [Lee, Hyoung-joo] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England.
   [Lee, Sungjoo] Ajou Univ, Dept Ind & Informat Syst Engn, Suwon, Gyeonggi Do, South Korea.
   [Yoon, Byungun] Dongguk Univ Seoul, Dept Ind & Syst Engn, Seoul 100715, South Korea.
RP Lee, S (reprint author), Ajou Univ, San 5, Suwon, Kyunggi Do, South Korea
EM imhjlee@gmail.com
   sungjoo@ajou.ac.kr
   postman3@dongguk.edu
CR Yu G, 2010, SCIENTOMETRICS, V84, P81, DOI 10.1007/s11192-009-0090-2
   Aunger R, 2010, TECHNOL FORECAST SOC, V77, P762, DOI 10.1016/j.techfore.2010.01.008
   No HJ, 2010, TECHNOL FORECAST SOC, V77, P63, DOI 10.1016/j.techfore.2009.06.006
   Chen TY, 2009, ENERG POLICY, V37, P2900, DOI 10.1016/j.enpol.2009.03.028
   Hacklin F, 2009, TECHNOL FORECAST SOC, V76, P723, DOI 10.1016/j.techfore.2009.03.003
   Lee S, 2009, TELECOMMUN POLICY, V33, P253, DOI 10.1016/j.telpol.2009.02.004
   Gholami RR, 2009, IEEE T ENG MANAGE, V56, P329, DOI 10.1109/TEM.2009.2016044
   Roth S, 2009, ANN NUCL ENERGY, V36, P409, DOI 10.1016/j.anucene.2008.11.029
   Sood A, 2009, MARKET SCI, V28, P36, DOI 10.1287/mksc.1080.0382
   Maqueira-Marin JM, 2009, TECHNOL ANAL STRATEG, V21, P491, DOI 10.1080/09537320902818991
   Kim YG, 2008, EXPERT SYST APPL, V34, P1804, DOI 10.1016/j.eswa.2007.01.033
   Choi C, 2007, TECHNOL FORECAST SOC, V74, P1296, DOI 10.1016/j.techfore.2006.10.008
   Guan JC, 2007, SCIENTOMETRICS, V72, P403, DOI 10.1007/s11192-007-1741-1
   Yoon B, 2007, IEEE T ENG MANAGE, V54, P588, DOI 10.1109/TEM.2007.900796
   Shin J, 2007, INF ECON POLICY, V19, P249, DOI 10.1016/j.infoecopol.2007.01.003
   Rafols I, 2007, SCIENTOMETRICS, V70, P633, DOI 10.1007/s11192-007-0305-3
   Park J, 2007, INFORM SYST RES, V18, P86, DOI 10.1287/isre.1070.0116
   Shin J, 2006, SCIENTOMETRICS, V69, P551
   Daim TU, 2006, TECHNOL FORECAST SOC, V73, P981, DOI 10.1016/j.techfore.2006.04.004
   Lin BW, 2006, IEEE T ENG MANAGE, V53, P17, DOI 10.1109/TEM.2005.861813
   TAN PN, 2006, INTRO DATA MINING
   Chen DZ, 2005, SCIENTOMETRICS, V64, P31
   *OECD, 2005, OECD HDB EC GLOB IND
   Jorgenson DW, 2005, SCAND J ECON, V107, P631, DOI 10.1111/j.1467-9442.2005.00430.x
   TSENG YH, 2005, IACIS PAC 2005 C P, P755
   *OECD, 2005, OECD INF TECHN OUTL
   GANGULI P, 2004, WORLD PATENT INF, V26, P61, DOI 10.1016/j.wpi.2003.10.015
   YOON B, 2004, HIGH TECH MANAGE R, V15, P37
   Dedrick J, 2003, ACM COMPUT SURV, V35, P1, DOI 10.1145/641865.641866
   ERNST H, 2003, WORLD PATENT INFORM, V25, P233, DOI 10.1016/S0172-2190(03)00077-2
   Lacasa ID, 2003, SCIENTOMETRICS, V57, P175, DOI 10.1023/A:1024133517484
   Zhu DH, 2002, TECHNOL FORECAST SOC, V69, P495
   Teng JTC, 2002, IEEE T ENG MANAGE, V49, P13, DOI 10.1109/17.985744
   LAMIREL JC, 2002, P ACL 2003 WORKSH PA
   Lee CS, 2001, INFORM MANAGE, V39, P191
   Fleming L, 2001, RES POLICY, V30, P1019
   Rosenkopf L, 2001, STRATEGIC MANAGE J, V22, P287
   Meyer M, 2000, SCIENTOMETRICS, V48, P151
   MACLACHLAN G, 2000, FINITE MIXTURE MODEL
   Jain AK, 1999, ACM COMPUT SURV, V31, P264
   JORDAN MI, 1999, LEARNING GRAPHICAL M
   Tam KY, 1998, INFORM SYST RES, V9, P85
   Jeong GH, 1997, TECHNOL FORECAST SOC, V55, P203
   LEE H, 1997, TELECOMMUN POLICY, V21, P30
   Archibugi D, 1996, TECHNOVATION, V16, P451
   BARUA A, 1995, INFORM SYST RES, V6, P3
   KIVIJARVI H, 1995, INFORM MANAGE, V28, P143
   BARKER D, 1995, LONG RANGE PLANN, V28, P495
   HARIANTO F, 1994, RES POLICY, V23, P293
   *OECD, 1993, TECHN FUS PATH INN C, P7
   KODAMA F, 1992, HARVARD BUS REV, V70, P70
   TRAJTENBERG M, 1990, RAND J ECON, V21, P172
   RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626
   JAJUGA K, 1987, COMPUT STAT DATA AN, V5, P357
   BASBERG BL, 1987, RES POLICY, V16, P141
   BASBERG BL, 1984, WORLD PATENT INFORM, V6, P158
   SCHWARZ G, 1978, ANN STAT, V6, P461
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   BAUM LE, 1972, INEQUALITIES, V3, P1
   VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260
NR 60
TC 0
Z9 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD JUL
PY 2011
VL 78
IS 6
BP 953
EP 967
DI 10.1016/j.techfore.2011.02.002
PG 15
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 785OC
UT WOS:000292237300006
ER
PT J
AU Chen, YH
   Chen, CY
   Lee, SC
AF Chen, Yu-Heng
   Chen, Chia-Yon
   Lee, Shun-Chung
TI Technology forecasting and patent strategy of hydrogen energy and fuel
   cell technologies
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article
DE S-Curves; Hydrogen energy; Logistic growth curve; Patent strategy; Fuel
   cell
ID DIFFUSION; MODEL; GASIFICATION; SUBSTITUTION; DATABASES; INDUSTRY;
   EXAMPLE; GROWTH
AB This study presents the technological S-curves that integrates the
   Bibliometric and patent analysis into the Logistic growth curve model
   for hydrogen energy and fuel cell technologies and identifies the
   optimal patent strategy for the fuel cell industry, including PEMFC,
   SOFC, and DMFC/DAFC. Empirical analysis is via an expert survey and
   Co-word analysis using the United States Patent and Trademark Office
   database to obtain useful data. Analytical results demonstrate that the
   S-curves is a highly effective means of quantifying how technology
   forecasting of cumulative publication patent number. Analytical results
   also indicate that technologies for generating and storing hydrogen have
   not yet reached technological maturity; thus, additional R&D funding is
   needed to accelerate the development of hydrogen technology. Conversely,
   fuel cell technologies have reached technological maturity, and related
   patent strategies include freedom to operate, licensing, and niche
   inventions. The proposed model can be applied to all high-technology
   cases, and particularly to new clean technologies. The study concludes
   by outlining the limitations of the proposed model and directions for
   further research. Copyright (C) 2011, Hydrogen Energy Publications, LLC.
   Published by Elsevier Ltd. All rights reserved.
C1 [Chen, Yu-Heng; Chen, Chia-Yon; Lee, Shun-Chung] Natl Cheng Kung Univ, Dept Resources Engn, Tainan 701, Taiwan.
RP Lee, SC (reprint author), Natl Cheng Kung Univ, Dept Resources Engn, 1 Univ Rd, Tainan 701, Taiwan
EM luegg100@gmail.com
   mjchen@mail.ncku.edu.tw
   n4895102@mail.ncku.edu.tw
FU National Science Council of the Republic of China,
   Taiwan[NSC97-3114-E011-001, NSC98-3114-P-006-002]
FX The authors would like to thank the National Science Council of the
   Republic of China, Taiwan, for financially supporting this research
   under Contract No. NSC97-3114-E011-001 and No. NSC98-3114-P-006-002.
CR Yazici MS, 2011, INT J HYDROGEN ENERG, V36, P11239, DOI 10.1016/j.ijhydene.2010.11.120
   Panahandeh B, 2011, INT J HYDROGEN ENERG, V36, P4185, DOI 10.1016/j.ijhydene.2010.07.151
   Venetsanos AG, 2011, INT J HYDROGEN ENERG, V36, P2693, DOI 10.1016/j.ijhydene.2010.05.030
   Beck J, 2011, APPL ECON, V43, P1737, DOI 10.1080/00036840802600624
   Madsen AN, 2010, ENERG POLICY, V38, P5372, DOI 10.1016/j.enpol.2009.03.040
   Lee SC, 2010, ENERG ECON, V32, pS67, DOI 10.1016/j.eneco.2010.04.010
   Chen YH, 2010, AFR J BUS MANAGE, V4, P1372
   Dergiades T, 2010, APPL ECON LETT, V17, P1823, DOI 10.1080/13504850903373258
   *NREL, 2010, 2009 FUEL CELL MARK
   Chu WL, 2009, TELECOMMUN POLICY, V33, P506, DOI 10.1016/j.telpol.2009.07.003
   Mori D, 2009, INT J HYDROGEN ENERG, V34, P4569, DOI 10.1016/j.ijhydene.2008.07.115
   Schilling MA, 2009, ENERG POLICY, V37, P1767, DOI 10.1016/j.enpol.2009.01.004
   *RNCOS, 2009, FUEL CELL IND AN
   MICHAEL B, 2009, HYDROGEN EC OPPORTUN
   Gasafi E, 2008, BIOMASS BIOENERG, V32, P1085, DOI 10.1016/j.biombioe.2008.02.021
   Edwards PP, 2008, ENERG POLICY, V36, P4356, DOI 10.1016/j.enpol.2008.09.036
   Beccali M, 2008, RENEW ENERG, V33, P366, DOI 10.1016/j.renene.2007.03.013
   Kothari R, 2008, RENEW SUST ENERG REV, V12, P553, DOI 10.1016/j.rser.2006.07.012
   Cheng AC, 2008, ROM J ECON FORECAST, V9, P88
   Galvita V, 2007, INT J HYDROGEN ENERG, V32, P3899, DOI 10.1016/j.ijhydene.2007.05.039
   Lee M, 2007, APPL ECON LETT, V14, P477, DOI 10.1080/13504850500461431
   Satyapal S, 2007, CATAL TODAY, V120, P246, DOI 10.1016/j.cattod.2006.09.022
   Bengisu M, 2006, TECHNOL FORECAST SOC, V73, P835, DOI 10.1016/j.techfore.2005.09.001
   *IEA, 2006, HYDR PROD
   Frank LD, 2004, TECHNOL FORECAST SOC, V71, P391, DOI 10.1016/S0040-1625(02)00392-X
   Watts RJ, 2003, TECHNOL FORECAST SOC, V70, P735, DOI 10.1016/S0040-1625(02)00355-4
   Martino JP, 2003, TECHNOL FORECAST SOC, V70, P719, DOI 10.1016/S0040-1625(02)00375-X
   Morris S, 2002, COMPUT IND ENG, V43, P841
   DUTTON AG, 2002, TWP17 TYNDALL WORKIN
   NORTON MJ, 2001, INTRODUCTORY CONCEPT
   Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P247
   Rogner HH, 1998, INT J HYDROGEN ENERG, V23, P833
   Meade N, 1998, MANAGE SCI, V44, P1115
   Watts RJ, 1997, TECHNOL FORECAST SOC, V56, P25
   Ernst H, 1997, SMALL BUS ECON, V9, P361
   BHARGAVA SC, 1995, TECHNOL FORECAST SOC, V49, P27
   NARIN F, 1994, EVALUATION REV, V18, P65
   BERKOWITZ L, 1993, RES TECHNOL MANAGE, V36, P26
   EFRON BTR, 1993, INTRO BOOTSTRAP
   PORTER AL, 1991, FORECASTING MANAGE T
   EFRON B, 1979, ANN STAT, V7, P1
   GARFIELD E, 1978, METRIC SCI ADVENT SC
   ZWANZIG R, 1973, P NATL ACAD SCI USA, V70, P3048
   LOTKA AJ, 1925, ELEMENTS PHYS BIOL
   VELHURST PF, 1838, CORRESP MATH PHYS, V10, P113
NR 45
TC 0
Z9 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD JUN
PY 2011
VL 36
IS 12
BP 6957
EP 6969
DI 10.1016/j.ijhydene.2011.03.063
PG 13
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA 777NN
UT WOS:000291628500001
ER
PT J
AU Ferrand, Y
   Kelton, CML
   Guo, JJ
   Levy, MS
   Yu, Y
AF Ferrand, Yann
   Kelton, Christina M. L.
   Guo, Jeff J.
   Levy, Martin S.
   Yu, Yan
TI Using time-series intervention analysis to understand US Medicaid
   expenditures on antidepressant agents
SO RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY
LA English
DT Article
DE Time-series intervention analysis; Medicaid expenditures; Antidepressant
   drugs; Forecasting; Generic entry; Direct-to-consumer advertising
ID SUBSTANCE USE DISORDERS; PRIMARY-CARE; DEPRESSION; METAANALYSIS;
   MEDICATIONS; EFFICACY; TRENDS
AB Background: Medicaid programs' spending on antidepressants increased
   from $159 million in 1991 to $2 billion in 2005. The National Institute
   for Health Care Management attributed this expenditure growth to
   increases in drug utilization, entry of newer higher-priced
   antidepressants, and greater prescription drug insurance coverage.
   Rising enrollment in Medicaid has also contributed to this expenditure
   growth.
   Objectives: This research examines the impact of specific events,
   including branded-drug and generic entry, a black box warning,
   direct-to-consumer advertising (DTCA), and new indication approval, on
   Medicaid spending on antidepressants.
   Methods: Using quarterly expenditure data for 1991-2005 from the
   national Medicaid pharmacy claims database maintained by the Centers for
   Medicare and Medicaid Services, a time-series autoregressive integrated
   moving average (ARIMA) intervention analysis was performed on 6 specific
   antidepressant drugs and on overall antidepressant spending. Twenty-nine
   potentially relevant interventions and their dates of occurrence were
   identified from the literature. Each was tested for an impact on the
   time series. Forecasts from the models were compared with a holdout
   sample of actual expenditure data.
   Results: Interventions with significant impacts on Medicaid expenditures
   included the patent expiration of Prozac (R) (P < 0.01) and the entry of
   generic paroxetine producers (P = 0.04), which reduced expenditures on
   Prozac (R) and Paxil (R), respectively, and the 1997 increase in DTCA (P
   = 0.05), which increased spending on Wellbutrin (R). Except for Paxil
   (R), the A RIMA models had low prediction errors.
   Conclusions: Generic entry at the aggregate level did not lead to a
   reduction in overall expenditures (P > 0.05), implying that the
   expanding market for antidepressants overwhelmed the effect of generic
   competition. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Ferrand, Yann; Kelton, Christina M. L.; Levy, Martin S.; Yu, Yan] Univ Cincinnati, Coll Business, Cincinnati, OH 45221 USA.
   [Guo, Jeff J.] Univ Cincinnati, Coll Pharm, Cincinnati, OH 45221 USA.
RP Kelton, CML (reprint author), Univ Cincinnati, Coll Business, Cincinnati, OH 45221 USA
EM chris.kelton@uc.edu
CR NAGAR S, 2009, RES SOC ADM PHARM
   Chen Y, 2008, RES SOC ADMIN PHARM, V4, P244, DOI 10.1016/j.sapharm.2007.06.019
   Kelton CML, 2008, J MENT HEALTH POLICY, V11, P33
   *IMS HLTH, 2008, US SAL PRESCR INF
   Gibbons RD, 2007, AM J PSYCHIAT, V164, P1356, DOI 10.1176/j.appi.apj.2007.07030454
   JING Y, 2007, AIDS RES THER, V4
   JING Y, 2007, DRUG BENEFIT TRENDS, V19, P27
   2007, CLIN PHARM DATABASE
   Chen H, 2006, J CLIN PSYCHIAT, V67, P972
   JING Y, 2006, DRUG BENEFIT TRENDS, V18, P580
   Barry CL, 2005, PSYCHIAT SERV, V56, P1193
   Torrens M, 2005, DRUG ALCOHOL DEPEN, V78, P1, DOI 10.1016/j.drugalcep.2004.09.004
   WEI WWS, 2005, TIME SERIES ANAL UNI
   SAMUELSON WF, 2005, MANAGERIAL EC
   *ADV AG, 2005, MEG 2005 200 MEG RAN
   *NAT PHARM COUNC I, 2005, PHARM BEN STAT MED A
   Donohue JM, 2004, MED CARE, V42, P1176
   Donohue JM, 2004, J PUBLIC POLICY MARK, V23, P115
   GUO JJ, 2004, INT J PHARM MED, V18, P271
   Henriksson S, 2003, ACTA PSYCHIAT SCAND, V108, P427
   Adelmann PK, 2003, ADM POLICY MENT HLTH, V31, P111
   BROCKLEBANK J, 2003, SAS FORECASTING TIME
   *KAIS COMM MED UN, 2003, MED OUTP PRESCR DRUG
   *FTC, 2002, GEN DRUG ENTR PRIOR
   Katon W, 2001, ANN INTERN MED, V134, P917
   Anderson IM, 2000, J AFFECT DISORDERS, V58, P19
   Kendrick T, 1999, ANN MED, V31, P359
   GOETZL D, 1999, ADVERTISING AGE
   *US FDA, 1999, CONS DIR BROADC ADV
   Pincus HA, 1998, JAMA-J AM MED ASSOC, V279, P526
   Frank RG, 1997, J ECON MANAGE STRAT, V6, P75
   HENRY JA, 1995, BRIT MED J, V310, P221
   POLE A, 1994, APPL BAYESIAN FORECA
   HUSZONEK J, 1993, ANN CLIN PSYCHIAT, V5, P7
   PANKRATZ A, 1991, FORECASTING DYNAMIC
   BOX GEP, 1976, TIME SERIES ANAL FOR
   BOX GEP, 1975, J AM STAT ASSOC, V70, P70
   *BUR LAB STAT, CONS PRIC IND ALL UR
   *CTR MED MED SERV, STAT DRUG UT DAT
NR 39
TC 0
Z9 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1551-7411
J9 RES SOC ADMIN PHARM
JI Res. Soc. Adm. Pharm.
PD MAR
PY 2011
VL 7
IS 1
BP 64
EP 80
DI 10.1016/j.sapharm.2009.12.002
PG 17
WC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
SC Public, Environmental & Occupational Health; Pharmacology & Pharmacy
GA 740GC
UT WOS:000288778600007
ER
PT J
AU Yoon, J
   Kim, K
AF Yoon, Janghyeok
   Kim, Kwangsoo
TI TrendPerceptor: A property-function based technology intelligence system
   for identifying technology trends from patents
SO EXPERT SYSTEMS WITH APPLICATIONS
LA English
DT Article
DE Technology intelligence; Property; Function; Patent mining; Patent
   analysis; Social network analysis; TRIZ trend; Natural language
   processing
AB Technology intelligence systems are vital components for planning of
   technology development and formulation of technology strategies.
   Although such systems provide computation supports for technology
   analysis, much effort and intervention of experts, who may be expensive
   or unavailable, is required in gathering processes of information for
   analysis. As a remedy, this paper proposes TrendPerceptor, a system that
   uses a property-function based approach. The proposed system assists
   experts (1) to identify trends in invention concepts from patents, and
   (2) to perform evolution trend analysis of patents for technology
   forecasting. For this purpose, a module of the system uses grammatical
   analysis of textual information to automatically extract properties and
   functions, which show innovation directions in a given technology. Using
   the identified properties and functions, a module for invention concept
   analysis based on network analysis and a module for evolution trend
   analysis based on TRIZ (Russian acronym of the Theory of Inventive
   Problem Solving) trends are suggested. This paper describes the
   architecture of a system composed of these three modules, and
   illustrates two case studies using the system. (C) 2011 Elsevier Ltd.
   All rights reserved.
C1 [Yoon, Janghyeok; Kim, Kwangsoo] Pohang Univ Sci & Technol, Dept Ind & Management Engn, Pohang 790784, Kyungbuk, South Korea.
RP Kim, K (reprint author), Pohang Univ Sci & Technol, Dept Ind & Management Engn, San 31, Pohang 790784, Kyungbuk, South Korea
EM janghyoon@postech.ac.kr
   kskim@postech.ac.kr
FU National Research Foundation of Korea (NRF); Korea Government
   (MEST)[2009-0088379]
FX This work was supported by the National Research Foundation of Korea
   (NRF) Grant funded by the Korea Government (MEST) (No. 2009-0088379).
CR Yoon J, 2011, EXPERT SYST APPL, V38, P15540, DOI 10.1016/j.eswa.2011.06.005
   Yoon J, 2011, SCIENTOMETRICS, V86, P687, DOI 10.1007/s11192-010-0303-8
   Chang PL, 2010, SCIENTOMETRICS, V82, P5, DOI 10.1007/s11192-009-0033-y
   2010, ENGLISH STOPWORDS
   *JUNG, 2010, JAV UN NETW GRAPH FR
   VERHAEGEN PA, 2009, CIRP J MANUFACTURING, V1, P126, DOI DOI 10.1016/J.CIRPJ.2008.09.010
   Lee B, 2008, SCIENTOMETRICS, V77, P3, DOI 10.1007/s11192-007-1819-4
   Yoon B, 2008, EXPERT SYST APPL, V35, P124, DOI 10.1016/j.eswa.2007.06.022
   *OECD, 2008, OECD FACTB 2008 EC E
   DEMARNEFFE M, 2008, STANFORD TYPED DEPEN
   TONG LH, 2006, WORLD PATENT INFORM, V28, P6
   KERR CIV, 2006, INT J TECHNOLOGY INT, V2, P73, DOI 10.1504/IJTIP.2006.010511
   DEWULF S, 2006, ETRIA TRIZ FUTURES
   HANNEMAN R, 2005, INTRO SOCIAL NETWORK
   DIESTEL R, 2005, GRAPH THEORY GRADUAT
   DEWULF S, 2005, TRIZ J 1
   SIMPSON T, 2005, WORDNET BASED SEMANT
   Lichtenthaler E, 2004, J ENG TECHNOL MANAGE, V21, P331, DOI 10.1016/j.jengtecman.2004.09.003
   SCHUH G, 2004, TRIZ BASED TECHNOLOG
   Mann DL, 2003, TECHNOL FORECAST SOC, V70, P779, DOI 10.1016/S0040-1625(02)00357-8
   TRIPPE AJ, 2003, WORLD PATENT INFORM, V25, P211, DOI 10.1016/S0172-2190(03)00079-6
   CHEN L, 2003, PATENT DOCUMENT RETR
   Morris S, 2002, COMPUT IND ENG, V43, P841
   Hirtz J, 2002, RES ENG DES, V13, P65, DOI 10.1007/S00163-001-0008k-3
   PETROV V, 2002, TRIZ J, V3, P9
   MANN D, 2002, HANDS ON SYSTEMATIC
   MANN D, 2002, TRIZ J
   RESNIK P, 1999, J ARTIFICIAL INTELLI, V11, P130
   MILLER G, 1995, COMMUN ACM, V38, P41
   ALTSCHULLER G, 1984, CREATIVITY EXACT SCI
   FREEMAN LC, 1979, SOC NETWORKS, V1, P215
NR 31
TC 0
Z9 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0957-4174
J9 EXPERT SYST APPL
JI Expert Syst. Appl.
PD FEB 15
PY 2011
VL 39
IS 3
BP 2927
EP 2938
DI 10.1016/j.eswa.2011.08.154
PG 12
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic; Operations Research & Management Science
SC Computer Science; Engineering; Operations Research & Management Science
GA 858SP
UT WOS:000297823300074
ER
PT J
AU Liddell, K
   Newton, T
   Adams, M
   Muller, B
AF Liddell, K.
   Newton, T.
   Adams, M.
   Muller, B.
TI Energy consumption for Kell hydrometallurgical refining versus
   conventional pyrometallurgical smelting and refining of PGM concentrates
SO JOURNAL OF THE SOUTH AFRICAN INSTITUTE OF MINING AND METALLURGY
LA English
DT Article
DE PGM; UG2; Merensky; smelting; chromite; electricity; hydrometallurgy;
   Kell Process; Eskom
AB Current practice for the recovery of platinum group metals (PGM) from,
   flotation concentrates is by energy-intensive smelting processes
   followed by separation and refining of the base and precious metals.
   Energy costs are rapidly increasing in South Africa and this trend is
   forecast to continue in future years. Moreover, the smelting operations
   are highly susceptible to deleterious constituents, particularly
   chromite; and the increasing tonnages of UG2 chromititic ore being mined
   results in an increasing chromite content of smelter feeds. Hence there
   is a substantial incentive to assess and implement alternative processes
   to smelting for the treatment of PGM concentrates.
   The Kell process is a patented hydrometallurgical alternative to
   smelting that: is totally insensitive to the chromite content of the
   feed concentrate and comprises three commercially proven unit operations
   (pressure oxidation leaching of base metals and sulfur, roasting and
   chlorination of precious metals). The Kell process provides the
   opportunity for existing and new PGM producers to significantly reduce
   their energy consumption, and hi. particular their consumption of
   electricity, by removing the need to smelt PGM concentrates. Energy
   costs, greenhouse gas emissions and installed power requirements are
   also much reduced. Compared with sinelting and refining these reductions
   are calculated as:
   Total energy consumption-50% reduction
   Electrical energy consumption-84% reduction
   Energy consumption costs-76% reduction
   CO(2) emissions-70% reduction
   Installed power requirement-92% reduction.
   The data obtained from simple laboratory batch amenability testing can
   be readily applied to the Simulus mass and energy balance simulation
   procedure to determine energy and reagent consumptions, equipment
   selection and process optimization.
   The applicability of Kell to treating low-grade 'dirty' concentrates
   with high UG2 content as well as to polymetallic concentrates containing
   base metals as the major payable metals with subordinate Pal means that
   these savings can also be,expected when the process is used for treating
   a range of concentrate types and grades.
C1 [Liddell, K.] Lifezone Ltd, Fruit Hts, UT USA.
   [Adams, M.] Mutis Liber Pty Ltd, Guildford, Surrey, England.
RP Liddell, K (reprint author), Lifezone Ltd, Fruit Hts, UT USA
CR LIDDELL KS, 2010, J S AFR I MIN UNPUB
   ADAMS MD, 2010, MINERALS ENG    0706
   Rule CM, 2009, J S AFR I MIN METALL, V109, P39
   Van Manen PK, 2009, J S AFR I MIN METALL, V109, P47
   *LONM PLC, 2009, PROC DIV PRES
   CRAMER LA, 2008, 3 INT PLAT C PLAT TR, P387
   JONES RT, 2005, 44 ANN C MET CALG AL, P147
   LIDDELL KS, 1999
   LIDDELL KS, 1999
   LIDDELL KS, 1998
   *NAT EN REG S AFR, MED STAT 24 FEG 2010
   *ANGL PLAT LIM, POL MET COMPL 2010
   *ANGL PLAT LIM, SUST DEV REP 2009
   *ESKOM HOLD LIM, 2010 INT REP
NR 14
TC 0
Z9 0
PU SOUTH AFRICAN INST MINING METALLURGY
PI MARSHALLTOWN         L
PA 5 HOLLARD ST, 5TH FLOOR, CHAMBER OF MINES BUILDING, PO BOX 61127,
   MARSHALLTOWN         L 2107, SOUTH AFRICA
SN 0038-223X
J9 J S AFR I MIN METALL
JI J. S. Afr. Inst. Min. Metall.
PD FEB
PY 2011
VL 111
IS 2
BP 127
EP 132
PG 6
WC Metallurgy & Metallurgical Engineering; Mining & Mineral Processing
SC Metallurgy & Metallurgical Engineering; Mining & Mineral Processing
GA 752OI
UT WOS:000289701500010
ER
PT J
AU Curran, CS
   Leker, J
AF Curran, Clive-Steven
   Leker, Jens
TI Patent indicators for monitoring convergence - examples from NFF and ICT
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE Converging industries; Patent analysis; IPC co-classification;
   Technology forecasting; Nutraceuticals and Functional Foods; Information
   technologies; Consumer electronics; Telecommunications
ID TECHNOLOGICAL CONVERGENCE; INNOVATION STRATEGIES; INDUSTRY; SCIENCE;
   FUSION; PRODUCTIVITY; PERFORMANCE; KNOWLEDGE
AB The blurring of boundaries between hitherto distinct scientific
   disciplines, technologies or markets is a common and powerful
   phenomenon. Concentrating on monitoring convergence through patent
   indicators, we discuss convergence with examples from the area of
   Nutraceuticals and Functional Foods (NFF)/Cosmeceuticals as well as
   information technologies, consumer electronics, and telecommunications
   (ICT). We analyze 7455 scientific and patent references on phytosterols
   with the aid of SciFinder Scholar and 3836 documents employing STN
   AnaVist. Furthermore, we test an IPC co-classification based approach on
   859,469 ICT-related and 341,846 NFF-related patents. Our results show
   clear indications for convergence and a proof of principle for our
   monitoring concept. Academics may better evaluate environmental
   parameters, like cases of convergence, influencing companies' actions.
   Implications for practitioners are based on a more reliable assessment
   prior to the forming of strategic alliances or mergers and acquisitions.
   This could help avoid costly adventures such as the mergers and
   acquisitions seen in ICT. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Curran, Clive-Steven; Leker, Jens] Univ Munster, Dept Chem & Pharm, Inst Business Adm, D-48149 Munster, Germany.
RP Curran, CS (reprint author), Univ Munster, Dept Chem & Pharm, Inst Business Adm, Leonardo Campus 1, D-48149 Munster, Germany
EM curran@uni-muenster.de
CR Curran CS, 2010, TECHNOL FORECAST SOC, V77, P385, DOI 10.1016/j.techfore.2009.10.002
   Broring S, 2010, INT J TECHNOL MANAGE, V49, P272
   Porter AL, 2009, SCIENTOMETRICS, V81, P719, DOI 10.1007/s11192-008-2197-2
   Hacklin F, 2009, TECHNOL FORECAST SOC, V76, P723, DOI 10.1016/j.techfore.2009.03.003
   SUGIMOTO C, 2009, P AM SOC INFORM SCI, V46, P1
   CURRAN CS, 2009, INT J INNOVATION MAN, V13, P637, DOI 10.1142/S1363919609002455
   *WIPO, 2009, INT PAT CLASS
   CURRAN CS, 2009, P PICMET 09 TECHN MA
   *INT CORP, 2009, WORLDS 1 2 BILL TRAN
   CURRAN CS, 2009, 2009 AC MAN ANN M CH
   Schnaars S, 2008, J MACROMARKETING, V28, P157, DOI 10.1177/0276146708314588
   Donnelly WJ, 2008, INT J DAIRY TECHNOL, V61, P11, DOI 10.1111/j.1471-0307.2008.00369.x
   YANG YY, 2008, WORLD PATENT INFORM, V30, P280
   HACKLIN F, 2008, CONTR MANAGE SCI, pR7
   *NAT CANC I, 2008, PHYT
   CURRAN CS, 2008, R D MAN C 2008 OTT C
   NYSTROM AG, 2008, UNDERSTANDING CHANGE
   CURRAN CS, 2008, 19 ISPIM C TOURS FRA
   Makri M, 2007, R&D MANAGE, V37, P303
   Porter AL, 2007, SCIENTOMETRICS, V72, P117, DOI 10.1007/s11192-007-1700-5
   BRORING S, 2007, CREATIVITY INNOVATIO, V16, P165
   Kim J, 2007, INT J TECHNOL MANAGE, V38, P220
   CROMPTON S, 2007, TIMES ONLINE
   WEAVER B, 2007, 19 NFF C BERG NORW
   Broring S, 2006, R&D MANAGE, V36, P487, DOI 10.1111/j.1467-9310.2006.00449.x
   Moruisi KG, 2006, J AM COLL NUTR, V25, P41
   FISCHER G, 2006, WORLD PATENT INFORM, V28, P312, DOI 10.1016/j.wpi.2006.04.007
   Bainbridge WS, 2006, ANN NY ACAD SCI, V1093, P24, DOI 10.1196/annals.1382.003
   2006, OXFORD DICT ENGLISH
   GASSMANN O, 2006, PATENTMANAGEMENT INN
   DUREJA H, 2005, INDIAN J PHARM, V37, P155
   HACKLIN F, 2005, INT J INNOVATION TEC, V2, P313
   BALLY N, 2005, DERIVING MANAGERIAL
   LIND J, 2005, DRUID AC WINT 2005 P
   BRORING S, 2005, FRONT END INNOVATION, P342
   MCNAMARA L, 2004, INT J MED MARKETING, V4, P18
   GASSMANN O, 2004, LEADING PHARM INNOVA, P178
   STIEGLITZ N, 2004, STRATEGIE WETTBEWERB
   LIND J, 2004, 15 BIENN ITS C BERL
   ICHIJI Y, 2004
   GORDON R, 2003, DIGITAL JOURNALISM E, P57
   Bores C, 2003, TECHNOVATION, V23, P1
   Murray F, 2002, RES POLICY, V31, P1389
   Ostlund RE, 2002, ANNU REV NUTR, V22, P533, DOI 10.1146/annurev.nutr.22.020702.075220
   Zucker LG, 2002, MANAGE SCI, V48, P138
   2002, OFFICIAL J L, V249, P21
   EISFELD W, 2002
   CHOI D, 2001, EUROPEAN MANAGEMENT, V19, P424
   PENNINGS J, 2001, ECIS C FUT INN STUD
   FAI F, 2001, STRUCTURAL CHANGE EC, V12, P141
   BIERLY P, 2001, INT J MANUFACTURING, V3, P31
   MEYER H, 2001
   Athreye S, 2000, TECHNOVATION, V20, P227
   Fujimoto M, 2000, TECHNOVATION, V20, P169
   Meyer M, 2000, RES POLICY, V29, P409
   FRANSMAN M, 2000, CONVERGENCE COMMUNIC
   KALUZA B, 1999, CURRENT STATE EC SCI, P2223
   BIERLY P, 1999, DYNAMICS INNOVATION, P7
   Gambardella A, 1998, RES POLICY, V27, P445
   DUYSTERS G, 1998, INT J EC BUSINESS, V5, P355
   WACHTER R, 1998
   *EUR COMM, 1997, GREEN PAP CONV TEL M
   KATZ ML, 1996, IND CORP CHANGE, V5, P1079
   ERNST H, 1996, BETRIEBSWIRTSCHAFTSL
   ERNST H, 1995, TECHNOVATION, V15, P225
   KODAMA F, 1992, HARVARD BUS REV, V70, P70
   *OECD, 1992, OECD DIG EC PAP, V5
   COLE M, 1991, INT REV          JUN, P15
   ADAMS JD, 1990, J POLIT ECON, V98, P673
   1990, OFFICIAL J L, V192
   OETTINGER AG, 1971, COMPUTERS COMMUNICAT
   SCHMOOKLER J, 1966, INVENTION EC GROWTH
   MOORE GE, 1965, ELECTRONICS, V38, P8
   ROSENBERG N, 1963, J ECON HIST, V23, P414
   *STN INT, INPADOCDB INTERNATIO
NR 75
TC 0
Z9 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD FEB
PY 2011
VL 78
IS 2
SI SI
BP 256
EP 273
DI 10.1016/j.techfore.2010.06.021
PG 18
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 722MZ
UT WOS:000287437700006
ER
PT J
AU Jarvenpaa, HM
   Makinen, SJ
   Seppanen, M
AF Jarvenpaa, Heini M.
   Makinen, Saku J.
   Seppanen, Marko
TI Patent and publishing activity sequence over a technology's life cycle
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE Emerging technology; Technology Life Cycle; Diffusion; Publication;
   Patents; Media; Sequence
ID SCIENCE-AND-TECHNOLOGY; EMERGING TECHNOLOGIES; INNOVATION;
   INFRASTRUCTURE; BIBLIOMETRICS; INDICATORS; STATISTICS
AB The use of multiple indicators in analyzing technological developments
   and exploiting the increasing availability of information has been
   recommended widely in order to decrease systematic biases between single
   measures. One of the few frameworks that take multiple sources into
   account is the Technology Life Cycle indicators that provide a measure
   for the totality of sources available for analysis and take their
   timeliness into account, although the linear model that the framework
   represents is often questioned. The aim of this paper is to provide
   bibliometric studies with insight into the timely relevance of using
   different databases. To assess the reporting sequence between different
   databases, this paper measures the reporting activity of three case
   technologies in different databases and analyzes the yearly reporting
   volumes of a number of items that mention the technology in the
   databases as suggested by the TLC indicators. The results of this paper
   suggest that, when science is the source of new ideas and the driver for
   technological development and innovations, communication can happen in
   the order suggested by the TLC indicators. However, this model does not
   seem to be a general model for detecting and forecasting a technological
   life cycle. In addition, the results of the paper point to the
   possibility of studying non-linear models of innovation and contexts
   where this type of dynamics might take place. (C) 2010 Elsevier Inc. All
   rights reserved.
C1 [Jarvenpaa, Heini M.] Tampere Univ Technol, Ctr Innovat & Technol Res, Dept Ind Management, FIN-33101 Tampere, Finland.
RP Jarvenpaa, HM (reprint author), Tampere Univ Technol, Ctr Innovat & Technol Res, Dept Ind Management, FIN-33101 Tampere, Finland
EM heini.jarvenpaa@tut.fil
CR Balconi M, 2010, RES POLICY, V39, P1, DOI 10.1016/j.respol.2009.09.013
   Kajikawa Y, 2009, TECHNOL FORECAST SOC, V76, P1115, DOI 10.1016/j.techfore.2009.04.004
   Shin J, 2009, TECHNOL FORECAST SOC, V76, P1078, DOI 10.1016/j.techfore.2009.04.001
   Nelson AJ, 2009, RES POLICY, V38, P994, DOI 10.1016/j.respol.2009.01.023
   Caraca J, 2009, TECHNOL FORECAST SOC, V76, P861, DOI 10.1016/j.techfore.2008.08.003
   Suurs RAA, 2009, ENERGY, V34, P669, DOI 10.1016/j.energy.2008.09.002
   TUOMINEN J, 2009, ENG COATINGS LASER C, P223
   PALMBERG C, 2009, NANOTECHNOLOGY OVERV
   *IDC, 2009, TACKL INF OV SOURC
   *NAT BIOD BOARD, 2009, 2009 BIOD DEF
   Kostoff RN, 2008, J INFORMETR, V2, P354, DOI 10.1016/j.joi.2008.06.004
   Dubourg L, 2008, SURF COAT TECH, V202, P5863, DOI 10.1016/j.surfcoat.2008.06.122
   Kajikawa Y, 2008, TECHNOL FORECAST SOC, V75, P771, DOI 10.1016/j.techfore.2007.05.005
   Kostoff RN, 2007, TECHNOL FORECAST SOC, V74, P1609, DOI 10.1016/j.techfore.2007.02.007
   Chuang KY, 2007, SCIENTOMETRICS, V72, P201, DOI 10.1007/s11192-007-1721-0
   Chao CC, 2007, TECHNOVATION, V27, P268, DOI 10.1016/j.technovation.2006.09.003
   Haupt R, 2007, RES POLICY, V36, P387, DOI 10.1016/j.respol.2006.12.004
   Deacon D, 2007, EUR J COMMUN, V22, P5, DOI 10.1177/0267323107073743
   Akasaki I, 2007, J CRYST GROWTH, V300, P2, DOI 10.1016/j.jcrysgro.2006.10.259
   WOLVAARDT E, 2007, JOURNALISM CAN HIDE
   Godin B, 2006, SCI TECHNOL HUM VAL, V31, P639, DOI 10.1177/0162243906291865
   Trumbach CC, 2006, TECHNOL FORECAST SOC, V73, P937, DOI 10.1016/j.techfore.2006.05.018
   Bengisu M, 2006, TECHNOL FORECAST SOC, V73, P835, DOI 10.1016/j.techfore.2005.09.001
   Moser P, 2005, AM ECON REV, V95, P1214
   Kostoff RN, 2005, TECHNOL FORECAST SOC, V72, P798, DOI 10.1016/j.techfore.2005.02.001
   VANRAAN AFJ, 2005, MEASUREMENT, V3, P1, DOI DOI 10.1207/S15366359MEA0301_1
   KLEINKNECHT A, 2002, EC INNOVATION NEW TE, V11, P109
   Mishra S, 2002, TECHNOL FORECAST SOC, V69, P1
   BERGMAN CL, 2002, ANNU REV INFORM SCI, V36, P2
   Watanabe C, 2001, TECHNOVATION, V21, P783
   Kostoff RN, 2001, TECHNOL FORECAST SOC, V68, P223
   NORTON MJ, 2000, INTRO CONCEPTS INFOR
   Abrahamson E, 1999, ADMIN SCI QUART, V44, P708
   PALMER PJ, 1999, ENG SCI EDUC J, V8, P233
   GRILICHES Z, 1998, R D PRODUCTIVITY EC
   Gupta BM, 1997, SCIENTOMETRICS, V40, P507
   Watts RJ, 1997, TECHNOL FORECAST SOC, V56, P25
   LUNDVALL BA, 1994, J IND STUDIES, V1, P23
   ROSENBERG N, 1994, EXPLORING BLACK BOX, P274
   MARTINO JP, 1993, TECHNOLOGICAL FORECA, P462
   GRILICHES Z, 1990, J ECON LIT, V28, P1661
   WHITE HD, 1989, ANNU REV INFORM SCI, V24, P119
   KLINE SJ, 1986, POSITIVE SUM STRATEG, P275
NR 43
TC 0
Z9 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD FEB
PY 2011
VL 78
IS 2
SI SI
BP 283
EP 293
DI 10.1016/j.techfore.2010.06.020
PG 11
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 722MZ
UT WOS:000287437700008
ER
PT J
AU Zagirnyak, M
   Shvedchikova, I
   Miljavec, D
AF Zagirnyak, Mykhaylo
   Shvedchikova, Irina
   Miljavec, Damijan
TI Forming a genetic record of cylindrical magnetic separator structures
SO PRZEGLAD ELEKTROTECHNICZNY
LA English
DT Article
DE chromosome set; generating structure; genetic model; structural genetic
   algorithm
AB A possibility of realization of structural genetic algorithm (SGA) for
   synthesis of separators magnetic systems structural varieties is
   demonstrated taking basic Species of cylindrical
   longitudinally-symmetric y-oriented ones as an example. The veracity of
   synthesis results is proved by means of comparison of the synthesis
   results with the data of patent information research. A forecasted
   component of the synthesis results is determined.
C1 [Zagirnyak, Mykhaylo] Kremenchuk Mykhaylo Ostrogradskiy Natl Univ, UA-39600 Kremenchuk, Ukraine.
   [Shvedchikova, Irina] E Ukrainian Volodymyr Dal Natl Univ, UA-91034 Lugansk, Ukraine.
   [Miljavec, Damijan] Univ Ljubljana, Ljubljana 1000, Slovenia.
RP Zagirnyak, M (reprint author), Kremenchuk Mykhaylo Ostrogradskiy Natl Univ, Ul Pershotravneva 20, UA-39600 Kremenchuk, Ukraine
EM mzagirn@kdu.edu.ua
   snu2008@mail.ru
   miljavec@fe.uni-lj.si
CR SHINKARENKO V, 2009, EL FIELDS MECH EL EL, P471
   ZAGIRNYAK MV, 2008, P 17 INT EL COMP SCI, P7
   SHINKARENKO V, 1996, P 2 INT SCI TECHN C, P367
   ZAGIRNYAK MV, 1985, IEEE T MAGN, V22, P63
NR 4
TC 0
Z9 0
PU WYDAWNICTWO SIGMA-N O T SP Z O O
PI WARSAW
PA UL RATUSZOWA 11, PO BOX 1004, 00-950 WARSAW, POLAND
SN 0033-2097
J9 PRZ ELEKTROTECHNICZN
JI Prz. Elektrotechniczny
PY 2011
VL 87
IS 3
BP 220
EP 223
PG 4
WC Engineering, Electrical & Electronic
SC Engineering
GA 729VD
UT WOS:000287978700057
ER
PT J
AU Trappey, CV
   Wu, HY
   Taghaboni-Dutta, F
   Trappey, AJC
AF Trappey, Charles V.
   Wu, Hsin-Ying
   Taghaboni-Dutta, Fataneh
   Trappey, Amy J. C.
TI Using patent data for technology forecasting: China RFID patent analysis
SO ADVANCED ENGINEERING INFORMATICS
LA English
DT Article
DE Radio Frequency Identification (RFID); Clustering; Patent analysis;
   China patents; Patent mapping
ID GROWTH; INNOVATION; CAPACITY; MODEL
AB China is one of the world's largest manufacturers and consumers of Radio
   Frequency Identification (RFID) applications. Current estimates show
   that China will need over 3 billion RFID tags to satisfy demand in the
   year 2009. The applications for RFID patents have spread across a very
   diverse range of inventions and in the future it is likely that most
   products manufactured in China will contain an RFID tag. China's RFID
   industry has grown along with the demand and researchers are making
   significant technological advances. In this research, patent data from
   the State Intellectual Property Office of the People's Republic of China
   (SIPO) have been used to explore RFID technology development and its
   trends. Patent abstracts containing the keyword and phrase "RFID" and
   "Radio Frequency Identification" were collected for analysis, content
   extraction, and clustering. In total, 1389 patents from the SIPO
   database covering the years 1995-2008 were retrieved and archived for
   analysis. Patents provide exclusive rights and legal protection for
   inventors, play an important role in the development and fair diffusion
   of technology, and contain detailed specifications necessary to define
   and protect the boundaries of an invention. Through patent analysis,
   companies monitor the development of technology and evaluate the
   position of potential competitors in the market. This research introduce
   a methodology which combines patent content clustering and technology
   life cycle forecasting to find a niche space of RFID technology
   development in China.
   A patent content clustering method is used to cluster different patent
   documents into homogenous groups, and then technology forecasting is
   applied to evaluate possible market opportunities for future inventors
   and investors. The results suggest that the cluster called RFID wireless
   communication devices has entered the saturation stage and thus provides
   limited opportunity for development. Four other clusters; RFID concepts
   and applications, RFID architecture, RFID tracking implementation, and
   RFID transmission apparatus, have entered the mature stage. The RFID
   frequency and waves cluster appears to be in early growth stage with
   good development potential. Since the technology related to basic RFID
   concepts and devices has reached a mature stage in China, the research
   and development seems to be targeting the improvement of the RFID
   frequencies and waves as a means to develop more reliable RFID systems
   and applications. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Taghaboni-Dutta, Fataneh] Univ Illinois, Dept Business Adm, Coll Business, Champaign, IL 61820 USA.
   [Trappey, Charles V.; Wu, Hsin-Ying] Natl Chiao Tung Univ, Dept Management Sci, Hsinchu, Taiwan.
   [Trappey, Amy J. C.] Natl Taipei Univ Technol, Dept Ind Engn & Management, Taipei, Taiwan.
   Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Hsinchu, Taiwan.
RP Taghaboni-Dutta, F (reprint author), Univ Illinois, Dept Business Adm, Coll Business, Champaign, IL 61820 USA
EM trappey@faculty.nctu.edu.tw
   cindywu.ms94g@nctu.edu.tw
   fataneh@illinois.edu
   trappey@ie.nthu.edu.tw
CR TAGHABONIDUTTA F, 2009, MANAGEMENT RES NEWS, V32, P1163
   MA J, 2009, NATL EC STEADY FAST
   *ABI RES, 2008, RFID ANN MARK OV VER
   *STAT INT PROP OFF, 2008, STAT INT PROP OFF PE
   Boretos GP, 2007, TECHNOL FORECAST SOC, V74, P331, DOI 10.1016/j.techfore.2005.11.005
   WU YJ, 2007, CONNECTIVE TECHNOLOG, P159
   WU NC, 2007, 2007 1 ANN
   Wu NC, 2006, TECHNOVATION, V26, P1317, DOI 10.1016/j.technovation.2005.08.012
   Bengisu M, 2006, TECHNOL FORECAST SOC, V73, P835, DOI 10.1016/j.techfore.2005.09.001
   Want R, 2006, IEEE PERVAS COMPUT, V5, P25, DOI 10.1109/MPRV.2006.2
   Hsu FC, 2006, INT J TECHNOL MANAGE, V36, P336
   WU YJ, 2006, INT J MANUFACTURING, V10, P106
   WARD M, 2006, JISC TECHNOLOGY STAN
   *BEA SYST INC, 2006, RFID RET BLUEPR BOTT
   HSU FC, 2006, THESIS NATL TSING HU
   Walton SRR, 2005, ANTITRUST LAW J, V72, P509
   TAGHABONIDUTTA F, 2005, INT J ELECT BUSINESS, V3, P165
   FORCINIO H, 2005, PHARM TECHNOLOGY, V29, P42
   CHEN B, 2005, COMP SYST BIOINF C A
   RADJOU N, 2005, FORRESTER RES, P1
   HUSSAIN O, 2005, INTELLECTUAL PROPERT, P1
   PITZEK S, 2005, ONTOLOGY RFID DOMAIN
   CLAMPITT H, 2005, RFID J NEWS
   Furman JL, 2002, RES POLICY, V31, P899
   BERKHIN P, 2002, SURVEY CLUSTERING DA
   JUNG S, 2002, WORLD PATENT INFORM, V24, P303
   Marinova D, 2001, TECHNOVATION, V21, P571
   Ernst H, 2001, RES POLICY, V30, P143
   Crosby M, 2000, ECON REC, V76, P255
   LIU S, 2000, SCI TECH POLICY REV, V8908, P1085
   Andersen B, 1999, J EVOL ECON, V9, P487
   Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P209
   Meade N, 1998, MANAGE SCI, V44, P1115
   Ernst H, 1997, SMALL BUS ECON, V9, P361
   Liu SJ, 1997, INT J TECHNOL MANAGE, V13, P661
   BERRY MJA, 1997, DATA MINING TECHNIQU, P55
   Stuart TE, 1996, STRATEGIC MANAGE J, V17, P21
   MORRISON J, 1996, J BUSINESS FORECAST, V15, P6
   MEADE N, 1995, INT J FORECASTING, V11, P199
   LEVARY RR, 1995, IND MANAGE, V37, P14
   LACKMAN CL, 1993, IND MANAGEMENT, V35, P20
   CAMPBELL RS, 1983, WORLD PATENT INFORM, V5, P137
   DAS R, PLAYERS OPPORTUNITIE
NR 43
TC 1
Z9 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1474-0346
J9 ADV ENG INFORM
JI Adv. Eng. Inform.
PD JAN
PY 2011
VL 25
IS 1
SI SI
BP 53
EP 64
DI 10.1016/j.aei.2010.05.007
PG 12
WC Computer Science, Artificial Intelligence; Engineering,
   Multidisciplinary
SC Computer Science; Engineering
GA 716YL
UT WOS:000287009300008
ER
PT J
AU Janin, YL
AF Janin, Yves L.
TI Synthetic Accesses to 3/5-pyrazole Carboxylic Acids
SO MINI-REVIEWS IN ORGANIC CHEMISTRY
LA English
DT Article
DE Pyrazoles; side chain oxidation; cyclocondensation reactions; [2+3]
   cycloaddition reactions; diazomethane; ethyldiazoacetate
ID ACETYLENE-DICARBOXYLIC-ACID; 1,3-DIPOLAR CYCLO-ADDITIONS; HALOACETYLATED
   ENOL ETHERS; NIACIN RECEPTOR GPR109A; ONE-POT SYNTHESIS; SERIE DES
   AZOLES; REGIOSELECTIVE SYNTHESIS; REGIOSPECIFIC SYNTHESIS; DIAZOCARBONYL
   COMPOUNDS; CYCLOADDITION REACTIONS
AB This review attempts to sum up all the synthetic accesses to
   3/5-pyrazole carboxylic acids or esters published, or patented, in the
   last 120 years. Many of them have demonstrated their robustness as well
   as quite large scopes. However, a majority are relying on the
   regioselectivity of reactions such as ketones deprotonations,
   cyclocondensations or [2+3] cycloadditions. For this reason, the
   preparation of original 3/5-carboxypyrazoles featuring a structure
   departing from the inherent regioselectivity of these synthetic accesses
   could be problematic. Moreover, a large scale synthesis of some
   3/5-carboxypyrazoles could be a real challenge. It is thus reasonable to
   forecast that even more synthetic methodologies should be reported in
   the future in attempts to meet such requirements.
C1 Inst Pasteur, CNRS, URA 2128, F-75724 Paris 15, France.
RP Janin, YL (reprint author), Inst Pasteur, CNRS, URA 2128, 28 Rue Dr Roux, F-75724 Paris 15, France
EM yves.janin@pasteur.fr
FU Region Ile de France[I 06-222/R, I 09-1739/R]
FX This work was supported by the Medicen initiative (Chemical Library
   Project) grants of the Region Ile de France no I 06-222/R and I
   09-1739/R.
CR He S, 2009, TETRAHEDRON LETT, V50, P2443, DOI 10.1016/j.tetlet.2009.03.030
   Fan H, 2009, EUR J MED CHEM, V44, P593, DOI 10.1016/j.ejmech.2008.03.040
   Guillou S, 2008, SYNTHESIS-STUTTGART, P3504, DOI 10.1055/s-0028-1083186
   Semple G, 2008, J MED CHEM, V51, P5101, DOI 10.1021/jm800258p
   Rosa FA, 2008, SYNLETT, P1673, DOI 10.1055/s-2008-1078482
   Pfefferkorn JA, 2008, BIOORG MED CHEM LETT, V18, P3338, DOI 10.1016/j.bmcl.2008.04.028
   Fustero S, 2008, J ORG CHEM, V73, P3523, DOI 10.1021/jo800251g
   Sachse A, 2008, SYNTHESIS-STUTTGART, P800, DOI 10.1055/s-2008-1032180
   Moura S, 2008, LETT ORG CHEM, V5, P91
   Dang TT, 2008, TETRAHEDRON, V64, P2207, DOI 10.1016/j.tet.2007.12.024
   Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h
   YET L, 2008, COMPREHENSIVE HETERO, V4, P1
   SAMAT A, 2008, RECENT PAT CARDIOVAS, V3, P187
   Lahm GP, 2007, BIOORG MED CHEM LETT, V17, P6274, DOI 10.1016/j.bmc1.2007.09.012
   Skinner PJ, 2007, BIOORG MED CHEM LETT, V17, P5620, DOI 10.1016/j.bmcl.2007.07.101
   Gharbaoui T, 2007, BIOORG MED CHEM LETT, V17, P4914, DOI 10.1016/j.bmel.2007.06.028
   Dragovich PS, 2007, TETRAHEDRON, V63, P1154, DOI 10.1016/j.tet.2006.11.053
   Barnes MJ, 2007, BIOORG MED CHEM LETT, V17, P354, DOI 10.1016/j.bmcl.2006.10.044
   Qi XB, 2007, ANGEW CHEM INT EDIT, V46, P3242, DOI 10.1002/anie.200700069
   Diaz-Ortiz A, 2006, TETRAHEDRON LETT, V47, P8761, DOI 10.1016/j.tetlet.2006.10.006
   Persson T, 2006, ORG LETT, V8, P3219, DOI 10.1021/ol0611088
   Chang EM, 2006, SYNLETT, P901, DOI 10.1055/s-2006-939041
   Carpino PA, 2006, BIOORG MED CHEM LETT, V16, P731, DOI 10.1016/j.bmcl.2005.10.019
   Al-Saleh B, 2006, SYNTHESIS-STUTTGART, P59, DOI 10.1055/s-2005-921750
   MERCK CO INC, 2006
   AR PHARM INC, 2005
   THOMPSON F, 2005
   THOMPSON F, 2005
   BARTH F, 2005
   Geronikaki A, 2004, BIOORGAN MED CHEM, V12, P6559, DOI 10.1016/j.bmc.2004.09.016
   Martins MAP, 2004, SYNTHETIC COMMUN, V34, P1915, DOI 10.1081/SCC-120034176
   Ranatunge RR, 2004, J MED CHEM, V47, P2180, DOI 10.1021/jm030276s
   DAUMAS M, 2004
   Martins MAP, 2003, SYNTHESIS-STUTTGART, P2353, DOI 10.1055/s-2003-42407
   Martins MAP, 2003, J FLUORINE CHEM, V123, P249, DOI 10.1016/S0022-1139(03)00161-1
   van Herk T, 2003, J MED CHEM, V46, P3945, DOI 10.1021/jm030888c
   Finn J, 2003, BIOORG MED CHEM LETT, V13, P2231, DOI 10.1016/S0960-894X(03)00298-1
   Hanzlowsky A, 2003, J HETEROCYCLIC CHEM, V40, P487
   Adamo MFA, 2003, TETRAHEDRON, V59, P2197, DOI 10.1016/S0040-4020(03)00244-8
   Haque TS, 2002, J MED CHEM, V45, P4669, DOI 10.1021/jm020112w
   El-Alali A, 2002, CAN J CHEM, V80, P1293, DOI 10.1139/V02-169
   Molteni G, 2002, NEW J CHEM, V26, P1340, DOI 10.1039/b205063c
   E, 2002, CHEMISTRY, V6, P52
   STANOVIK E, 2002, SCI SYNTHESIS, V12, P15
   HARRIS LJ, 2002
   Turnbull K, 2000, ORG PREP PROCED INT, V32, P593
   Zhang JD, 2000, BIOORG MED CHEM LETT, V10, P2575
   Totoe H, 2000, J SUPERCRIT FLUID, V18, P131
   Cabarrocas G, 2000, TETRAHEDRON-ASYMMETR, V11, P2483
   Washizuka KI, 2000, TETRAHEDRON LETT, V41, P691
   MASS G, 2000, TETRAHEDRON, V56, P4139
   Palacios F, 1999, TETRAHEDRON, V55, P14451
   Washizuka K, 1999, TETRAHEDRON LETT, V40, P8849
   Shire D, 1999, LIFE SCI, V65, P627
   Kudo N, 1999, CHEM PHARM BULL, V47, P857
   Foti F, 1999, TETRAHEDRON LETT, V40, P2605
   Martins MAP, 1999, J HETEROCYCLIC CHEM, V36, P217
   Erian AW, 1999, SYNTHETIC COMMUN, V29, P1527
   Dumitrascu F, 1997, LIEBIGS ANN-RECL, P2613
   Erion MD, 1997, NUCLEOS NUCLEOT, V16, P315
   Terrett NK, 1996, BIOORG MED CHEM LETT, V6, P1819
   ELGUERO J, 1996, COMPREHENSIVE HETERO, V3, P1
   Martins MAP, 1995, SYNTHESIS-STUTTGART, P1491
   SUBRAMANYAM C, 1995, SYNTHETIC COMMUN, V25, P761
   RINALDICARMONA M, 1994, FEBS LETT, V350, P240
   BRAVO P, 1994, TETRAHEDRON, V50, P8827
   ZHENG JH, 1993, J FLUORINE CHEM, V61, P17
   ASHTON WT, 1993, J HETEROCYCLIC CHEM, V30, P307
   BOOKERMILBURN KI, 1992, SYNLETT, P327
   PATEL HV, 1991, SYNTHETIC COMMUN, V21, P1583
   SAUER DR, 1990, J ORG CHEM, V55, P5535
   HEINISCH G, 1990, J CHEM SOC PERK T 1, P1829
   MURRAY WV, 1989, J HETEROCYCLIC CHEM, V26, P1389
   FARINA F, 1989, HETEROCYCLES, V29, P967
   KATRITZKY AR, 1989, TETRAHEDRON, V45, P4253
   BALDOLI C, 1989, J HETEROCYCLIC CHEM, V26, P241
   CATIVIELA C, 1988, J HETEROCYCLIC CHEM, V25, P851
   KARAKHANOVA NK, 1988, VESTN MOSK U KHIM+, V29, P290
   PILLING GM, 1988, TETRAHEDRON LETT, V29, P1341
   PADWA A, 1987, J HETEROCYCLIC CHEM, V24, P1225
   SHIMIZU T, 1985, J ORG CHEM, V50, P904
   DANISHEFSKY SJ, 1985, J AM CHEM SOC, V107, P1280
   SEKI K, 1984, CHEM PHARM BULL, V32, P1568
   FROISSARD J, 1984, J FLUORINE CHEM, V26, P47
   FLIEGE W, 1984, CHEM BER-RECL, V117, P1194
   MARKOVA NK, 1983, ZH ORG KHIM+, V19, P2281
   TEWARI RS, 1983, TETRAHEDRON, V39, P129
   MANAEV YA, 1982, J GEN CHEM USSR, V52, P2291
   BANKS RE, 1982, J CHEM SOC PERK T 1, P1593
   ELKASABY MA, 1981, INDIAN J CHEM B, V20, P366
   ABDALLAH H, 1980, TETRAHEDRON LETT, V21, P2239
   HUISGEN R, 1979, ANGEW CHEM INT EDIT, V18, P330
   HUISGEN R, 1979, J AM CHEM SOC, V101, P3647
   JUST G, 1977, CAN J CHEM, V55, P427
   BUSCH W, 1976
   KATNER AS, 1975
   SUCROW W, 1975, ANGEW CHEM INT EDIT, V14, P560
   SUCROW W, 1974, CHEM BER-RECL, V107, P1318
   TYUPALO NF, 1974
   BUTLER DE, 1972, J ORG CHEM, V37, P215
   FARKAS J, 1971, TETRAHEDRON LETT, V12, P1591
   ATHERTON JH, 1968, J CHEM SOC C, P1507
   WITIAK DT, 1968, J ORG CHEM, V33, P4451
   PLIENINGER H, 1968, TETRAHEDRON LETT, V9, P4371
   GRANDBERG II, 1967, KHIM GETEROTSIKL, P1076
   HAUPTMAN.S, 1967, J PRAKT CHEM, V35, P105
   FUSCO R, 1967, PYRAZOLES PYRAZOLINE, P1
   ELGUERO J, 1966, B SOC CHIM FR, P619
   HUISGEN R, 1966
   ELGUERO J, 1966, B SOC CHIM FR, P293
   PIOZZI F, 1965, GAZZ CHIM ITAL, V95, P814
   RINGEL C, 1964, J PRAKT CHEM, V26, P333
   COOKSON RC, 1963, J CHEM SOC, P6062
   ALEMAGNA A, 1963, GAZZ CHIM ITAL, V93, P748
   ALBERTI C, 1961, PHARM ED SCI, V16, P527
   FUSCO R, 1961, GAZZ CHIM ITAL, V91, P1233
   FINAR IL, 1960, J CHEM SOC, P1588
   TERENTEV AP, 1960, ZH OBSHCH KHIM+, V30, P2925
   FATUTTA S, 1959, GAZZ CHIM ITAL, V89, P964
   HUTTEL R, 1959, LIEBIGS ANN CHEM, V625, P55
   BRAIN EG, 1958, J CHEM SOC, P2435
   PARRINI V, 1957, ANN CHIM, V47, P929
   HUTTEL R, 1956, LIEBIGS ANN CHEM, V598, P186
   ROEDIG A, 1955, LIEBIGS ANN CHEM, V597, P217
   PARHAM WE, 1954, J AM CHEM SOC, V76, P799
   MELTZER RI, 1953, J AM PHARM ASSOC SCI, V42, P594
   PARHAM WE, 1950, J AM CHEM SOC, V72, P3843
   MUSANTE C, 1949, GAZZ CHIM ITAL, V79, P683
   DEWAR MJS, 1945, J CHEM SOC, P114
   MUSANTE C, 1945, GAZZ CHIM ITAL, V75, P121
   Lehninger AL, 1944, J BIOL CHEM, V153, P561
   FUSCO R, 1942, GAZZ CHIM ITAL, V72, P411
   Tracy AH, 1941, J ORG CHEM, V6, P70
   Huttel R, 1941, BER DTSCH CHEM GES, V74, P1680
   FUSCO R, 1939, GAZZ CHIM ITAL, V69, P344
   AUWERS KC, 1938, LIEBIGS ANN CHEM, V536, P97
   BIRKINSHAW JH, 1936, BIOCHEM J, V30, P395
   Chattaway FD, 1935, J CHEM SOC, P1005
   Diels O, 1934, LIEBIGS ANN CHEM, V511, P168
   Gough GAC, 1933, J CHEM SOC, P350
   von Auwers K, 1933, BER DTSCH CHEM GES, V66, P1205
   von Auwers K, 1929, LIEBIGS ANN CHEM, V469, P57
   von Auwers K, 1929, LIEBIGS ANN CHEM, V470, P284
   Rojahn CA, 1926, BER DTSCH CHEM GES, V59, P607
   AUWERS KV, 1926, BER, V59, P1282
   Kohler EP, 1919, J AM CHEM SOC, V41, P1093
   Bulow C, 1904, BER DTSCH CHEM GES, V37, P2198
   Klages A, 1902, J PRAKTISCHE CHEMIE, V65, P387
   Wolff L, 1902, LIEBIGS ANN CHEM, V325, P129
   BUCHNER E, 1902, BER DTSCH CHEM GES, P35
   PECHMAN V, 1900, BER DTSCH CHEM GES, V33, P3590
   WOLFF L, 1900, LIEBIGS ANN CHEM, V313, P13
   PECHMAN VH, 1900, BER DTSCH CHEM GES, V33, P3594
   Gray T, 1900, BER DTSCH CHEM GES, V33, P1220
   Wolff L, 1900, LIEBIGS ANN CHEM, V313, P1
   CLAISEN L, 1894, LIEBIGS ANN CHEM, V278, P274
   ROTHENBURG RV, 1893, BER DTSCH CHEM GES, V26, P1720
   ROTHENBURG RV, 1893, BER DTSCH CHEM GES, V26, P2053
   ROTHENBURG RV, 1893, BER, V26, P1719
   BUCHNER E, 1889, BER, V22, P2929
NR 160
TC 1
Z9 1
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1570-193X
J9 MINI-REV ORG CHEM
JI Mini-Rev. Org. Chem.
PD NOV
PY 2010
VL 7
IS 4
BP 314
EP 323
PG 10
WC Chemistry, Organic
SC Chemistry
GA 686KM
UT WOS:000284695200009
ER
PT J
AU Wong, CY
   Goh, KL
AF Wong, Chan-Yuan
   Goh, Kim-Leng
TI Growth behavior of publications and patents: A comparative study on
   selected Asian economies
RID C-1044-2010
RID B-3949-2009
SO JOURNAL OF INFORMETRICS
LA English
DT Article
DE Diffusion of science and technology; Logistic growth function;
   Self-propagating behavior
ID SCIENCE-AND-TECHNOLOGY; FORECASTING EMERGING TECHNOLOGIES; FUNCTIONALITY
   DEVELOPMENT; INNOVATION SYSTEMS; MODEL SELECTION; PERFORMANCE;
   INDICATORS; DIFFUSION; MARKET; CHINA
AB This study attempts to model the growth behavior of the number of
   publications and patents of South Korea, Taiwan, Japan and Malaysia.
   Three competing growth functions, namely, simple logistic growth
   function, bi-logistic growth function and logistic function within a
   dynamic carrying capacity were considered. The findings provide insight
   to the diffusion process of science and technology, often measured by
   the number of publications and patents, respectively. The function that
   provides the best fit to the observed data was opted for explaining the
   diffusion process. The function with the best fit is the bi-logistic
   growth function for the number of publications as well as the number of
   patents of South Korea and Taiwan, the logistic growth function within a
   dynamic carrying capacity (LGDCC) for the number of publications and the
   bi-logistic growth function for the number of patents of Japan, and the
   LGDCC for the number of publications and simple growth function for the
   number of patents of Malaysia. The results suggest a dynamic
   self-propagating growth for the science and technology, and thereby a
   transition from science and technology-push to market-pull growth for
   South Korea and Taiwan. While a similar transition was observed for the
   technology of Japan, the growth in science had entered a maturity stage.
   On the other hand, the growth potential in science is dynamic for
   Malaysia, but its technological advancement is relatively lower and
   static compared to the other economies. (C) 2010 Elsevier Ltd. All
   rights reserved.
C1 [Wong, Chan-Yuan] Univ Malaya, Fac Sci, Dept Sci & Technol Studies, Kuala Lumpur 50603, Malaysia.
   [Goh, Kim-Leng] Univ Malaya, Fac Econ & Adm, Kuala Lumpur 50603, Malaysia.
RP Wong, CY (reprint author), Univ Malaya, Fac Sci, Dept Sci & Technol Studies, Kuala Lumpur 50603, Malaysia
EM wongcy111@gmail.com
   klgoh@um.edu.my
CR WONG CY, 2010, SCIENTOMETRICS
   OYELARANOYEYINK.B, 2009, UNEVEN PATHS DEV INN
   RASIAH R, 2009, ICT STRATEGY REV 200
   Kostoff RN, 2008, J INFORMETR, V2, P354, DOI 10.1016/j.joi.2008.06.004
   NELSON R, 2008, OXFORD DEV STUDIES, V36, P9
   Kostoff RN, 2007, TECHNOL FORECAST SOC, V74, P1609, DOI 10.1016/j.techfore.2007.02.007
   Schmoch U, 2007, RES POLICY, V36, P1000, DOI 10.1016/j.respol.2006.11.008
   Hu MC, 2007, TECHNOL FORECAST SOC, V74, P298, DOI 10.1016/j.techfore.2006.04.001
   DACHS B, 2007, INNOVATION TECHNOLOG, P127
   KONDO M, 2007, ASIAN J TECHNOL INNO, V15, P55
   ASGARI B, 2007, ASIAN J TECHNOL INNO, V15, P167
   Daim TU, 2006, TECHNOL FORECAST SOC, V73, P981, DOI 10.1016/j.techfore.2006.04.004
   Bengisu M, 2006, TECHNOL FORECAST SOC, V73, P835, DOI 10.1016/j.techfore.2005.09.001
   Chen CJ, 2006, TECHNOL FORECAST SOC, V73, P731, DOI 10.1016/j.techfore.2005.07.008
   Sharif N, 2006, RES POLICY, V35, P745, DOI 10.1016/j.respol.2006.04.001
   Watanabe C, 2006, OMEGA-INT J MANAGE S, V34, P178, DOI 10.1016/j.omega.2004.09.002
   Zhou P, 2006, RES POLICY, V35, P83, DOI 10.1016/j.respol.2005.08.006
   *ISI, 2006, THOMS ISI NAT SCI IN
   NAGANO M, 2006, J ASIAN EC, V17, P653, DOI 10.1016/j.asieco.2006.06.006
   Park HW, 2005, SCIENTOMETRICS, V65, P3, DOI 10.1007/s11192-005-0257-4
   Leydesdorff L, 2005, SCIENTOMETRICS, V63, P617, DOI 10.1007/s11192-005-0231-1
   Tassey G, 2005, RES POLICY, V34, P287, DOI 10.1016/j.respol.2005.01.012
   RASIAH R, 2005, INT J TECHNOLOGY GLO, V1, P400
   *USPTO, 2005, PAT TECHN MON REP
   Geels FW, 2004, RES POLICY, V33, P897, DOI 10.1016/j.respol.2004.01.015
   Watanabe C, 2004, TECHNOL FORECAST SOC, V71, P723, DOI 10.1016/s0040-1625(02)00306-2
   Watanabe C, 2004, TECHNOVATION, V24, P651, DOI 10.1016/S0166-4972(02)00126-8
   King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a
   Watanabe C, 2004, TECHNOVATION, V24, P467, DOI 10.1016/S0166-4972(02)00103-7
   Bhattacharya S, 2004, SCIENTOMETRICS, V61, P361
   Martino JP, 2003, TECHNOL FORECAST SOC, V70, P719, DOI 10.1016/S0040-1625(02)00375-X
   Ohmura A, 2003, TECHNOVATION, V23, P833, DOI 10.1016/S0166-4972(02)00028-7
   Bernardes AT, 2003, RES POLICY, V32, P865
   Watanabe C, 2003, TECHNOVATION, V23, P205, DOI 10.1016/S0166-4972(01)00106-7
   KONDO R, 2003, TECHNOL SOC, V25, P319
   Genius M, 2002, ECON LETT, V74, P363
   PEREZ C, 2002, TECHNOLOGICAL REVOLU
   JUNG S, 2002, WORLD PATENT INFORM, V24, P303
   Watanabe C, 2001, TECHNOL FORECAST SOC, V68, P81
   Thomas P, 2001, SCIENTOMETRICS, V51, P319
   Choung JY, 2000, SCIENTOMETRICS, V48, P413
   Forster MR, 2000, J MATH PSYCHOL, V44, P205, DOI 10.1006/jmps.1999.1284
   Golden RM, 2000, J MATH PSYCHOL, V44, P153, DOI 10.1006/jmps.1999.1281
   Andersen B, 1999, J EVOL ECON, V9, P487
   Kumaresan N, 1999, RES POLICY, V28, P563
   Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P209
   WONG PK, 1999, DRUID NAT INN SYST I
   Okubo Y, 1998, SCIENTOMETRICS, V41, P273
   KRAHMER M, 1998, RES POLICY, V27, P835
   TIDD J, 1997, MANAGING INNOVATION
   Schmoch U, 1997, SCIENTOMETRICS, V38, P103
   Grupp H, 1996, J EVOL ECON, V6, P175
   *OECD, 1996, KNOWL BAS EC
   GOURLEROUX C, 1995, STAT ECONOMETRIC MOD
   MEYER P, 1994, TECHNOL FORECAST SOC, V47, P89
   GRUPP H, 1994, EC TECHNOLOGY, P223
   PAVITT K, 1988, HDB QUANTITATIVE STU, P509
   FREEMAN C, 1987, TECHNOLOGY EC PERFOR
   PAVITT K, 1987, SCI PUBL POLICY, V14, P182
   PAVITT K, 1985, SCIENTOMETRICS, V7, P1
   DUIJN JJ, 1983, WAVE EC LIFE
   ROGERS EM, 1982, ACCEPTABILITY FERTIL
   ROGERS EM, 1962, DIFFUSION INNOVATION
   ROGERS EM, 1961, RURAL SOCIOL, V26, P325
NR 64
TC 2
Z9 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-1577
J9 J INFORMETR
JI J. Informetr.
PD OCT
PY 2010
VL 4
IS 4
BP 460
EP 474
DI 10.1016/j.joi.2010.04.002
PG 15
WC Information Science & Library Science
SC Information Science & Library Science
GA 647KA
UT WOS:000281616200002
ER
PT J
AU Pangarkar, N
   Pharoah, M
   Nigam, A
   Hutmacher, DW
   Champ, S
AF Pangarkar, Nitin
   Pharoah, Marc
   Nigam, Avinav
   Hutmacher, Dietmar W.
   Champ, Simon
TI Advanced Tissue Sciences Inc.: learning from the past, a case study for
   regenerative medicine
SO REGENERATIVE MEDICINE
LA English
DT Article
DE Advanced Tissue Sciences; business model; business strategy; Dermagraft
   (R); investment; regenerative medicine; tissue engineering
AB On 31st March 2003 Advanced Tissue Sciences (ATS) was liquidated, with
   the effect that in excess of US$300 million of stakeholder financing was
   destroyed. Although successful in the development of breakthrough
   technologies in the regenerative medicine arena and the building of a
   substantial portfolio of patents, the company never made a profit. In
   this case study, ATS' business strategy, market and competitive
   environment will be discussed in the context of the company's historical
   development. A number of important lessons from this case are discussed
   From a management perspective the most critical lesson is the importance
   of effective financial planning and management of costs, and in
   particular R&D costs, including the significant costs associated with
   clinical trials. In addition, a clear strategic focus is extremely
   important due to the significant resources required in the development
   of a new therapy: From an investor's perspective the lessons to be
   gathered from the ATS case are related to the risk involved in investing
   in the field of regenerative medicine. This case indicates that both
   professional and private investors did not fully question the validity
   of ATS' business strategy and financial forecasts. A clear and focused
   strategy based on long-term investor commitment is essential for the
   successful commercialization of regenerative medicine.
C1 [Pharoah, Marc; Champ, Simon] Proago Consulting, Zurich, Switzerland.
   [Pangarkar, Nitin] Natl Univ Singapore, Sch Business, Singapore 0511, Singapore.
   [Hutmacher, Dietmar W.] Queensland Univ Technol, Brisbane, Qld 4001, Australia.
RP Champ, S (reprint author), Proago Consulting, Zurich, Switzerland
EM simon@proago.ch
CR BONFIGLIO GA, 2006, FUNDING EXIT STRATEG
   BRENNAN T, 2003, DAILY DEAL      0320
   MORSE JM, 2002, INT J QUALITATIVE ME, V1
   WEBB M, 2002, SAN DIEGO BUSINESS J, V23, P1
   CRABTREE P, 2002, KNIGHT RIDDER T 1011, P1
   2002, KNIGHT RIDDER T 1012, P1
   ROSE CD, 2002, KNIGHT RIDDER T 1114
   WEBB M, 2001, SAN DIEGO BUSINESS J, V22, P9
   WEBB M, 2000, SAN DIEGO BUSINESS J, V21, P6
   2000, WALL STREET J   0915, pC14
   RUNDLE RL, 1999, WALL ST J A     0809, P1
   WEBB M, 1998, SAN DIEGO BUSINESS J, V19, P1
   1998, WALL STREET J   0612, P1
   KRAVETZ S, 1998, WALL STREET J   0615, P1
   ARNST C, 1998, BUS WEEK        0518, P118
   1997, WALL STREET J   0319, pB4
   1996, ECONOMIST, V338, P65
   1996, WALL STREET J   0430, pB8
   RUNDLE RL, 1996, WALL STREET J   1120, pB10
   SILVERMAN SD, 1994, INT BUSINESS, V7, P68
   FIKES BJ, 1994, SAN DIEGO BUSINESS J, V15, P1
   1994, WALL STREET J   0215, pB2
   PITTA J, 1993, FORBES, V151, P170
   FIKES BJ, 1993, SAN DIEGO BUSINESS J, V14, P6
   DIEKMAN JM, 1992, HLTH IND TODAY, V5, P7
   FIKES BJ, 1992, SAN DIEGO BUSINESS J, V13, P12
   HOWER W, 1992, BOSTON BUSINESS J, V12, P7
   TURNER R, 1992, WALL STREET J   1019
   *ADV TISS SCI LIQ, FIN CASH BAS FIN STA
   SHAW G, SAN DIEGO METROPOLIT
   CHAMP S, THESIS WARWICK BUSIN
NR 31
TC 0
Z9 0
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
J9 REGEN MED
JI Regen. Med.
PD SEP
PY 2010
VL 5
IS 5
BP 823
EP 835
DI 10.2217/RME.10.66
PG 13
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 660CD
UT WOS:000282615700017
ER
PT J
AU Chen, YH
   Chen, CY
   Lee, SC
AF Chen, Yu-Heng
   Chen, Chia-Yon
   Lee, Shun-Chung
TI Technology forecasting of new clean energy: The example of hydrogen
   energy and fuel cell
SO AFRICAN JOURNAL OF BUSINESS MANAGEMENT
LA English
DT Article
DE Hydrogen energy; technology forecasting; S-curves; bibliometric
   analysis; fuel cell
ID INDUSTRY; DIFFUSION; DATABASES
AB Due to energy shortage, global warming and climate change, balanced
   development of energy security, economic growth, and environmental
   protection (3Es) has become a major energy policy issue and prompted the
   development of low-carbon economies. The goals of exploiting new clean
   energies, improving the efficiency of conventional energy sources, and
   improving renewable energy technologies have gathered considerable
   attention of governments worldwide. Among the many clean energies,
   hydrogen energy plays an important part in new clean energy fields
   nowadays. However, little has been done in discussing the technology
   forecasting for the hydrogen energy development. Therefore, this study
   predicts the technological S-curves for hydrogen energy and fuel cell
   technologies by integrating bibliometric and patent analysis into the
   logistic growth curve model, which includes generation, storage, proton
   exchange membrane fuel cell (PEMFC), solid oxide fuel cell (SOFC) and
   direct methanol fuel cell/direct alcohol fuel cell (DMFC/DAFC).
   Empirical analysis is via an expert survey and co-word analysis using
   the USPTO database to obtain useful data. The results demonstrate that
   technologies for generating and storing hydrogen have not yet reached
   technological maturity, and the fuel cell technology is either in the
   mature stage or approaching maturity.
C1 [Chen, Yu-Heng; Chen, Chia-Yon; Lee, Shun-Chung] Natl Cheng Kung Univ, Dept Resources Engn, Tainan 70101, Taiwan.
RP Chen, YH (reprint author), Natl Cheng Kung Univ, Dept Resources Engn, Tainan 70101, Taiwan
EM luegg100@gmail.com
CR Chu WL, 2009, TELECOMMUN POLICY, V33, P506, DOI 10.1016/j.telpol.2009.07.003
   Schilling MA, 2009, ENERG POLICY, V37, P1767, DOI 10.1016/j.enpol.2009.01.004
   Gasafi E, 2008, BIOMASS BIOENERG, V32, P1085, DOI 10.1016/j.biombioe.2008.02.021
   Beccali M, 2008, RENEW ENERG, V33, P366, DOI 10.1016/j.renene.2007.03.013
   Kothari R, 2008, RENEW SUST ENERG REV, V12, P553, DOI 10.1016/j.rser.2006.07.012
   Cheng AC, 2008, TECHNOL FORECAST SOC, V75, P131, DOI 10.1016/j.techfore.2006.08.002
   CHENG AC, 2008, ROM J ECON FORECAST, V4, P88
   Bengisu M, 2006, TECHNOL FORECAST SOC, V73, P835, DOI 10.1016/j.techfore.2005.09.001
   Frank LD, 2004, TECHNOL FORECAST SOC, V71, P391, DOI 10.1016/S0040-1625(02)00392-X
   Watts RJ, 2003, TECHNOL FORECAST SOC, V70, P735, DOI 10.1016/S0040-1625(02)00355-4
   Martino JP, 2003, TECHNOL FORECAST SOC, V70, P719, DOI 10.1016/S0040-1625(02)00375-X
   Morris S, 2002, COMPUT IND ENG, V43, P841
   NORTON MJ, 2001, INTRO CONCEPTS INFOR
   Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P247
   Meade N, 1998, MANAGE SCI, V44, P1115
   Watts RJ, 1997, TECHNOL FORECAST SOC, V56, P25
   Ernst H, 1997, SMALL BUS ECON, V9, P361
   CUNNINGHAM SW, 1997, THESIS UK
   AYRES RU, 1994, J ECON BEHAV ORGAN, V24, P35
   NARIN F, 1994, EVALUATION REV, V18, P65
   CHRISTENSEN CM, 1994, PROD OPER MANAG, V1, P334
   CHRISTENSEN CM, 1993, BUS HIST REV, V67, P531
   EFRON BTR, 1993, INTRO BOOTSTRAP
   TWISS BC, 1992, IEE MANAGEMENT TECHN, V15
   PORTER AL, 1991, FORECASTING MANAGEME
   FOSTER R, 1986, INNOVATION ATTACKERS
   EFRON B, 1979, ANN STAT, V7, P1
   GARFIELD E, 1978, METRIC SCI ADVENT SC
NR 28
TC 7
Z9 7
PU ACADEMIC JOURNALS
PI VICTORIA ISLAND
PA P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA
SN 1993-8233
J9 AFR J BUS MANAGE
JI Afr. J. Bus. Manag.
PD JUL 4
PY 2010
VL 4
IS 7
BP 1372
EP 1380
PG 9
WC Business; Management
SC Business & Economics
GA 631LV
UT WOS:000280349500017
ER
PT J
AU Wettermark, B
   Persson, ME
   Wilking, N
   Kalin, M
   Korkmaz, S
   Hjemdahl, P
   Godman, B
   Petzold, M
   Gustafsson, LL
AF Wettermark, Bjorn
   Persson, Marie E.
   Wilking, Nils
   Kalin, Mats
   Korkmaz, Seher
   Hjemdahl, Paul
   Godman, Brian
   Petzold, Max
   Gustafsson, Lars L.
CA Regional Drug Expert Consortium
TI Forecasting drug utilization and expenditure in a metropolitan health
   region
RID G-3902-2010
SO BMC HEALTH SERVICES RESEARCH
LA English
DT Article
ID ATRIAL-FIBRILLATION; ORAL ANTICOAGULANTS; RANDOMIZED-TRIALS;
   BREAST-CANCER; THERAPY; MEDICINE; ISSUES; IMPACT; TECHNOLOGIES;
   CHEMOTHERAPY
AB Background: New pharmacological therapies are challenging the healthcare
   systems, and there is an increasing need to assess their therapeutic
   value in relation to existing alternatives as well as their potential
   budget impact. Consequently, new models to introduce drugs in healthcare
   are urgently needed. In the metropolitan health region of Stockholm,
   Sweden, a model has been developed including early warning (horizon
   scanning), forecasting of drug utilization and expenditure, critical
   drug evaluation as well as structured programs for the introduction and
   follow-up of new drugs. The aim of this paper is to present the
   forecasting model and the predicted growth in all therapeutic areas in
   2010 and 2011.
   Methods: Linear regression analysis was applied to aggregate sales data
   on hospital sales and dispensed drugs in ambulatory care, including both
   reimbursed expenditure and patient co-payment. The linear regression was
   applied on each pharmacological group based on four observations
   2006-2009, and the crude predictions estimated for the coming two years
   2010-2011. The crude predictions were then adjusted for factors likely
   to increase or decrease future utilization and expenditure, such as
   patent expiries, new drugs to be launched or new guidelines from
   national bodies or the regional Drug and Therapeutics Committee. The
   assessment included a close collaboration with clinical, clinical
   pharmacological and pharmaceutical experts from the regional Drug and
   Therapeutics Committee.
   Results: The annual increase in total expenditure for prescription and
   hospital drugs was predicted to be 2.0% in 2010 and 4.0% in 2011.
   Expenditures will increase in most therapeutic areas, but most
   predominantly for antineoplastic and immune modulating agents as well as
   drugs for the nervous system, infectious diseases, and blood and
   blood-forming organs.
   Conclusions: The utilisation and expenditure of drugs is difficult to
   forecast due to uncertainties about the rate of adoption of new
   medicines and various ongoing healthcare reforms and activities to
   improve the quality and efficiency of prescribing. Nevertheless, we
   believe our model will be valuable as an early warning system to start
   developing guidance for new drugs including systems to monitor their
   effectiveness, safety and cost-effectiveness in clinical practice.
C1 [Wettermark, Bjorn; Persson, Marie E.; Kalin, Mats; Korkmaz, Seher; Gustafsson, Lars L.] Stockholm Cty Council, Dept Drug Management & Informat, Stockholm, Sweden.
   [Wettermark, Bjorn; Godman, Brian; Gustafsson, Lars L.] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden.
   [Wilking, Nils] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden.
   [Kalin, Mats] Karolinska Univ Hosp Solna, Dept Infect Dis, Stockholm, Sweden.
   [Korkmaz, Seher; Hjemdahl, Paul] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med Solna, Div Clin Pharmacol, Stockholm, Sweden.
   [Godman, Brian] Mario Negri Inst Pharmacol Res, Milan, Italy.
   [Petzold, Max] Nord Sch Publ Hlth, Gothenburg, Sweden.
RP Wettermark, B (reprint author), Stockholm Cty Council, Dept Drug Management & Informat, Stockholm, Sweden
EM bjorn.wettermark@sll.se
FU Stockholm County Council; Karolinska Institutet
FX This development and research has been feasible due to commitment and
   expertise from a number of people. We particularly express our gratitude
   to Tore Andersson, Goran Holm, Margaretha Julander, Bo Ringertz and
   Maria von Witting from the Department of Drug Management and Informatics
   and Henrik Almkvist and Gunilla Thornwall-Bergendahl at the Department
   of Finance and Planning, both Stockholm County Council The work has been
   funded by Stockholm County Council and partly by Karolinska Institutet.
   The Regional Drug Expert Consortium also includes; Eva
   Andersen-Karlsson, Peter Aspelin, Jonas Bergh, Bo Billing, Peter Ekman,
   Carl-Gustaf Elinder, Mia von Euler, Johan Franck, Urban Hellgren,
   Michael Lagerkranser, Lena Lundeberg, Angelica L Hirschberg, Gerd
   Larfars, Georgios Panagiotidis, Jan Persson, Daniel Schmidt, Gunilla
   Sundelin, Leif Tallstedt, Matti Viitanen, Ake Ortqvist
CR Wettermark B, 2010, HEALTH POLICY, V94, P221, DOI 10.1016/j.healthpol.2009.09.014
   Truffer CJ, 2010, HEALTH AFFAIR, V29, P522, DOI 10.1377/hlthaff.2009.1074
   Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Jonasson JM, 2009, DIABETOLOGIA, V52, P1745, DOI 10.1007/s00125-009-1444-2
   den Exter A, 2009, LANCET, V374, P599
   Lichtenberg FR, 2009, HEALTH ECON, V18, P519, DOI 10.1002/hec.1382
   Joppi R, 2009, BRIT J CLIN PHARMACO, V67, P494, DOI 10.1111/j.1365-2125.2009.03369.x
   Jonsson B, 2009, EUR J CANCER, V45, P1100, DOI 10.1016/j.ejca.2009.01.035
   Zimetbaum PJ, 2009, NEW ENGL J MED, V360, P1811
   Winter MC, 2009, EXPERT OPIN DRUG SAF, V8, P223, DOI 10.1517/14740330902750114
   Hohnloser SH, 2009, NEW ENGL J MED, V360, P668
   Hughes B, 2009, NAT REV DRUG DISCOV, V8, P93, DOI 10.1038/nrd2813
   Hoffman JM, 2009, AM J HEALTH-SYST PH, V66, P237, DOI 10.2146/ajhp080636
   GODMAN B, 2009, EXPERT REV PHARM OUT, V9, P65
   WETTERMARK B, 2009, QUAL PRIM CARE, V17, P179
   Jansen AGSC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub3
   BROUWERS L, 2009, EURO SURVEILL, V14
   ROSS JS, 2009, ONCOLOGIST, V25, P320
   ERIKSSON G, 2009, REV MED TREATING LIP
   Garattini S, 2008, EUR J CLIN PHARMACOL, V64, P1137, DOI 10.1007/s00228-008-0537-z
   Gora-Tybor J, 2008, CURR MED CHEM, V15, P3036
   Quinn TC, 2008, AIDS, V22, pS7, DOI 10.1097/01.aids.0000327510.68503.e8
   Tepper SJ, 2008, HEADACHE, V48, P1259
   Fisher R, 2008, CURR OPIN PEDIATR, V20, P441
   Lee TH, 2008, NEW ENGL J MED, V359, P333
   Yau T, 2008, ALIMENT PHARM THER, V27, P997, DOI 10.1111/j.1365-2036.2008.03684.x
   Cross TJS, 2008, POSTGRAD MED J, V84, DOI 10.1136/pgmj.2008.068205
   Garattini L, 2008, HEALTH POLICY, V85, P305, DOI 10.1016/j.healthpol.2007.08.005
   Mellstedt H, 2008, ANN ONCOL, V19, P411, DOI 10.1093/annonc/mdm345
   Palumbo E, 2008, AM J THER, V15, P167
   Hoffman JM, 2008, AM J HEALTH-SYST PH, V65, P234, DOI 10.2146/ajhp070629
   Clarke M, 2008, LANCET, V371, P29
   Turpie AGG, 2008, EUR HEART J, V29, P155, DOI 10.1093/eurheartj/ehm575
   *INT DIAB FED, 2008, DIAB ATL
   CATLIN A, 2008, HLTH AFF MILLWOOD, V27, P25
   STRUWE J, 2008, SWEDRES 2008 REPORT
   2008, DRUG THER B, V46, P49
   GUSTAFSSON LL, 2008, LAKARTIDNINGEN, V105, P2917
   HEDBERG N, 2008, REV MED LOWERING BLO
   *WHO, 2008, GUID ATC CLASS DDD A
   BERENSON JR, 2008, CURR OPIN SUPPORT PA, V2, P204
   Schmidt-Erfurth UM, 2007, ACTA OPHTHALMOL SCAN, V85, P486, DOI 10.1111/j.1600-0420.2007.00979.x
   Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294
   Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761
   Lesko LJ, 2007, CLIN PHARMACOL THER, V81, P807, DOI 10.1038/sj.clpt.6100204
   Murphy K, 2007, INT J TECHNOL ASSESS, V23, P324
   Andersson K, 2007, HEALTH POLICY, V81, P376, DOI 10.1016/j.healthpol.2006.07.005
   Cutler DM, 2007, NEW ENGL J MED, V356, P1292
   Scheffler RM, 2007, HEALTH AFFAIR, V26, P450, DOI 10.1377/hlthaff.26.2.450
   Meropol NJ, 2007, J CLIN ONCOL, V25, P180, DOI 10.1200/JCO.2006.09.6081
   Wadman M, 2007, NATURE, V445, P13, DOI 10.1038/445013a
   Ettinger AB, 2007, NEUROTHERAPEUTICS, V4, P75
   Sturm H, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006731
   *MED PROD AG, 2007, NEDR UR KVINN
   *NAT BOARD HLTH WE, 2007, REK SCREEN PAT FATT
   KENDIRCI M, 2007, THER CLIN RISK MANAG, V3, P277
   AMORI E, 2007, JAMA-J AM MED ASSOC, V298, P194
   Hayward RA, 2006, ANN INTERN MED, V145, P520
   Packer C, 2006, INT J TECHNOL ASSESS, V22, P419
   Askling J, 2006, ANN RHEUM DIS, V65, P707, DOI 10.1136/ard.2005.045872
   Eriksson BI, 2006, DRUGS, V66, P1411
   Puppo F, 2005, AUTOIMMUN REV, V4, P537, DOI 10.1016/j.autrev.2005.04.016
   Barton JH, 2005, JAMA-J AM MED ASSOC, V294, P2075
   Kalow W, 2005, EXPERT OPIN PHARMACO, V6, P1299, DOI 10.1517/14656566.6.8.1299
   Abe O, 2005, LANCET, V365, P1687
   Reeves JD, 2005, DRUGS, V65, P1747
   LICHTENBERG F, 2005, INT J HEALTH CARE FI, V5, P47
   MASON AR, 2005, APPL HLTH EC HLTH PO, V4, P111
   Simpson S, 2004, INT J TECHNOL ASSESS, V20, P381
   Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626
   Grol R, 2004, MED J AUSTRALIA, V180, pS57
   WALLEY T, 2004, FINANCIAL INCENTIVES
   De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6
   Melander H, 2003, BRIT MED J, V326, P1171
   Klein R, 2002, HEALTH AFFAIR, V21, P177
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49
   Drews J, 2000, SCIENCE, V287, P1960
   *EUR MED AG, QUEST ANSW REC REF C
NR 80
TC 1
Z9 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6963
J9 BMC HEALTH SERV RES
JI BMC Health Serv. Res.
PD MAY 17
PY 2010
VL 10
AR 128
DI 10.1186/1472-6963-10-128
PG 14
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA 625EP
UT WOS:000279877600001
ER
PT J
AU Haken, N
   Burbank, J
   Baker, PH
AF Haken, Nate
   Burbank, Joelle
   Baker, Pauline H.
TI Casting Globally: Using Content Analysis for Conflict Assessment and
   Forecasting
SO MILITARY OPERATIONS RESEARCH
LA English
DT Article
ID TELEVISION; COVERAGE
AB Computer-based content analysis offers many unique benefits for conflict
   assessment and forecasting. Yet is it underutilized, despite the fact
   that the information age offers vast amounts of new data gathering
   opportunities. Nate Ha ken, Joelle Burbank, and Dr. Pauline H. Baker
   describe the methodology of content analysis, situate it within
   communications theory, and explore its strengths and weaknesses. They
   describe (CAST(c)) a patented content analysis software developed by The
   Fund for Peace, which intelligence officials, policy analysts, military
   commanders, and scholars can use to better assess and anticipate violent
   conflict.
C1 [Haken, Nate; Baker, Pauline H.] Fund Peace, Washington, DC USA.
RP Haken, N (reprint author), Fund Peace, Washington, DC USA
EM nhaken@fundforpeace.org
   jburbank@fundforpeace.org
   pbaker@fundforpeace.org
CR Shearer R, 2007, MIL OPER RES, V12, P5
   Lacina B, 2005, EUR J POPUL, V21, P145, DOI 10.1007/s10680-005-6851-6
   2005, QUEST VIABL PEAC, P1
   King G, 2003, INT ORGAN, V57, P617, DOI 10.1017/S0020818303573064
   Fearon JD, 2003, AM POLIT SCI REV, V97, P75
   ROTBERG RI, 2003, STATE FAILURE STATE
   Sambanis N, 2001, J CONFLICT RESOLUT, V45, P259
   Jenkins JC, 2001, J CONFLICT RESOLUT, V45, P3
   COLLIER P, 2001, C DAT COLL ARM CONFL
   SCHRODT PA, 2001, MONITORING CONFLICT
   Bond D, 1997, J CONFLICT RESOLUT, V41, P553
   WIMMER R, 1997, MASS MEDIA RES INTRO
   LESTER PM, 1994, JOURNALISM QUART, V71, P380
   EDEANI DO, 1994, AFRICAN MEDIA REV, V8, P25
   OCALLAGHAN J, 1992, JOURNALISM QUART, V69, P195
   TRUJILLO N, 1987, JOURNALISM QUART, V64, P368
   AUSTIN JL, 1980, DO THINGS WORDS W JA
   GERBNER G, 1976, J COMMUN, V26, P173
   HOLSTI OR, 1969, CONTENT ANAL SOCIAL
   DEFLEUR ML, 1964, PUBLIC OPIN QUART, V28, P57
   ZINNES DA, 1961, INT POLITICS FOREIGN
   DAVIS FJ, 1951, AM J SOCIOL, V57, P325
   LASSWELL H, 1948, COMMUNICATION IDEAS
   BAKER PH, CONFLICT ASSESSMENT
   CUNNINGHAM DF, IT TAKES 2 DYADIC AN
NR 25
TC 0
Z9 0
PU MILITARY OPERATIONS RESEARCH SOC
PI ALEXANDRIA
PA 1703 N BEAUREGARD ST, STE 450, ALEXANDRIA, VA 22311-1717 USA
SN 0275-5823
J9 MIL OPER RES
JI Mil. Oper. Res.
PY 2010
VL 15
IS 2
BP 5
EP +
PG 16
WC Operations Research & Management Science
SC Operations Research & Management Science
GA 632QE
UT WOS:000280439900001
ER
PT J
AU Liu, CY
   Wang, JC
AF Liu, Chen-Yuan
   Wang, Jhen-Cheng
TI Forecasting the development of the biped robot walking technique in
   Japan through S-curve model analysis
SO SCIENTOMETRICS
LA English
DT Article
DE Patent growth trend; Forecast; S curve; The walking technique of the
   biped robot
ID LOGLET LAB SOFTWARE; LOGISTIC GROWTH; SCIENCE
AB Patents contain much significant technical information which can serve
   as an indicator of technological and economical development. This study
   attempts to forecast the development of the biped robot walking
   technique in Japan by use of the patent data obtained from the Japan
   Patent Office. The study applies linear regression to the patent data
   using three S-curve models developed by Loglet Lab, Pearl, and Gompertz
   individually. Various parameters inherent to each model including the
   least sum of modulus error and the least mean of square error of the
   model are analyzed. The most appropriate model for measuring the
   inflection point, the growth and the saturation time of the technique is
   described. Based on the Gompertz model analysis, this study finds that
   the biped robot walking technique will continue to develop for several
   decades in Japan and the saturation period is estimated to be around the
   year 2079-2082. This finding can help related researchers and managers
   in the robot field to foresee the development trend of the biped robot
   walking technique in this century.
C1 [Liu, Chen-Yuan] Tungnan Univ, Dept Informat Technol & Commun, Taipei 222, Taiwan.
   [Wang, Jhen-Cheng] Tungnan Univ, Dept Elect Engn, Taipei 222, Taiwan.
RP Liu, CY (reprint author), Tungnan Univ, Dept Informat Technol & Commun, 152 Sec 3,Pei Shen Rd, Taipei 222, Taiwan
EM cyliu@mail.tnu.edu.tw
CR Liu CY, 2008, SCIENTOMETRICS, V75, P51, DOI 10.1007/s11192-007-1835-4
   Boretos GP, 2007, TECHNOL FORECAST SOC, V74, P331, DOI 10.1016/j.techfore.2005.11.005
   Gutierrez R, 2006, APPL MATH COMPUT, V183, P738, DOI 10.1016/j.amc.2006.05.099
   Bengisu M, 2006, TECHNOL FORECAST SOC, V73, P835, DOI 10.1016/j.techfore.2005.09.001
   CIOFFI DF, 2005, INT J PROJECT MANAGE, V23, P215, DOI 10.1016/j.ijproman.2004.08.001
   Golden BL, 2004, TECHNOL FORECAST SOC, V71, P417, DOI 10.1016/j.techfore.2003.07.003
   DRAGAN J, 2004, J COMPUT APPL MATH, V169, P359
   JAN KM, 2003, STICRPR09204 NAT SCI
   MAI F, 2002, STICRPR09107 NAT SCI
   AZEVEDO C, 2002, P IEEE INT C ROB AUT, P2762, DOI 10.1109/ROBOT.2002.1013650
   Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P247
   Yung JW, 1999, TECHNOL FORECAST SOC, V61, P273
   CAUX S, 1997, P INT C SYST MAN CYB, P3249
   PERRIN B, 1997, P IEEE INT C ROB AUT, P1088
   LI Q, 1991, P IEEE RSJ INT WORKS, P1568
   RAJESWARI AR, 1989, SCIENTOMETRICS, V17, P227
   MIYAZAKI F, 1980, ASME, V102, P233
   GOLLIDAY CL, 1977, IEEE T AUTOMAT CONTR, V22, P963
NR 18
TC 0
Z9 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0138-9130
J9 SCIENTOMETRICS
JI Scientometrics
PD JAN
PY 2010
VL 82
IS 1
SI SI
BP 21
EP 36
DI 10.1007/s11192-009-0055-5
PG 16
WC Computer Science, Interdisciplinary Applications; Information Science &
   Library Science
SC Computer Science; Information Science & Library Science
GA 548HK
UT WOS:000273950900003
ER
PT J
AU Czado, C
   Gneiting, T
   Held, L
AF Czado, Claudia
   Gneiting, Tilmann
   Held, Leonhard
TI Predictive Model Assessment for Count Data
RID A-8773-2009
RID E-8159-2010
SO BIOMETRICS
LA English
DT Article
DE Calibration; Forecast verification; Model diagnostics; Predictive
   deviance; Probability integral transform; Proper scoring rule
ID MIXED-POISSON-REGRESSION; TIME-SERIES; PROBABILISTIC FORECASTS;
   DISPERSION; RESIDUALS; SYSTEMS; CHOICE; PROPER; RATES
AB P>We discuss tools for the evaluation of probabilistic forecasts and the
   critique of statistical models for count data. Our proposals include a
   nonrandomized version of the probability integral transform, marginal
   calibration diagrams, and proper scoring rules, such as the predictive
   deviance. In case studies, we critique count regression models for
   patent data, and assess the predictive performance of Bayesian
   age-period-cohort models for larynx cancer counts in Germany. The
   toolbox applies in Bayesian or classical and parametric or nonparametric
   settings and to any type of ordered discrete outcomes.
C1 [Czado, Claudia] Tech Univ Munich, Zentrum Math, D-85748 Garching, Germany.
   [Gneiting, Tilmann] Univ Washington, Dept Stat, Seattle, WA 98195 USA.
   [Held, Leonhard] Univ Zurich, Biostat Abt, Inst Sozial & Praventivmed, CH-8001 Zurich, Switzerland.
RP Czado, C (reprint author), Tech Univ Munich, Zentrum Math, Boltzmannstr 3, D-85748 Garching, Germany
EM tilmann@stat.washington.edu
FU German Research Foundation[CZ 86/1-3]; National Science
   Foundation[ATM-0724721, DMS-0706745]; Office of Naval
   Research[N00014-01-10745]; Swiss National Science Foundation
FX The authors are grateful to the editors and referees for exceptionally
   helpful and constructive reports. C.C. was supported by the German
   Research Foundation under grant CZ 86/1-3. T.G. acknowledges support by
   the National Science Foundation under Awards ATM-0724721 and DMS-0706745
   and by the DoD Multidisciplinary University Research Initiative (MURI)
   program administered by the Office of Naval Research under Grant
   N00014-01-10745. L.H. acknowledges support by the Swiss National Science
   Foundation.
CR FRUHWIRTHSCHNAT.S, 2009, STAT COMPUT IN PRESS
   Gschlossl S, 2008, STAT PAP, V49, P531, DOI 10.1007/s00362-006-0031-6
   Grammig J, 2008, J ECON DYN CONTROL, V32, P2370, DOI 10.1016/j.jedc.2008.02.007
   WINKELMANN R, 2008, ECONOMETRIC ANAL COU
   Brockwell AE, 2007, STAT PROBABIL LETT, V77, P1473, DOI 10.1016/j.spl.2007.02.008
   Czado C, 2007, STAT MODEL, V7, P125, DOI 10.1177/1471082X0700700202
   Jolliffe IT, 2007, WEATHER FORECAST, V22, P637, DOI 10.1175/WAF989.1
   Brocker J, 2007, WEATHER FORECAST, V22, P382, DOI 10.1175/WAF966.1
   Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437
   Gneiting T, 2007, J ROY STAT SOC B, V69, P243
   GSCHLOSSL S, 2007, SCANDINAVIAN ACTUARI, V107, P202
   Fruhwirth-Schnatter S, 2006, BIOMETRIKA, V93, P827
   Clements MS, 2006, AM J EPIDEMIOL, V164, P292, DOI 10.1093/aje/kwj221
   Elsner JB, 2006, J CLIMATE, V19, P2935
   Nelson KP, 2006, STAT MED, V25, P1413, DOI 10.1002/sim.2274
   Liesenfeld R, 2006, EMPIR ECON, V30, P795, DOI 10.1007/s00181-005-0001-1
   Baker A, 2005, AM J EPIDEMIOL, V162, P798, DOI 10.1093/aje/kwi273
   Clements MS, 2005, BIOSTATISTICS, V6, P576
   Candille G, 2005, Q J ROY METEOR SOC, V131, P2131, DOI 10.1256/qj.04.71
   McCabe BPM, 2005, INT J FORECASTING, V21, P315, DOI 10.1016/j.ijforecast.2004.11.001
   CLEMENTS MP, 2005, EVALUATING ECONOMETR
   Gotway CA, 2003, STAT MED, V22, P1415, DOI 10.1002/sim.1523
   JOLLIFFE IT, 2003, FORECAST VERIFICATIO
   PEPE MS, 2003, STAT EVALUATION MED
   OHAGAN A, 2003, HIGHLY STRUCTURED ST, P423
   Christensen OF, 2002, BIOMETRICS, V58, P280, DOI 10.1111/j.0006-341X.2002.00280.x
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583
   KNORRHELD L, 2001, BIOSTATISTICS, V2, P109
   Hamill TM, 2001, MON WEATHER REV, V129, P550
   Dawid AP, 1999, ANN STAT, V27, P65
   HANDCOCK MS, 1999, RELATIVE DISTRIBUTIO
   Diebold FX, 1998, INT ECON REV, V39, P863
   Gelfand AE, 1998, BIOMETRIKA, V85, P1
   Wang PM, 1998, J BUS ECON STAT, V16, P27
   Carroll SS, 1997, J HYDROL, V190, P42, DOI 10.1016/S0022-1694(96)03062-4
   FruhwirthSchnatter S, 1996, ENVIRON ECOL STAT, V3, P291
   IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299
   WINKLER RL, 1996, TEST, V5, P1
   BESAG J, 1995, STAT SCI, V10, P3
   WECKER WE, 1989, J BUS ECON STAT, V7, P418
   VUONG QH, 1989, ECONOMETRICA, V57, P307
   MCCULLAGH P, 1989, GEN LINEAR MODELS
   LAWLESS JF, 1987, CAN J STAT, V15, P209
   SMITH JQ, 1985, J FORECASTING, V4, P283
   DAWID AP, 1984, J ROY STAT SOC A STA, V147, P278
   RUBIN DB, 1984, ANN STAT, V12, P1151
   STONE M, 1977, J R STAT SOC B, V39, P44
   EPSTEIN ES, 1969, J APPL METEOROL, V8, P985
   GOOD IJ, 1952, J ROY STAT SOC B, V14, P107
NR 49
TC 13
Z9 13
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0006-341X
J9 BIOMETRICS
JI Biometrics
PD DEC
PY 2009
VL 65
IS 4
BP 1254
EP 1261
DI 10.1111/j.1541-0420.2009.01191.x
PG 8
WC Biology; Mathematical & Computational Biology; Statistics & Probability
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology; Mathematics
GA 524FC
UT WOS:000272128200027
ER
PT J
AU Rathore, SS
   Ketcham, JD
   Alexander, GC
   Epstein, AJ
AF Rathore, Saif S.
   Ketcham, Jonathan D.
   Alexander, G. Caleb
   Epstein, Andrew J.
TI Influence of Patient Race on Physician Prescribing Decisions: A
   Randomized On-Line Experiment
SO JOURNAL OF GENERAL INTERNAL MEDICINE
LA English
DT Article
DE patient race; prescription medication; hypertension;
   hypercholesterolemia; diabetes
ID HIGH BLOOD-PRESSURE; RACIAL DISPARITIES; HEALTH-CARE; QUALITY;
   HYPERTENSION; MANAGEMENT; CHOLESTEROL; ENROLLEES; VIGNETTES; BLACKS
AB Prior research reports black patients have lower medication use for
   hypercholesterolemia, hypertension, and diabetes.
   To assess whether patient race influences physicians' prescribing.
   Web-based survey including three clinical vignettes
   (hypercholesterolemia, hypertension, diabetes), with patient race
   (black, white) randomized across vignettes.
   A total of 716 respondents from 5,141 eligible sampled primary care
   physicians (14% response rate).
   None
   Medication recommendation (any medication vs none, on-patent branded vs
   generic, and therapeutic class) and physicians' treatment adherence
   forecast (10-point Likert scale, 1-definitely not adhere, 10-definitely
   adhere).
   Respondents randomized to view black patients (n = 371) and white
   patients (n = 345) recommend any medications at comparable rates for
   hypercholesterolemia (100.0% white vs 99.5% black, P = 0.50),
   hypertension (99.7% white vs 99.5% black, P = 1.00), and diabetes (99.7%
   white vs 99.7% black, P = 1.00). Patient race influenced medication
   class chosen in the hypertension vignette; respondents randomized to
   view black patients recommended calcium channel blockers more often
   (20.8% black vs 3.2% white) and angiotensin-converting enzyme inhibitors
   less often (47.4% black vs 62.6% white) (P < 0.001). Patient race did
   not influence medication class for hypercholesterolemia or diabetes.
   Respondents randomized to view black patients reported lower forecasted
   patient adherence for hypertension (P < 0.001, mean: 7.3 black vs 7.7
   white) and diabetes (P = 0.05 mean: 7.4 black vs 7.6 white), but race
   had no meaningful influence on forecasted adherence for
   hypercholesterolemia (P = 0.15, mean: 7.2 black vs 7.3 white).
   Racial differences in outpatient prescribing patterns for hypertension,
   hypercholesterolemia, and diabetes are likely attributable to factors
   other than prescribing decisions based on patient race.
C1 [Rathore, Saif S.] Yale Univ, Sch Med, SHM IE 61, MD PhD Program, New Haven, CT 06520 USA.
   [Ketcham, Jonathan D.] Arizona State Univ, WP Carey Sch Business, Tempe, AZ USA.
   [Alexander, G. Caleb] Univ Chicago, Ctr Hlth & Social Serv, Chicago, IL 60637 USA.
   [Alexander, G. Caleb] Univ Chicago, Dept Med, Gen Internal Med Sect, Chicago, IL 60637 USA.
   [Alexander, G. Caleb] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA.
   [Alexander, G. Caleb] Univ Illinois, Dept Pharm Practice, Chicago Sch Pharm, Chicago, IL USA.
   [Epstein, Andrew J.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA.
   [Epstein, Andrew J.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.
RP Rathore, SS (reprint author), Yale Univ, Sch Med, SHM IE 61, MD PhD Program, POB 208025, New Haven, CT 06520 USA
EM saif.rathore@yale.edu
CR Sequist TD, 2008, ARCH INTERN MED, V168, P1145, DOI 10.1001/archinte.168.11.1145
   *AG HEALTHC RES QU, 2008, NAT HEALTHC DISP REP
   EPSTEIN AJ, 2008, AM J MANAGED CARE SP, V14, P5
   Goldstein CE, 2008, J GEN INTERN MED, V23, P81, DOI 10.1007/s11606-007-0413-z
   Gellad WF, 2006, J GEN INTERN MED, V21, P115
   Trivedi AN, 2005, NEW ENGL J MED, V353, P692
   Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520
   Balsa AI, 2005, HEALTH SERV RES, V40, P227
   Rathore SS, 2004, ANN INTERN MED, V141, P635
   Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001
   Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   SEGHAL AR, 2004, HYPERTENSION, V43, P566
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560
   Douglas JG, 2003, ARCH INTERN MED, V163, P525
   Virnig BA, 2002, HEALTH AFFAIR, V21, P224
   Nelson K, 2002, ARCH INTERN MED, V162, P929, DOI 10.1001/archinte.162.8.929
   SMEDLEY BD, 2002, UNEQUAL TREATMENT CO
   VANRYN M, 2002, MED CARE S, V40, P40
   Weisse CS, 2001, J GEN INTERN MED, V16, P211
   Rathore SS, 2000, AM J MED, V108, P561
   Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715
   Schulman KA, 1999, NEW ENGL J MED, V340, P618
   Monane M, 1996, AM J PUBLIC HEALTH, V86, P1805
   ALEXANDER CS, 1978, PUBLIC OPIN QUART, V42, P93
NR 25
TC 1
Z9 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0884-8734
J9 J GEN INTERN MED
JI J. Gen. Intern. Med.
PD NOV
PY 2009
VL 24
IS 11
BP 1183
EP 1191
DI 10.1007/s11606-009-1077-7
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA 514VA
UT WOS:000271422600002
ER
PT J
AU Cassar, G
AF Cassar, Gavin
TI Financial Statement and Projection Preparation in Start-Up Ventures
RID A-1038-2007
SO ACCOUNTING REVIEW
LA English
DT Article
DE accounting information; agency costs; decision-making; financial
   projections; financial statements; start-ups
ID MANAGEMENT ACCOUNTING SYSTEMS; VOLUNTARY; EARNINGS; DISCLOSURE; INCOME;
   MARKET; COMPANIES; EQUITY; GROWTH; ROLES
AB Using a representative sample of entrepreneurs who are in the process of
   starting a business, this study investigates the determinants of the
   preparation of financial statements and projections in start-up
   ventures. Consistent with predictions from information economics and
   contracting, I find that the use of outside funding, level of
   competition, and venture scale are positively associated with the
   intended frequency of financial statement preparation. However,
   comparing the economic significance of alternative influences suggests
   that the benefit of reducing competitive and fundamental uncertainty is
   more influential in explaining variations in intentions to prepare
   financial statements. Further, I find the determinants of preparation
   frequency vary among different financial statements; for instance, cash
   statements are more important for start-ups with products in earlier
   stages of development and with greater competition. In contrast to
   financial statements, the preparation of projections such as formal
   financial projections and regular sales forecasts by start-ups is
   positively associated with the importance of intangible investments such
   as patents, research and development, and with start-ups in high-tech
   industries.
C1 Univ Penn, Philadelphia, PA 19104 USA.
RP Cassar, G (reprint author), Univ Penn, Philadelphia, PA 19104 USA
CR Butler M, 2007, J ACCOUNT ECON, V43, P181, DOI 10.1016/j.jacceco.2007.02.001
   Sandino T, 2007, ACCOUNT REV, V82, P265
   CASSAR G, 2007, ARE INDIVIDUALS ENTE
   Parker SC, 2006, SMALL BUS ECON, V27, P81, DOI 10.1007/s11187-006-9003-4
   Davila A, 2005, ACCOUNT REV, V80, P1039
   Davila T, 2005, ACCOUNT ORG SOC, V30, P223, DOI 10.1016/j.aos.2004.05.006
   GRANLUND M, 2005, MANAGEMENT ACCOUNTIN, V16, P21
   Barton J, 2004, J ACCOUNT ECON, V38, P65, DOI 10.1016/j.jacceco.2004.06.001
   Cassar G, 2004, J BUS VENTURING, V19, P261, DOI 10.1016/S0883-9026(03)00029-6
   GARTNER WB, 2004, HDB ENTREPRENEURIAL
   Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9101.88.5.879
   Sivakumar K, 2003, J ACCOUNTING RES, V41, P397
   KENNEDY P, 2003, GUIDE ECONOMETRICS
   Chen SP, 2002, J ACCOUNT ECON, V33, P229
   Armington C, 2002, REG STUD, V36, P33
   HAYEK FA, 2002, Q J AUSTRIAN EC, V5, P9
   KOTHARI SP, 2002, REV ACCOUNT STUD, V7, P355
   Zimmerman JL, 2001, J ACCOUNT ECON, V32, P411
   Holthausen RW, 2001, J ACCOUNT ECON, V31, P3
   Barth ME, 2001, J ACCOUNTING RES, V39, P1
   Moores K, 2001, ACCOUNT ORG SOC, V26, P351
   Davila T, 2000, ACCOUNT ORG SOC, V25, P383
   Price R, 1999, J ACCOUNT ECON, V28, P391
   Lafontaine F, 1999, J POLIT ECON, V107, P1041
   Berger AN, 1998, J BANK FINANC, V22, P613
   Chenhall RH, 1998, ACCOUNT ORG SOC, V23, P243
   Lafontaine F, 1998, J BUS VENTURING, V13, P95
   Barth ME, 1998, J ACCOUNT ECON, V25, P1
   Gimeno J, 1997, ADMIN SCI QUART, V42, P750
   Kirzner IM, 1997, J ECON LIT, V35, P60
   Mick DG, 1996, J CONSUM RES, V23, P106
   Carter NM, 1996, J BUS VENTURING, V11, P151
   GOMPERS PA, 1995, J FINANC, V50, P1461
   GATEWOOD EJ, 1995, J BUS VENTURING, V10, P371
   ETTREDGE M, 1994, J ACCOUNT ECON, V18, P131
   SIVAKUMAR KN, 1994, CONTEMP ACCOUNT RES, V10, P673
   GOLDEN BR, 1992, ACAD MANAGE J, V35, P848
   BRADBURY ME, 1992, J ACCOUNTING RES, V30, P137
   GORMAN M, 1989, J BUS VENTURING, V4, P231
   CHOW CW, 1987, ACCOUNT REV, V62, P533
   CHENHALL RH, 1986, ACCOUNT REV, V61, P16
   *FIN ACC STAND BOA, 1986, 181 FASB
   HUBER GP, 1985, STRATEGIC MANAGE J, V6, P171
   GORDON LA, 1984, ACCOUNT ORG SOC, V9, P33
   LEFTWICH RW, 1981, J ACCOUNTING RES, V19, P50
   CHANDLER AD, 1977, VISIBLE HAND MANAGER
   KHANDWALLA PN, 1972, J ACCOUNT RES, V10, P275
   Coase RH, 1937, ECONOMICA-NEW SER, V4, P386
   Littleton AC, 1937, ACCOUNT REV, V12, P13
NR 49
TC 7
Z9 7
PU AMER ACCOUNTING ASSOC
PI SARASOTA
PA 5717 BESSIE DR, SARASOTA, FL 34233 USA
SN 0001-4826
J9 ACCOUNT REV
JI Account. Rev.
PD JAN
PY 2009
VL 84
IS 1
BP 27
EP 51
DI 10.2308/accr.2009.84.1.27
PG 25
WC Business, Finance
SC Business & Economics
GA 401RC
UT WOS:000262958600002
ER
PT J
AU Chang, SB
   Lai, KK
   Chang, SM
AF Chang, Shann-Bin
   Lai, Kuei-Kuei
   Chang, Shu-Min
TI Exploring technology diffusion and classification of business methods:
   Using the patent citation network
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE Patent; Patent citation; Basic patent; Technology diffusion
ID INNOVATION; EVOLUTION; MODELS
AB Among the many technology forecasting indicators, patents and patent
   citations are useful and important indicators. The more frequently a
   certain patent is cited by subsequent patents, the more the related
   technology can be said to be diffused, implying that the technology is
   more widely applied and thus more valuable. This paper analyzes the
   business methods technology which retrieves patents from the USPTO
   database. There are two purposes of this paper: 1. establish the
   indicators for finding basic patents and measure the relationship of
   these basic patents; 2. classify the basic patents and explain the
   groups of technology diffusion. Finally, this study identifies the two
   mainstreams in business method technology: one is focused on marketing
   technology, and the other one stresses on data security. Both are
   important for Internet data processes or e-commerce activities. (C) 2008
   Elsevier Inc. All rights reserved.
C1 [Chang, Shann-Bin] Ling Tung Univ, Dept Commercial Technol & Management, Taichung 40852, Taiwan.
   [Lai, Kuei-Kuei] Natl Yunlin Univ Sci & Technol, Dept Business Adm, Touliu, Taiwan.
   [Chang, Shu-Min] Nan Kai Inst Technol, Dept Ind Engn & Management, Nantou, Taiwan.
   [Chang, Shu-Min] Natl Yunlin Univ Sci & Technol, PhD Program BA, Touliu, Taiwan.
RP Chang, SB (reprint author), Ling Tung Univ, Dept Commercial Technol & Management, Taichung 40852, Taiwan
EM stephen.22@hotmail.com
CR Bocquet R, 2007, RES POLICY, V36, P367, DOI 10.1016/j.respol.2006.12.005
   CHANG SB, 2007, J TECHNOL MANAG, V12, P1
   Okamura K, 2006, TECHNOL ANAL STRATEG, V18, P535, DOI 10.1080/09537320601019677
   Daim TU, 2006, TECHNOL FORECAST SOC, V73, P981, DOI 10.1016/j.techfore.2006.04.004
   Sorenson O, 2006, RES POLICY, V35, P994, DOI 10.1016/j.respol.2006.05.002
   Park G, 2006, TECHNOL FORECAST SOC, V73, P793, DOI 10.1016/j.techfore.2005.09.006
   LAI KK, 2006, J TECHNOL MANAG, V11, P137
   CHANG SM, 2006, BUSINESS REV CAMBRID, V5, P122
   Lai KK, 2005, INFORM PROCESS MANAG, V41, P313, DOI 10.1016/j.ipm.2003.11.004
   LAI KK, 2004, J TECHNOLOGY MANAGEM, V9, P1
   STOPLE M, 2002, RES POLICY, V31, P1181
   CHEN S, 2001, STRATEGIC MANAGEMENT
   Geroski PA, 2000, RES POLICY, V29, P603
   SCOTT J, 2000, SOCIAL NETWORK ANAL
   KHALIL TM, 2000, MANAGEMENT TECHNOLOG, P8
   *USPTO, 2000, USPTO WHITE PAPER AU
   AFUAH A, 1998, INNOVATION MANAGEMEN
   HAIR J, 1998, MULTIVARIATE DATA AN
   Narin F, 1997, RES POLICY, V26, P317
   Stuart TE, 1996, STRATEGIC MANAGE J, V17, P21
   *USPTO, 1996, EX GUID COMP REL INV
   MOORE GA, 1995, INSIDE TORNADO MARKE
   JAFFE AB, 1993, Q J ECON, V108, P577
   TUSHMAN ML, 1992, RES ORGAN BEHAV, V14, P311
   HENDERSON RM, 1990, ADMIN SCI QUART, V35, P9
   MAHAJAN V, 1990, J MARKETING, V54, P1
   TUSHMAN ML, 1986, ADMIN SCI QUART, V31, P439
   FOSTER R, 1986, INNOVATION ATTACKERS
   ABERNATHY WJ, 1985, RES POLICY, V14, P3
   ROGERS EM, 1983, DIFFUSION INNOVATION
   ABERNATHY WJ, 1978, TECHNOL REV, V80, P40
   BASS FM, 1969, MANAGE SCI, V15, P215
   KUHN TS, 1962, STRUCTURE SCI REVOLU
   MANSFIELD E, 1961, ECONOMETRICA, V29, P741
   FOURT LA, 1960, J MARKETING, V25, P31
   SCHUMPETER JA, 1950, CAPITALISM SOCIALISM, P3
NR 36
TC 10
Z9 10
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD JAN
PY 2009
VL 76
IS 1
BP 107
EP 117
DI 10.1016/j.techfore.2008.03.014
PG 11
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 402OD
UT WOS:000263022100009
ER
PT J
AU Quintella, CM
   Teixeira, LSG
   Korn, MGA
   Neto, PRC
   Torres, EA
   Castro, MP
   Jesus, CAC
AF Quintella, Cristina M.
   Teixeira, Leonardo S. G.
   Korn, Maria Gracas A.
   Costa Neto, Pedro R.
   Torres, Ednildo A.
   Castro, Marilu P.
   Jesus, Carlos A. C.
TI BIODIESEL CHAIN FROM THE LAB BENCH TO THE INDUSTRY: AN OVERVIEW WITH
   TECHNOLOGY ASSESMENT, R&D&I OPPORTUNITIES AND TASKS.
SO QUIMICA NOVA
LA Portuguese
DT Review
DE biofuels production chain; technology assessment; forecasting
ID SOYBEAN OIL; GAS-CHROMATOGRAPHY; VEGETABLE-OILS; TRANSESTERIFICATION;
   DIESEL; CATALYSTS; ESTERS; FUELS; SPECTROMETRY; EMISSIONS
AB BIODIESEL CHAIN FROM THE LAB BENCH TO THE INDUSTRY: AN OVERVIEW WITH
   TECHNOLOGY ASSESMENT, R&D&I OPPORTUNITIES AND TASKS. Contextualized
   overview of the Biodiesel Production Chain, from the lab bench to the
   industry, with critical evaluation of state-of-art and technological
   development through scientific articles and patents, focusing on
   feedstock, reaction/production, first and second generation processes,
   specification and quality, transport, storage, co-products (effluents
   and sub-products), and emissions. Challenges are identified and
   solutions are proposed based on the Brazilian feedstock, edaphoclimatic
   conditions, process monitoring in remote regions, state policy, and
   environment preservation, among others. Forecasts are made based on the
   technology assessment, identifying future trends and opportunities for
   R&D&I.
C1 [Quintella, Cristina M.; Teixeira, Leonardo S. G.; Korn, Maria Gracas A.; Costa Neto, Pedro R.; Torres, Ednildo A.; Castro, Marilu P.; Jesus, Carlos A. C.] Univ Fed Bahia, Inst Quim, BR-40170290 Salvador, BA, Brazil.
RP Quintella, CM (reprint author), Univ Fed Bahia, Inst Quim, Campus Ondina, BR-40170290 Salvador, BA, Brazil
EM cristina@ufba.br
CR Garcez CAG, 2009, ENERGY, V34, P645, DOI 10.1016/j.energy.2008.11.005
   FERRO AA, 2009
   Monteiro MR, 2008, TALANTA, V77, P593, DOI 10.1016/j.talanta.2008.07.001
   Shahid EM, 2008, RENEW SUST ENERG REV, V12, P2484, DOI 10.1016/j.rser.2007.06.001
   Guarieiro LLN, 2008, ATMOS ENVIRON, V42, P8211, DOI 10.1016/j.atmosenv.2008.07.053
   Perin G, 2008, FUEL, V87, P2838, DOI 10.1016/j.fuel.2008.01.018
   Sharma YC, 2008, FUEL, V87, P2355, DOI 10.1016/j.fuel.2008.01.014
   Azcan N, 2008, FUEL, V87, P1781, DOI 10.1016/j.fuel.2007.12.004
   Marchetti JM, 2008, FUEL PROCESS TECHNOL, V89, P740, DOI 10.1016/j.fuproc.2008.01.007
   Ranganathan SV, 2008, BIORESOURCE TECHNOL, V99, P3975, DOI 10.1016/j.biortech.2007.04.060
   Kawashima A, 2008, BIORESOURCE TECHNOL, V99, P3439, DOI 10.1016/j.biortech.2007.08.009
   Georgogianni KG, 2008, FUEL PROCESS TECHNOL, V89, P503, DOI 10.1016/j.fuproc.2007.10.004
   Schenk PM, 2008, BIOENERG RES, V1, P20, DOI 10.1007/s12155-008-9008-8
   Pradhan A, 2008, T ASABE, V51, P185
   de la Piscina PR, 2008, CHEM SOC REV, V37, P2459, DOI 10.1039/b712181b
   Chaves ES, 2008, J BRAZIL CHEM SOC, V19, P856, DOI 10.1590/S0103-50532008000500008
   Urioste D, 2008, QUIM NOVA, V31, P407, DOI 10.1590/S0100-40422008000200038
   Melo WC, 2008, J BRAZIL CHEM SOC, V19, P418, DOI 10.1590/S0103-50532008000300008
   Rocha DD, 2008, QUIM NOVA, V31, P1062
   Milinsk MC, 2008, J BRAZIL CHEM SOC, V19, P1475, DOI 10.1590/S0103-50532008000800006
   Guarieiro LLN, 2008, QUIM NOVA, V31, P421, DOI 10.1590/S0100-40422008000200041
   LEITINHO JL, 2008, AN 18 C BRAS ENG CIE
   CRUZ RS, 2008, REV BAHIA ANAL UNPUB
   JESUS CAC, 2008, THESIS U FEDERAL BAH
   SILVA ARV, 2008, REV ELCT MAT PROCESS, V3, P26
   MIYAZAKI SF, 2008, CADERNOS PROSPECCAO, V1, P10
   SANTOS FN, 2008, CADERNOS PROSPECCAO, V1, P22
   VINICIO E, 2008, CADERNOS PROSPECCAO, V1, P24
   SOUZA MP, 2008, CADERNOS PROSPECCAO, V1, P28
   CURVELO A, 2008, CADERNOS PROSPECCAO, V1, P30
   CERQUEIRA G, 2008, CADERNOS PROSPECCAO, V1, P38
   MAYERHOFF ZDV, 2008, CADERNOS PROSPECCAO, V1, P7
   Ferreira SL, 2008, QUIM NOVA, V31, P539
   Souza AG, 2007, J THERM ANAL CALORIM, V90, P945, DOI 10.1007/s10973-006-8199-5
   Geris R, 2007, QUIM NOVA, V30, P1369, DOI 10.1590/S0100-40422007000500053
   Rinaldi R, 2007, QUIM NOVA, V30, P1374, DOI 10.1590/S0100-40422007000500054
   Ribeiro NM, 2007, ENERG FUEL, V21, P2433, DOI 10.1021/ef070060r
   Issariyakul T, 2007, FUEL PROCESS TECHNOL, V88, P429, DOI 10.1016/j.fuproc.2006.04.007
   Suarez PAZ, 2007, QUIM NOVA, V30, P667
   Lima JRD, 2007, QUIM NOVA, V30, P600
   Narasimharao K, 2007, J BIOBASED MATER BIO, V1, P19, DOI 10.1166/jbmb.2007.002
   HUNTLEY ME, 2007, MITIG ADAPT STRAT GL, V12, P573, DOI 10.1007/s11027-006-7304-1
   Shibasaki-Kitakawa N, 2007, BIORESOURCE TECHNOL, V98, P416, DOI 10.1016/j.biortech.2005.12.010
   Suarez PAZ, 2007, QUIM NOVA, V30, P2068, DOI 10.1590/S0100-40422007000800046
   Domingos AK, 2007, J BRAZIL CHEM SOC, V18, P416, DOI 10.1590/S0103-50532007000200026
   Falate R, 2007, QUIM NOVA, V30, P1677
   Faria RCM, 2007, QUIM NOVA, V30, P1900, DOI 10.1590/S0100-40422007000800020
   ARAUJO JC, 2007, AN 2 C RED BRAS TECN
   BORGES S, 2007, AN 2 C RED BRAS TECN
   CARDOSO RV, 2007, AN 2 C RED BRAS TECN
   COSTA FX, 2007, AN 2 C RED BRAS TECN
   DASILVA CRB, 2007, AN 2 C RED BRAS TECN
   DOSSANTOS CMC, 2007, AN 2 C RED BRAS TECN
   FREITAS LBDE, 2007, AN 2 C RED BRAS TECN
   GUIMARAES J, 2007, AN 2 C RED BRAS TECN
   XAVIER D, 2007, AN 2 C RED BRAS TECN
   DESTEFANO AO, 2007
   MACHADO GSV, 2007
   POLI DM, 2007
   PREHN CM, 2007
   ZHANG Y, 2007, ENERG FUEL, V21, P2012
   BORGES SMS, 2007, B TECNICO PRODUCAO P, V2, P131
   Froehner S, 2007, QUIM NOVA, V30, P2016, DOI 10.1590/S0100-40422007000800037
   Macedo CCS, 2006, J BRAZIL CHEM SOC, V17, P1291, DOI 10.1590/S0103-50532006000700014
   Hamelinck CN, 2006, ENERG POLICY, V34, P3268, DOI 10.1016/j.enpol.2005.06.012
   Demirbas MF, 2006, ENERG CONVERS MANAGE, V47, P2371, DOI 10.1016/j.enconman.2005.11.014
   Meher LC, 2006, RENEW SUST ENERG REV, V10, P248, DOI 10.1016/j.rser.2004.09.002
   Kulkarni MG, 2006, IND ENG CHEM RES, V45, P2901, DOI 10.1021/ie0510526
   CAMARA GMS, 2006, AGRONEGOCIO PLANTAS
   ALMEIDA CHT, 2006, AN 1 C RED BRAS TECN
   CORREA SM, 2006, AN 1 C RED BRAS TECN
   ROBRA S, 2006, AN 1 C RED BRAS TECN
   TEIXEIRA C, 2006, AN C RED BRAS TECN B
   GUIMARAES AK, 2006, PREMIO PETROBRAS TEC
   ARANDA DAG, 2006
   AZCAN N, 2006
   CASTIGLIONI RF, 2006
   COVALSKI CE, 2006
   DAMELLO LMB, 2006
   DASILVA RM, 2006
   FERRARI RA, 2006
   GARCIA JL, 2006
   GOMES JR, 2006
   GUIMARAES JL, 2006
   GUIMARAES WG, 2006
   JORGE JB, 2006
   LOPES OC, 2006
   NAKAGAKI S, 2006
   SANTOS CMC, 2006
   SCHUCHARDT UF, 2006
   SILVA IPG, 2006
   SOARES JE, 2006
   HUBER GW, 2006, CHEM REV, V106, P404
   Pinto AC, 2005, J BRAZIL CHEM SOC, V16, P1313
   Ju YH, 2005, J SCI IND RES INDIA, V64, P866
   Ferrari RA, 2005, QUIM NOVA, V28, P19
   GOMES JR, 2005
   BORGES S, 2005, PREMIO PETROBRAS TEC
   AGNOL AD, 2005
   ANTUNES OAC, 2005
   CASTIGLIONI RF, 2005
   DEANDRADE JB, 2005
   DESANTIS EJ, 2005
   GOMES JR, 2005
   GOMES JR, 2005
   LOPES OC, 2005
   PAZ MJD, 2005
   PEREIRA AT, 2005
   PRADELLA JGD, 2005
   PREHN KG, 2005
   QUINTELLA CM, 2005
   TOMAZ AJG, 2005
   VIEIRA JAV, 2005
   OLIVEIRA LG, 2005, QUIM NOVA, V28, pS36
   Furuta S, 2004, CATAL COMMUN, V5, P721, DOI 10.1016/j.catcom.2004.09.001
   Suppes GJ, 2004, APPL CATAL A-GEN, V257, P213, DOI 10.1016/j.apcata.2003.07.010
   COOKE B, 2004
   DEAGUIAR FB, 2004
   HOUTEN MV, 2004
   IIJIMA W, 2004
   LUXEM FJ, 2004
   OGLIO ELD, 2004
   PORTNOFF MA, 2004
   PORTNOFF MA, 2004
   SATO S, 2004
   SILVA RDD, 2004
   DESANTIS EJ, 2004
   COOKE BS, 2003
   CRUZ CHB, 2003, SEM BRAS DES IE UFRJ
   COSTA A, 2003, 1 SEM BIOD EST PAR C
   CASTRO HF, 2003
   IIJIMA W, 2003
   LUXEM FJ, 2003
   CARMO M, 2003, QUIM NOVA, V26, P265
   Garofalo R, 2002, OCL-OL CORPS GRAS LI, V9, P299
   CAMARGO XIS, 2001
   Neto PRC, 2000, QUIM NOVA, V23, P531
   WAYNE RP, 2000, CHEM ATMOSPHERES
   TORRES EA, 2000, RES ENC NAC EN MEIO
   BOOCOCK DGB, 2000
   BOOCOCK DGB, 2000
   Ma FR, 1999, BIORESOURCE TECHNOL, V70, P1
   Bender M, 1999, BIORESOURCE TECHNOL, V70, P81, DOI 10.1016/S0960-8524(99)00009-7
   SHEEHAN J, 1998, NRELTP58024190
   FOGLIA TA, 1998
   SCHAFER F, 1995, REDUCED EMISSIONS FU
   BROWN LM, 1993, ENERG CONVERS MANAGE, V34, P1005
   WIMMER T, 1989
   FREEDMAN B, 1984, J AM OIL CHEM SOC, V61, P1638
   SPRULES FJ, 1950
   KEIM GI, 1945
   YAAKOUB MC, AN 2 C RED BRAS TECN
   LOURENCO S, B AGENCIA FAPESP
   QUINTELLA CM, BAHIA ANAL DAD UNPUB
NR 154
TC 4
Z9 4
PU SOC BRASILEIRA QUIMICA
PI SAO PAULO
PA CAIXA POSTAL 26037, 05599-970 SAO PAULO, BRAZIL
SN 0100-4042
J9 QUIM NOVA
JI Quim. Nova
PY 2009
VL 32
IS 3
BP 793
EP 808
PG 16
WC Chemistry, Multidisciplinary
SC Chemistry
GA 452OU
UT WOS:000266551600022
ER
PT J
AU Kuzhel, EV
   Herasymchuk, ZV
AF Kuzhel, E. V.
   Herasymchuk, Z. V.
TI INFORMATION ASPECTS OF FORECAST & ANALYTICAL RESEARCH
SO ACTUAL PROBLEMS OF ECONOMICS
LA Russian
DT Article
DE innovative component; forecast; research; innovations management; system
   approach; patent information
AB The article studies the possibilities of increasing the efficiency of
   managerial decisions in the field of innovations during the forecast &
   analytical research by means of using patent information.
CR PARKHOMENKO VD, 2008, INFORM ANALIZ PROGNO, P35
   NADZHAFAROV ZM, 2008, INFORMATSIYA INNOVAT, P2
   RIZHENKO AA, 2007, RYNOK TEKHNOL PROBL, P136
   FEDULOVA LI, 2006, EKONOMICHNE PROGNOZU, P65
   SAVERCHENKO OO, 2000, INFORM RESURSY NAUK, P97
   ALEKSANDROV LV, 1991, METOD PROGNOZ TEKHN
   KIRSANOV KA, 1991, PROGNOZ NAUCH TEKHN
   1980, MATER MIZNAROD SIMPO, P180
NR 8
TC 0
Z9 0
PU NATIONAL ACAD MANAGEMENT
PI KYIV
PA VUL PANASA MYMOGO 26, KYIV, 01011, UKRAINE
SN 1993-6788
J9 ACTUAL PROBL ECON
JI Actual Probl. Econ.
PY 2009
IS 92
BP 199
EP 203
PG 5
WC Economics
SC Business & Economics
GA 418QX
UT WOS:000264164600024
ER
PT J
AU Layton, B
AF Layton, Bradley
TI Recent Patents in Bionanotechnologies: Nanolithography,
   Bionanocomposites, Cell-Based Computing and Entropy Production
SO RECENT PATENTS ON NANOTECHNOLOGY
LA English
DT Article
DE Bionanotechnology; biomimickery; bio-inspired; dip-pen; nanotechnology;
   printing; information; entropy
ID DIP-PEN NANOLITHOGRAPHY; ATOMIC-FORCE MICROSCOPY; MICROELECTRODE ARRAYS;
   NEURONAL NETWORKS; CARBON NANOTUBES; COLLAGEN FIBRILS; SPRAGUE-DAWLEY;
   MOLECULES; FUTURE; NANOMANIPULATION
AB This article reviews recent disclosures of bio-inspired, bio-mimicked
   and bionanotechnologies. Among the patents discussed is a nanoscale
   porous structure for use in nanocomposites and nanoscale processing.
   Patents disclosing methods for printing biological materials using
   nanolithography techniques such as dip-pen technology are discussed, as
   are patents for optimizing drug design. The relevance of these
   technologies to disease prevention, disease treatment and disease
   resistance is discussed. The paper closes with a review of cell-based
   computing and a brief examination of how information technology has
   enabled the development of these technologies. Finally, a forecast of
   the how these technologies are likely to accelerate global entropization
   is discussed as well as a new classification of machine types.
C1 Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Layton, B (reprint author), Drexel Univ, Dept Mech Engn & Mech, 151G Curtis Hall,3141 Chestnut St, Philadelphia, PA 19104 USA
EM blay@drexel.edu
CR BECKER WM, 2009, WORLD CELL
   Greco F, 2008, FRONT BIOSCI-LANDMRK, V13, P2744, DOI 10.2741/2882
   Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258
   Chen W, 2007, J PHYS D APPL PHYS, V40, P6287, DOI 10.1088/0022-3727/40/20/S13
   van Winterswijk PJ, 2007, WOUNDS, V19, P277
   Chansin GAT, 2007, NANO LETT, V7, P2901, DOI 10.1021/nl071855d
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   Dyson F, 2007, NEW YORK REV BOOKS, V54, P4
   Kim MJ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/20/205302
   Cotton RGH, 2007, NAT GENET, V39, P433
   Freedman JR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711521
   Cavalcanti A, 2007, RECENT PAT NANOTECH, V1, P1
   Xie JW, 2007, INT J NANOMED, V2, P479
   2007, APPL PHYS LAB C SERI
   SASOGLU FM, 2007, 29 ANN INT C IEEE EN
   ADDISON E, 2007
   LAYTON BE, 2007
   MANDELL AJ, 2007
   MARQUEZ G, 2007
   Layton BE, 2006, ACTA BIOMATER, V2, P595, DOI 10.1016/j.actbio.2006.05.013
   Vuillaume D, 2006, PRAMANA-J PHYS, V67, P17
   Mattia D, 2006, J PHYS CHEM B, V110, P9850, DOI 10.1021/jp061138s
   PATEL RA, 2006, 8 BIENN ASME C ENG S
   ASMUSSEN J, 2006
   BREITENKAMP K, 2006
   Layton BE, 2005, MICROELECTRON J, V36, P644, DOI 10.1016/j.mejo.2005.04.051
   Ilic B, 2005, NANO LETT, V5, P925, DOI 10.1021/nl050456k
   Holmes DF, 2005, J MOL BIOL, V345, P773, DOI 10.1016/j.jmb.2004.10.078
   KURZWEIL R, 2005, SINGULARITY IS NEAR, pR17
   WADE LA, 2005
   Layton BE, 2004, J BIOMECH ENG-T ASME, V126, P803, DOI 10.1115/1.1824118
   Layton BE, 2004, BIOTECHNIQUES, V37, P564
   Bronco S, 2004, J PHYS CHEM B, V108, P10101, DOI 10.1021/jp049172z
   O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004
   Layton BE, 2004, J BIOMECH, V37, P879, DOI 10.1016/j.jbiomech.2003.11.008
   YOCKEY HP, 2004, INFORM THEORY EVOLUT
   DARBY PC, 2004
   Wang H, 2003, DIABETES-METAB RES, V19, P288, DOI 10.1002/dmrr.372
   Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230
   MOFFAT BA, 2003, MOL IMAGING, V2, P324, DOI 10.1162/153535003322750664
   AVERY J, 2003, INFORM THEORY EVOLUT
   ROUSCHE, 2003, NEURABOTICS INTEGRAT, P462
   POTTER, 2003, P IEEE EMBS, P4
   FORAN DJ, 2003
   Schaeferling M, 2002, ELECTROPHORESIS, V23, P3097
   Demers LM, 2002, SCIENCE, V296, P1836
   Egeland RD, 2002, ANAL CHEM, V74, P1590, DOI 10.1021/ac010953v
   Griscom L, 2002, SENSOR ACTUAT B-CHEM, V83, P15
   Houseman BT, 2002, NAT BIOTECHNOL, V20, P270
   Su M, 2002, J AM CHEM SOC, V124, P1560, DOI 10.1021/ja012502y
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660
   Wadu-Mesthrige K, 2001, BIOPHYS J, V80, P1891
   COREN RL, 2001, ENTROPY, V3, P259
   MAKALIWE JH, 2001, IEEE INT S ASS TASK
   Morefield SI, 2000, BIOSENS BIOELECTRON, V15, P383
   ABBAS AK, 2000, CELLULAR MOL IMMUNOL
   GARFINKLE SL, 2000, MIT TECHNOLOGY REV, V3, P70
   LAHOZBELTRA R, 2000, COMPUTATIONAL VIEW C
   KANEHISA M, 2000, POST GENOME INFORM
   HICKMAN JJ, 2000, WORKSH BIOL COMP DOE
   MONTGOMERY D, 2000
   Pancrazio JJ, 1999, ANN BIOMED ENG, V27, P697
   Piner RD, 1999, SCIENCE, V283, P661
   KOZA J, 1999, GENETIC PROGRAMMING
   FREITAS RA, 1999, NANOMEDICINE
   De Vos A, 1999, PROG QUANT ELECTRON, V23, P1
   KURZWEIL R, 1999, AGE SPIRITUAL MACHIN, pR12
   Pancrazio JJ, 1998, SENSOR ACTUAT B-CHEM, V53, P179
   Falvo MR, 1998, MICROSC MICROANAL, V4, P504
   Bondyopadhyay PK, 1998, P IEEE, V86, P78, DOI 10.1109/5.658761
   COREN RL, 1998, WORLD FUTURES GEN EV, V11, pR14
   DeVente JE, 1997, J ELECTRON MICROSC, V46, P353
   BRAY D, 1995, NATURE, V376, P307
   GROSS GW, 1995, BIOSENS BIOELECTRON, V10, P553
   ADLEMAN LM, 1994, SCIENCE, V266, P1021
   KOZA JR, 1994, GENETIC PROGRAMMING, pR2
   YOCKEY HP, 1992, INFORM THEORY MOL BI, pR19
   WASSERMAN PD, 1989, NEURAL COMPUTING THE
   MINSKY M, 1988, SOC MIND
   DREXLER KE, 1986, ENGINES CREATION, pR12
   HUNKAPILLER M, 1984, NATURE, V310, P105
   GROSS GW, 1977, NEUROSCI LETT, V6, P101
   CRICK F, 1970, NATURE, V227, P561
   MOROWITZ HJ, 1970, ENTROPY BIOL INTRO T
   MOORE GE, 1965, ELECTRONICS, V38, P114
   BORNSTEIN PG, 1964, J CLIN INVEST, V43, P1813
   CRICK FH, 1958, S SOC EXP BIOL, V12
   SHANNON CE, 1948, AT&T TECH J, V27, P623
NR 88
TC 0
Z9 0
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1872-2105
J9 RECENT PAT NANOTECH
JI Recent Pat. Nanotechnology
PD JUN
PY 2008
VL 2
IS 2
BP 72
EP 83
DI 10.2174/187221008784534532
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA V15QC
UT WOS:000207815500001
ER
PT J
AU Kim, YG
   Suh, JH
   Park, SC
AF Kim, Young Gil
   Suh, Jong Hwan
   Park, Sang Chan
TI Visualization of patent analysis for emerging technology
SO EXPERT SYSTEMS WITH APPLICATIONS
LA English
DT Article
DE visualization; patent analysis; k-Means clustering; semantic network;
   ubiquitous computing technology
AB Many methods have been developed to recognize those progresses of
   technologies, and one of them is to analyze patent information. And
   visualization methods are considered to be proper for representing
   patent information and its analysis results. However, current
   visualization methods for patent analysis patent maps have some
   drawbacks. Therefore, we propose an alternative visualization method in
   this paper. With colleted keywords from patent documents of a target
   technology field, we cluster patent documents by the k-Means algorithm.
   With the clustering results, we form a semantic network of keywords
   without respect of filing dates. And then we build up a patent map by
   rearranging each keyword node of the semantic network according to its
   earliest filing date and frequency in patent documents. Our approach
   contributes to establishing a patent map which considers both structured
   and unstructured items of a patent document. Besides, differently from
   previous visualization methods for patent analysis, ours is based on
   forming a semantic network of keywords from patent documents. And
   thereby it visualizes a clear overview of patent information in a more
   comprehensible way. And as a result of those contributions, it enables
   us to understand advances of emerging technologies and forecast its
   trend in the future. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Kim, Young Gil; Suh, Jong Hwan; Park, Sang Chan] Korea Adv Inst Sci & Technol, Dept Ind Engn, Taejon 305701, South Korea.
RP Park, SC (reprint author), Korea Adv Inst Sci & Technol, Dept Ind Engn, Guseong Dong, Taejon 305701, South Korea
EM sangchanpark@kaist.ac.kr
CR Trappey AJC, 2006, EXPERT SYST APPL, V31, P755, DOI 10.1016/j.eswa.2006.01.013
   RYOO JH, 2005, WORKSH H WHAT PATENT
   FLEISCH E, 2005, ITU WORKSH
   TSENG YH, 2005, IACIS PAC 2005 C P, P1109
   Fall CJ, 2004, EXPERT SYST APPL, V26, P269, DOI 10.1016/S0957-4174(03)00141-6
   YOON B, 2004, J HIGH TECHNOLOGY MA, V15, P37
   BLACK D, 2004, MACHINE LEARNING PAT
   GANAPATHY S, 2004, COMMUN ACM, V47, P92
   CAMUS C, 2003, WORLD PATENT INFORM, V25, P155, DOI 10.1016/S0172-2190(02)00131-X
   FATTORI M, 2003, WORLD PATENT INFORM, V25, P335
   *WIPO, 2003, WIPO MOST INT TRAIN, V16
   LIU SJ, 2003, 1 AS PAC C PAT MAPS, P2
   Morris S, 2002, COMPUT IND ENG, V43, P841
   LAMIREL JC, 2002, P ACL 2003 WORKSH PA
   MULLER CD, 2002, P 36 HAW INT C SYST
   CLEMONS E, 2000, INTERNET FUTURE FINA
   *JAP I INV INN, 2000, GUID BOOK PRACT US P
   WESTPHAL C, 1998, DATA MINING SOLUTION
   WEISER M, 1991, SCI AM, P94
NR 19
TC 16
Z9 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0957-4174
J9 EXPERT SYST APPL
JI Expert Syst. Appl.
PD APR
PY 2008
VL 34
IS 3
BP 1804
EP 1812
DI 10.1016/j.eswa.2007.01.033
PG 9
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic; Operations Research & Management Science
SC Computer Science; Engineering; Operations Research & Management Science
GA 262YB
UT WOS:000253183700022
ER
PT J
AU Sutradhar, BC
AF Sutradhar, Brajendra C.
TI On forecasting counts
SO JOURNAL OF FORECASTING
LA English
DT Article
DE non-stationary counts; observation-driven longitudinal autocorrelations;
   one-step-ahead forecasting; over-clispersion; regression effects
ID TIME-SERIES; MODELS
AB Forecasting for a time series of low counts, such as forecasting the
   number of patents to be awarded to an industry, is an important research
   topic in socioeconomic sectors. Recently (2004), Freeland and McCabe
   introduced a Gaussian type stationary correlation model-based
   forecasting which appears to work well for the stationary time series of
   low counts. In practice, however, it may happen that the time series of
   counts will be non-stationary and also the series may contain
   over-dispersed counts. To develop the forecasting functions for this
   type of non-stationary over-dispersed data, the paper provides all
   extension of the stationary correlation models for Poisson counts to the
   non-stationary correlation models for negative binomial counts. The
   forecasting methodology appears to work well, for example, for a US time
   series of polio counts, whereas the existing Bayesian methods of
   forecasting appear to encounter serious convergence problems. Further, a
   simulation study is conducted to examine the performance of the proposed
   forecasting functions. which appear to work well irrespective of whether
   the time series contains small or large counts. Copyright (c) 2008 John
   Wiley & Sons, Ltd.
C1 Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada.
RP Sutradhar, BC (reprint author), Mem Univ Newfoundland, Dept Math & Stat, St John, NF A1C 5S7, Canada
EM bsutradh@math.mun.ca
CR McCabe BPM, 2005, INT J FORECASTING, V21, P315, DOI 10.1016/j.ijforecast.2004.11.001
   MALLICK T, 2005, ANAL TIME SERIES NON
   Freeland RK, 2004, J TIME SER ANAL, V25, P701
   Freeland RK, 2004, INT J FORECASTING, V20, P427, DOI 10.1016/S0169-2070(03)00014-1
   Sutradhar BC, 2003, STAT SCI, V18, P377
   Jowaheer V, 2002, BIOMETRIKA, V89, P389
   Settimi R, 2000, J FORECASTING, V19, P135
   ALOSH MA, 1992, COMMUN STAT THEORY, V21, P2483
   HARVEY AC, 1989, J BUS ECON STAT, V7, P407
   HARVEY AC, 1989, FORECASTING STRUCTUR
   ZEGER SL, 1988, BIOMETRIKA, V75, P621
   MCKENZIE E, 1988, ADV APPL PROBAB, V20, P822
   MCKENZIE E, 1986, ADV APPL PROBAB, V18, P679
   ABRAMOWITZ M, 1965, HDB MATH FUNCTIONS
NR 14
TC 1
Z9 1
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0277-6693
J9 J FORECASTING
JI J. Forecast.
PD MAR
PY 2008
VL 27
IS 2
BP 109
EP 129
DI 10.1002/for.1044
PG 21
WC Management; Planning & Development
SC Business & Economics; Public Administration
GA 278FB
UT WOS:000254268700002
ER
PT J
AU Yoon, B
   Phaal, R
   Probert, D
AF Yoon, Byungun
   Phaal, Rob
   Probert, David
TI Morphology analysis for technology roadmapping: application of text
   mining
SO R & D MANAGEMENT
LA English
DT Article
ID FIELD ANOMALY RELAXATION; SCIENCE
AB The practice of technology roadmapping (TRM) has received much attention
   from researchers and practitioners, to support planning and forecasting
   in companies and sectors. However, little research has focused on the
   support of well-organized information for more effective roadmapping and
   the presentation of in-depth configurations of new products or
   technology. This paper proposes a roadmapping methodology to assist
   decision-making by applying a systematic approach based on quantitative
   data. To this end, key information is extracted from documents such as
   product manuals and patent documents by text mining, which is then used
   to identify the morphology of existing products and technology.
   Morphology analysis (MA) also plays a crucial role in deriving promising
   opportunities for new development of product or technology by matching
   product and technology morphology. Therefore, MA-based TRM can enable
   the effective exploitation of large quantities of significant
   information that might otherwise be left untapped, supporting innovation
   by generating a comprehensive set of detailed product and technology
   configurations. The proposed MA-based TRM approach can be applied to
   both incremental and radical innovation, supporting both market pull and
   technology push. The method is illustrated with a detailed example for
   mobile phones to demonstrate its practical application.
C1 [Yoon, Byungun] Dongguk Univ, Dept Ind & Syst Engn, Sch Engn, Seoul, South Korea.
   [Phaal, Rob; Probert, David] Univ Cambridge, Ctr Technol Management, Dept Engn, Mfg & Management Div, Cambridge, England.
RP Yoon, B (reprint author), Dongguk Univ, Dept Ind & Syst Engn, Sch Engn, 3-26 Pil Dong 3ga, Seoul, South Korea
EM postman3@dongguk.edu
   rp108@eng.cam.ac.uk
   drp1001@cam.ac.uk
CR Silin D, 2006, PHYSICA A, V371, P336, DOI 10.1016/j.physa.2006.04.048
   MEREDITH JR, 2005, PROJECT MANAGEMENT M
   GERDSRI N, 2005, P PICMET PORT OR
   PHAAL R, 2005, P PICMET PORTL OR
   PHAAL R, 2005, TECHNOLOGICAL FORECA, V71, P5
   Clifton C, 2004, IEEE T KNOWL DATA EN, V16, P949, DOI 10.1109/TKDE.2004.32
   Phaal R, 2004, TECHNOL FORECAST SOC, V71, P5, DOI 10.1016/S0040-1625(03)00072-6
   Kostoff RN, 2004, TECHNOL FORECAST SOC, V71, P141, DOI 10.1016/S0040-1625(03)00048-9
   Saritas O, 2004, TECHNOL FORECAST SOC, V71, P27, DOI 10.1016/S0040-1625(03)00067-2
   YASUNAGA Y, 2004, P IEMC SINGP
   YOON BU, 2004, TECHNOLOGICAL FORECA, V72, P145
   LIZASO F, 2004, INT J TECHNOLOGY INT, V1, P668
   Albright RE, 2003, RES TECHNOL MANAGE, V46, P31
   Phaal R, 2003, RES TECHNOL MANAGE, V46, P52
   LI M, 2003, P IEMC ALB NEW YORK
   ALBRIGHT RE, 2003, P IEMC NEW YORK
   GLENN JC, 2003, FUTURES RES METHODOL
   Adner R, 2002, CALIF MANAGE REV, V45, P50
   Zhu DH, 2002, TECHNOL FORECAST SOC, V69, P495
   Huckvale M, 2002, COMPUT SPEECH LANG, V16, P165, DOI 10.1006/csla.2001.0187
   Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283
   Porter AL, 2002, SCIENTOMETRICS, V53, P351
   RITCHEY T, 2002, P 4 INT C LOC AUTH S
   DUCKLES JM, 2002, P IEMC CAMBR UK
   YOON BU, 2002, R&D MANAGE, V34, P291
   Kostoff RN, 2001, IEEE T ENG MANAGE, V48, P132, DOI 10.1109/17.922473
   Dhillon IS, 2001, MACH LEARN, V42, P143
   Kappel TA, 2001, J PROD INNOVAT MANAG, V18, P39
   PHAAL R, 2001, P PICMET PORTL OR
   Probert D, 1999, INT J TECHNOL MANAGE, V17, P646
   MANI I, 1999, ADV AUTOMATIC TEXT S
   HSU CN, 1999, P INT JOINT C ART IN
   Galvin R, 1998, SCIENCE, V280, P803
   ALBRIGHT R, 1998, P TECHN ROADM WORKSH
   FELDMAN R, 1998, P 2 PAKM BAS SWITZ
   FREITAB D, 1998, P 15 C ART INT AAAI
   ROHRER RM, 1998, P 1998 IEEE S INF VI
   IANSITI M, 1998, TEHCNOLOGY INTEGRATI
   GARCIA ML, 1998, SAND970665
   Groenveld P, 1997, RES TECHNOL MANAGE, V40, P48
   Watts RJ, 1997, TECHNOL FORECAST SOC, V56, P25
   Coyle RG, 1996, FUTURES, V28, P269
   FELDMAN R, 1996, J INTELL INF SYST, V9, P83
   RHYNE R, 1995, FUTURES, V27, P657
   PIATETSKYSHAPIR.G, 1991, KNOWLEDGE DISCOVERY
   WISSEMA JG, 1976, FUTURES, V8, P146
NR 46
TC 12
Z9 12
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0033-6807
J9 R&D MANAGE
JI R D Manage.
PD JAN
PY 2008
VL 38
IS 1
BP 51
EP 68
PG 18
WC Business; Management
SC Business & Economics
GA 244JY
UT WOS:000251863400004
ER
PT J
AU Marshall, DA
   Douglas, PR
   Drummond, MF
   Torrance, GW
   MacLeod, S
   Manti, O
   Cheruvu, L
   Corvari, R
AF Marshall, Deborah A.
   Douglas, Patrick R.
   Drummond, Michael F.
   Torrance, George W.
   MacLeod, Stuart
   Manti, Orlando
   Cheruvu, Lokanadha
   Corvari, Ron
TI Guidelines for conducting pharmaceutical budget impact analyses for
   submission to public drug plans in Canada
SO PHARMACOECONOMICS
LA English
DT Review
ID ISPOR TASK-FORCE; PRINCIPLES
AB Until now, there has been no standardized method of performing and
   presenting budget impact analyses (BIAs) in Canada. Nevertheless, most
   drug plan managers have been requiring this economic data to inform drug
   reimbursement decisions. This paper describes the process used to
   develop the Canadian BIA Guidelines; describes the Guidelines
   themselves, including the model template; and compares this guidance
   with other guidance on BIAs. The intended audience includes those who
   develop, submit or use BIA models, and drug plan managers, who evaluate
   BIA submissions.
   The Patented Medicine Prices Review Board (PMPRB) initiated the
   development of the Canadian BIA Guidelines on behalf of the National
   Prescription Drug Utilisation Information System (NPDUIS). The findings
   and recommendations from a needs assessment with respect to BIA
   submissions were reviewed to inform guideline development. In addition,
   a literature review was performed to identify existing BIA guidance. The
   detailed guidance was developed on this basis, and with the input of the
   NPDUIS Advisory Committee, including drug plan managers from multiple
   provinces in Canada and a representative from the Canadian Agency for
   Drugs and Technologies in Health. A Microsoft(R) Excel-based interactive
   model template was designed to support BIA model development. Input
   regarding the guidelines and model template was sought from each NPDUIS
   Advisory Committee member to ensure compatibility with existing drug
   plan needs. Decisions were made by consensus through multiple rounds of
   review and discussion. Finally, BIA guidance in Canadian provinces and
   other countries were compared on the basis of multiple criteria.
   The BIA guidelines consist of three major sections: Analytic Framework,
   Inputs and Data Sources, and Reporting Format. The Analytic Framework
   section contains a discussion of nine general issues surrounding BIAs
   (model design, analytic perspective, time horizon, target population,
   costing, scenarios to be compared, the characterisation of uncertainty,
   discounting, and validation methods). The Inputs and Data Sources
   section addresses methods for market size estimation, comparator
   selection, scenario forecasting and drug price estimation. The Reporting
   Format section describes methods for BIA reporting.
   The new Canadian BIA Guidelines represent a significant departure from
   the limited guidance that was previously available from some of the
   provinces, because they include specific details of the methods of
   performing BIAs. The Canadian BIA Guidelines differ from the Principles
   of Good Research Practice for BIAs developed by the International
   Society for Pharmacoeconomic and Outcomes Research (ISPOR), which
   provide more general guidance.
   The Canadian BIA Guidelines and template build upon existing guidance to
   address the specific requirements of each of the participating drug
   plans in Canada. Both have been endorsed by the NPDUIS Steering
   Committee and the PMPRB for the standardization of BIA submissions.
C1 [Marshall, Deborah A.; Douglas, Patrick R.; Drummond, Michael F.; Torrance, George W.; MacLeod, Stuart] i3 Innovus, Global Hlth Econ & Outcomes Res, Burlington, ON L7L 6B8, Canada.
   [Marshall, Deborah A.; Torrance, George W.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.
   [Marshall, Deborah A.] St Josephs Hosp, Ctr Evaluat Med, Hamilton, ON, Canada.
   [Drummond, Michael F.] Univ York, York YO10 5DD, N Yorkshire, England.
   [MacLeod, Stuart] Child & Family Res Inst, Vancouver, BC, Canada.
   [Manti, Orlando; Cheruvu, Lokanadha; Corvari, Ron] Patented Med Prices Review Board, Ottawa, ON, Canada.
RP Marshall, DA (reprint author), i3 Innovus, Global Hlth Econ & Outcomes Res, 1016-A Sutton Dr, Burlington, ON L7L 6B8, Canada
EM Deborah.Marshall@i3innovus.com
CR Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x
   *INT SOC PHARM OUT, 2007, PHARM GUID WORLD
   *PAT MED PRIC REV, 2007, GUID COND PHARM BUDG
   *NAT I HLTH CLIN E, 2007, SPEC MAN SPONS SUBM
   *PAT MED PRIC REV, 2007, BUDG IMP AN GUID GUI
   Greenberg JD, 2006, ARTHRIT RHEUM-ARTHR, V55, P543, DOI 10.1002/art.22095
   *CADTH, 2006, GUID EC EV HLTH TECH
   *ALB HLTH WELL, 2006, BUDG IMP ASS ALB HLT
   *CCOHTA, 2005, COMM DRUG REV SUBM G
   *PAT MED PRIC REV, 2005, BUDG IMP AN GUID NEE
   Orlewska E, 2004, VALUE HEALTH, V7, P1
   Weinstein MC, 2003, VALUE HEALTH, V6, P9
   DICKSON M, 2003, SURVEY PHARMACOECONO
   *MAN HLTH, 2003, BUDG IMP ASS MAN HLT
   *DOHAA, 2002, GUID PHARM IND PREP
   *CCOHTA, 1994, GUID EC EV PHARM
   *ONT MIN HLTH LONG, ONT DRUG BEN PROGR O
NR 17
TC 8
Z9 9
PU ADIS INT LTD
PI AUCKLAND
PA 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 1311, NEW
   ZEALAND
SN 1170-7690
J9 PHARMACOECONOMICS
JI Pharmacoeconomics
PY 2008
VL 26
IS 6
BP 477
EP 495
DI 10.2165/00019053-200826060-00003
PG 19
WC Economics; Health Policy & Services; Pharmacology & Pharmacy
SC Business & Economics; Health Care Sciences & Services; Pharmacology &
   Pharmacy
GA 314QF
UT WOS:000256823200003
ER
PT J
AU Chin, CL
   Lee, P
   Wang, PW
   Kleinman, G
AF Chin, Chen-Lung
   Lee, Picheng
   Wang, Ping-Wen
   Kleinman, Gary
TI Does innovation matter to conference calls?
SO IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT
LA English
DT Article
DE conference calls; innovation; intellectual property; patents; patent
   value; research and development
ID R-AND-D; OWNERSHIP STRUCTURE; ANALYSTS FORECASTS; DISCLOSURE;
   INFORMATION; POLICY; DETERMINANTS; AMORTIZATION; EARNINGS; FIRM
AB The main purpose of this study is to investigate whether the likelihood,
   frequency, and information content of conference calls are positively
   associated with innovation. The study is based on 534 conference calls
   conducted in 340 firm-years from 1997 to 2001 in Taiwan. Our findings
   indicate that more innovative firms are more likely to conduct
   conference calls and conduct them more frequently than less innovative
   firms. Consistent with prior research, high-growth firms and larger
   firms are more likely to hold conference calls, and hold them more
   frequently, than other firms. Low price-earnings firms are, nonetheless,
   more likely and frequent to host conference calls when their stock price
   has been undervalued. We also find supporting evidence that cumulative
   abnormal returns surrounding the event dates of conference calls are
   positively associated with the level of and change in innovation
   investments. In addition, our empirical results of market reaction
   driven by conference calls are still robust after controlling the effect
   of selection bias, market expectation, and timing of conducting
   conference calls. Finally, we also find that firms that are more
   innovative are more likely to discuss innovation activities during
   conference calls.
C1 Natl Chengchi Univ, Dept Accounting, Taipei 116, Taiwan.
   Pace Univ, Lubin Sch Business, Dept Accounting, New York, NY 10038 USA.
   Natl Chung Cheng Univ, Dept Accounting, Chiayi 621, Taiwan.
   Robert Morris Univ, Dept Accounting & Taxat, Moon Township, PA 15108 USA.
RP Chin, CL (reprint author), Natl Chengchi Univ, Dept Accounting, Taipei 116, Taiwan
EM kim@nccu.edu.tw
   plee@pace.edu
   El10354@mail.nhisb.gov.tw
   Klemman@RMU.edu
CR EICHENWALD K, 2004, N Y TIMES       0710
   CHIN C, 2004, J MANAGE, V21, P175
   YANG CH, 2003, ASIAN ECON J, V17, P205
   Bushee BJ, 2003, J ACCOUNT ECON, V34, P149
   GU F, 2003, ASIA PACIFIC J ACCOU, V10, P143
   PENG M, 2003, ACAD MANAGE REV, V28, P276
   Fan JPH, 2002, J ACCOUNT ECON, V33, P401
   Matsumoto DA, 2002, ACCOUNT REV, V77, P483
   Barron OE, 2002, J ACCOUNTING RES, V40, P289
   Bowen RM, 2002, ACCOUNT REV, V77, P285
   ZUN WM, 2002, EC DAILY        0902
   SUNDER S, 2002, INVESTOR ACCESS C CA
   Barth ME, 2001, J ACCOUNTING RES, V39, P1
   YEH YH, 2001, REV PACIFIC BASIN FI, V4, P127
   Balkin DB, 2000, ACAD MANAGE J, V43, P1118
   Narayanan VK, 2000, STRATEGIC MANAGE J, V21, P707
   Leuz C, 2000, J ACCOUNTING RES, V38, P91
   CANIBANO L, 2000, J ACCOUNTING LIT, V19, P102
   GREENE WH, 2000, EC ANAL
   SEETHAMRAJU C, 2000, VALUE RELEVANCE TRAD
   TIMES ST, 2000, CORPORATE SCAND 0718
   ANANDARAJAN A, 2000, RES ACC REG, V14, P245
   Barth ME, 1999, J ACCOUNT ECON, V28, P211
   Frankel R, 1999, J ACCOUNTING RES, V37, P133
   HEALY P, 1999, CONTEMP ACCOUNT RES, V16, P485
   La Porta R, 1998, J POLIT ECON, V106, P1113
   TASKER S, 1998, REV ACCOUNT STUD, V3, P137
   TASKER S, 1998, J FINANCIAL STATEMEN, V4, P6
   Pegels CC, 1996, IEEE T ENG MANAGE, V43, P246, DOI 10.1109/17.511835
   Lev B, 1996, J ACCOUNT ECON, V21, P107
   PINCHES G, 1996, J APPL CORPORATE FIN, V9, P60
   KELM KM, 1995, ACAD MANAGE J, V38, P770
   HOLTHAUSEN RW, 1995, J ACCOUNT ECON, V19, P279
   LANG M, 1993, J ACCOUNTING RES, V31, P246
   HAND JRM, 1993, J ACCOUNT RES, V31, P21
   RULAND W, 1990, ACCOUNT REV, V65, P710
   TRAJTENBERG M, 1990, RAND J ECON, V21, P172
   LEV B, 1990, J ACCOUNTING RES, V28, P49
   VERRECCHIA RE, 1990, J ACCOUNT ECON, V12, P365
   BUBLITZ B, 1989, ACCOUNT REV, V64, P108
   LANEN WN, 1988, J ACCOUNT ECON, V10, P311
   HIRSCHEY M, 1985, J ACCOUNTING RES, V23, P326
   CONNOLLY RA, 1984, REV ECON STAT, V66, P682
   GRILICHES Z, 1981, ECON LETT, V7, P183
   WHITE H, 1980, ECONOMETRICA, V48, P817
   BELSLEY DA, 1980, REGRESSION DIAGNOSTI
   HECKMAN JJ, 1978, ECONOMETRICA, V46, P931
   JENSEN MC, 1976, J FINANC ECON, V3, P305
   ABDELKHALIK AR, 1975, ACCOUNT REV, V50, P657
NR 49
TC 1
Z9 1
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9391
J9 IEEE T ENG MANAGE
JI IEEE Trans. Eng. Manage.
PD NOV
PY 2007
VL 54
IS 4
BP 699
EP 715
DI 10.1109/TEM.2007.906841
PG 17
WC Business; Engineering, Industrial; Management
SC Business & Economics; Engineering
GA 225AQ
UT WOS:000250489900006
ER
PT J
AU Choi, C
   Kim, S
   Park, Y
AF Choi, Changwoo
   Kim, Seungkyum
   Park, Yongtae
TI A patent-based cross impact analysis for quantitative estimation of
   technological impact: The case of information and communication
   technology
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE cross impact analysis; technological impact analysis; patent analysis;
   information and communication technologies
ID INDICATORS; INNOVATION; SYSTEMS
AB The increasing syntheses and interactions between various technologies
   increase the usefulness of cross impact analysis (CIA) as a method for
   forecasting and analyzing them. Conventional CIA depends on an expert's
   qualitative judgment or intuition and thus it is difficult to evaluate
   quantitatively the impact of one technology on another. In this study,
   we employ patent analysis in CIA to examine such impacts between
   technologies based on multiple patent classifications. Patent
   information is used for facilitating quantitative and systematic
   approach in CIA. The distinctive feature and main contribution of the
   proposed approach is the overcoming of the limitations of conventional
   CIA, by employing conditional probabilities based on the patent
   information. The classification of patents, particularly the multiple
   classifications, is used to evaluate the relationships between
   technologies. As an illustration, a patent-based CIA with information
   and communication technologies (ICTs) was conducted. Firstly, the
   patent-based cross impact among ICTs was calculated. Secondly, the
   technology pairs were classified based on the cross impact score between
   ICTs. Thirdly, a cross impact network was constructed to identify the
   complex relation among ICTs. Finally, the changes in cross impact scores
   between technologies over time were analyzed. The results of this
   research are expected to help practitioners to forecast future trends
   and to develop better R&D strategies. (C) 2006 Elsevier Inc. All rights
   reserved.
C1 Seoul Natl Univ, Sch Engn, Dept Ind Engn, Seoul 151742, South Korea.
RP Park, Y (reprint author), Seoul Natl Univ, Sch Engn, Dept Ind Engn, San 56-1,, Seoul 151742, South Korea
EM parkyt@cybemet.snu.ac.kr
CR Asan U, 2004, OMEGA-INT J MANAGE S, V32, P443, DOI 10.1016/j.omega.2004.02.006
   YOON B, 2004, J HIGH TECHNOLOGY MA, V15, P37
   HIRSCHEY M, 2004, J EMPIR FINANC, V11, P91
   YOON BU, 2004, TECHNOLOGICAL FORECA, V72, P145
   SCHAPER M, 2003, PROPOSAL CORE INDICA
   Yoon BU, 2002, R&D MANAGE, V32, P291
   Breitzman A, 2002, RES TECHNOL MANAGE, V45, P28
   Meyer M, 2002, SCIENTOMETRICS, V54, P193
   TRAJITENBERG M, 2002, PATENTS CITATIONS IN
   *USPTO, 2002, OV CLASS SYST
   DERNIS H, 2001, STI REV, V27, P129
   Blanning RW, 1999, FUTURES, V31, P39
   ALARCON LF, 1998, INT J PROJECT MANAGE, V16, P145
   Lee H, 1997, TELECOMMUN POLICY, V21, P845
   Jeong GH, 1997, TECHNOL FORECAST SOC, V55, P203
   KARKI MMS, 1997, WORLD PATENT INFORMA, V19, P269
   TONG XS, 1994, RES POLICY, V23, P133
   MOGEE ME, 1994, TECHNOL ANAL STRATEG, V6, P485
   SCHULER A, 1991, IEEE T ENG MANAGE, V38, P224, DOI 10.1109/17.83755
   GRILICHES Z, 1990, J ECON LIT, V28, P1661
   NARIN F, 1987, RES POLICY, V16, P143
   CASELLESMONCHO A, 1986, INT J FORECASTING, V2, P295
   MARSDEN PV, 1984, J MATH SOCIOL, V10, P271
   KNOKE D, 1982, NETWORK ANAL
   KAYA Y, 1979, TECHNOL FORECAST SOC, V14, P243
   STOVER JG, 1978, HDB FUTURES RES GREE
   MITCHELL RB, 1977, FUTURES, V9, P205
   DUPERRIN JC, 1975, FUTURES, V7, P302
   HELMER O, 1972, FUTURES, V4, P149
   TUROFF M, 1972, TECHNOL FORECAST SOC, V3, P309
   DALKEY NC, 1972, TECHNOL FORECAST SOC, V3, P341
   ENZER S, 1972, FUTURES, V4, P30
   GORDON TJ, 1968, FUTURES, V1, P100
NR 33
TC 13
Z9 13
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD OCT
PY 2007
VL 74
IS 8
BP 1296
EP 1314
DI 10.1016/j.techfore.2006.10.008
PG 19
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 219YQ
UT WOS:000250124500011
ER
PT J
AU Shaik, A
   Moorthi, NSV
   Rudramoorthy, R
AF Shaik, Amjad
   Moorthi, N. Shenbaga Vinayaga
   Rudramoorthy, R.
TI Variable compression ratio engine: a future power plant for automobiles
   - an overview
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART D-JOURNAL OF
   AUTOMOBILE ENGINEERING
LA English
DT Article
DE spark ignition (SI) engines; variable compression ratio (VCR); thermal
   efficiency; fuel economy; clearance volume; knock
AB Increasingly stringent emissions and fuel economy standards have long
   remained a source of challenges for research in automobile engine
   technology development towards the more thermally efficient and less
   polluting engine. Spark ignition (SI) engines have lower part-load
   efficiency when compared with the diesel engines. The greatest
   opportunity for improving SI engine efficiency is by way of higher
   compression ratio, variable valve timing, low friction, reducing
   throttling losses, boosting, and down-sizing. Variable compression ratio
   (VCR) technology has long been recognized as a method for improving the
   fuel economy of SI engines. In order to vary the compression ratio, some
   method of varying the geometric compression ratio through changing the
   clearance volume is required. There are several ways of doing this;
   various patents have been filed and designs presented, including
   modification of the compression ratio by moving the cylinder head,
   variation of combustion chamber volume using a secondary piston or
   valve, variation of piston deck height, modification of connecting rod
   geometry, moving the crankpin within the crankshaft, and moving the
   crankshaft axis. The potential of these technologies needs to be
   evaluated by a trade-off between cost and consumption benefit. This
   paper reviews the geometric approaches and solutions used to achieve
   VCR, considers the results of prior research, and forecasts what
   benefits, if any, a VCR would bring to present engine design.
C1 PSG Coll Technol, Dept Automobile Engn, Coimbatore 641004, Tamil Nadu, India.
RP Shaik, A (reprint author), PSG Coll Technol, Dept Automobile Engn, Coimbatore 641004, Tamil Nadu, India
EM amjad72@gmail.com
CR SURESHBHAI MC, 2006, P WORLD AUT C FISITA
   KHATRI DS, 2006, SAE INDIA NEWSLE JUN, P7
   ASSANIS DC, 2005, 2005011648 SAE
   MOTEKI K, 2003, 2003010921 SAE
   HARALDSSON G, 2002, 2002012858 SAE
   DEGOOIJER B, 2002, TECHNICAL DOCUMENT
   SCHWADERLAPP M, 2002, 2002011103 SAE
   MALLIKARJUNA JM, 2002, 2002011740 SAE
   SYKES RG, 2000, P C ENG EXP
   CLARKE JR, 2000
   HEYWOOD JB, 1995, INTERNAOL COMBUSTION
   TAYLOR CF, 1960, INTERNAL COMBUSTION
NR 12
TC 3
Z9 3
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4070
J9 P I MECH ENG D-J AUT
JI Proc. Inst. Mech. Eng. Part D-J. Automob. Eng.
PD SEP
PY 2007
VL 221
IS D9
BP 1159
EP 1168
DI 10.1243/09544070JAUTO573
PG 10
WC Engineering, Mechanical; Transportation Science & Technology
SC Engineering; Transportation
GA 216RF
UT WOS:000249896000012
ER
PT J
AU Yoon, B
   Park, Y
AF Yoon, Byungun
   Park, Yongtae
TI Development of new technology forecasting algorithm: Hybrid approach for
   morphology analysis and conjoint analysis of patent information
SO IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT
LA English
DT Article
DE conjoint analysis (CA); hybrid approach; morphology analysis (MA);
   patent information; technology forecasting
ID PRODUCT DESIGN; COMMERCIAL USE; SCIENCE; ROADMAPS; DELPHI; UPDATE;
   FIELD; MODEL
AB Despite being a strong stimulus for the invention of new alternatives,
   morphology analysis (MA) suffers the limitations of being a
   nonquantitative, vague, and static methodology. As a consequence, the MA
   outcomes typically do not provide practical technology opportunities.
   This paper, therefore, proposes a new hybrid approach that enhances the
   performance of. MA by combining it with conjoint analysis (CA) and
   citation analysis of patent information. First, keywords are extracted
   from patent documents using text mining, and the morphology of existing
   patents is identified by these keywords. Alternatives for new technology
   development from among the emerging technologies are presented by
   combining the valuable levels of each attribute in a morphology matrix
   predefined by domain experts. Then, configurations of new technology are
   suggested in order of priority using CA, and the technological
   feasibility of each new configuration is subsequently investigated. The
   technological competitiveness of a company can be analyzed by a newly
   suggested index, "technology share," which is analogous to the concept
   of market share in traditional CA. The proposed MA-CA hybrid process is
   illustrated with a case example of patent information from the thin film
   transistor-liquid crystal display (TFT-LCD) patent database.
C1 Dongguk Univ, Dept Ind & Syst Engn, Seoul 100715, South Korea.
   Seoul Natl Univ, Dept Ind Engn, Seoul 151742, South Korea.
RP Yoon, B (reprint author), Dongguk Univ, Dept Ind & Syst Engn, Seoul 100715, South Korea
EM postman3@dongguk.edu
   parkyt@cybernet.snu.ac.kr
CR Bengisu M, 2006, TECHNOL FORECAST SOC, V73, P835, DOI 10.1016/j.techfore.2005.09.001
   Scholl A, 2005, EUR J OPER RES, V164, P760, DOI 10.1016/j.ejor.2004.01.026
   Porter AL, 2004, TECHNOL FORECAST SOC, V71, P287, DOI 10.1016/j.techfore.2003.11.004
   YOON B, 2004, J HIGH TECHNOLOGY MA, V15, P37
   Mann DL, 2003, TECHNOL FORECAST SOC, V70, P779, DOI 10.1016/S0040-1625(02)00357-8
   Martino JP, 2003, TECHNOL FORECAST SOC, V70, P719, DOI 10.1016/S0040-1625(02)00375-X
   Eto H, 2003, TECHNOL FORECAST SOC, V70, P231
   KESELJ V, 2003, P C PAC ASS COMP LIN, P255
   GLENN JC, 2003, FUTURES RES METHODOL
   CUESTAFRAU D, 2003, P 25 ANN INT C IEEE, V3, P17
   Pullman ME, 2002, J PROD INNOVAT MANAG, V19, P354
   Zhu DH, 2002, TECHNOL FORECAST SOC, V69, P495
   Mishra S, 2002, TECHNOL FORECAST SOC, V69, P1
   RITCHEY, 2002, 4 INT C LOC AUTH
   JAFFE AB, 2002, PATENTS CITATIONS IN
   MAYER M, 2002, RES POLICY, V29, P409
   Michel J, 2001, SCIENTOMETRICS, V51, P185
   Kostoff RN, 2001, IEEE T ENG MANAGE, V48, P132, DOI 10.1109/17.922473
   Coates V, 2001, TECHNOL FORECAST SOC, V67, P1
   HIRSCHEY M, 2001, PACIFIC BASIN FINANC, V9, P65
   GREEN PE, 2001, INTERFACES, V31, P56
   Belaziz M, 2000, COMPUT AIDED DESIGN, V32, P377
   HOLL B, 2000, MARKET VALUE PATENT
   JAFFE AB, 1999, EC INNOVATION NEW TE, V8, P105
   BAJAJ A, 1998, TECHNOLOGY FACTORS I
   HAIR J, 1998, MULTIVARIATE DATA AN
   Small H, 1997, SCIENTOMETRICS, V38, P275
   KARKI MMS, 1997, WORLD PATENT INFORMA, V19, P269
   KOSTOFF RN, 1997, 296021 ADA DTIC
   SUSHKOV V, 1997, TRIZ J, P1
   Balakrishnan A, 1996, J FAM WELFARE, V42, P8
   Lenk PJ, 1996, MARKET SCI, V15, P173
   PIDD M, 1996, TOOLS THINKING MODEL
   RHYNE R, 1995, FUTURES, V27, P657
   BARKER D, 1995, LONG RANGE PLANN, V28, P21
   GREEN PE, 1992, MARKET SCI, V11, P117
   TWISS B, 1992, FORECASTING TECHNICA
   YUN YC, 1991, TECHNOL FORECAST SOC, V40, P273
   MADU CN, 1991, LONG RANGE PLANN, V24, P105
   WOUNDENBERG F, 1991, TECHNOL FORECAST SOC, V40, P131
   GREEN PE, 1990, J MARKETING, V54, P3
   HAIDER W, 1990, LEISURE SCI, V12, P33
   WITTINK DR, 1989, J MARKETING, V53, P91
   SCHNAARS SP, 1989, MEGAMISTAKES FORECAS
   JOHNSON RM, 1987, P SAWT SOFTW C PERC, P253
   LEINHARD JH, 1985, TECHNOL FOREST SOC C, V27, P265
   MAJER H, 1985, TECHNOL FORECAST SOC, V27, P335
   MARTINO JP, 1983, TECHNOLOGICAL FORECA
   CATTIN P, 1982, J MARKETING, V46, P44
   GREEN PE, 1981, J MARKETING, V45, P17
   GREEN PE, 1981, J MARKETING, V45, P33
   MARTINO JP, 1980, MANAGE SCI, V26, P28
   WISSEMA JG, 1976, FUTURES, V8, P146
   JOHNSON RM, 1974, J MARKETING RES, V11, P121
   SRINIVASAN V, 1973, PSYCHOMETRIKA, V38, P479
   GREEN PE, 1971, J MARKETING RES, V8, P355
   ZWICKY F, 1969, DISCOVERY INVENTION
   AYERS RU, 1969, TECHNOLOGICAL FORECA
   LUCE RD, 1964, J MATH PSYCHOL, V1, P1
   ERIKSSON T, SCENARIO DEV USING C
NR 60
TC 13
Z9 13
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855 USA
SN 0018-9391
J9 IEEE T ENG MANAGE
JI IEEE Trans. Eng. Manage.
PD AUG
PY 2007
VL 54
IS 3
BP 588
EP 599
DI 10.1109/TEM.2007.900796
PG 12
WC Business; Engineering, Industrial; Management
SC Business & Economics; Engineering
GA 196CT
UT WOS:000248460000016
ER
PT J
AU Bawa, R
AF Bawa, Raj
TI Patents and nanomedicine
SO NANOMEDICINE
LA English
DT Article
DE commercialization; drug delivery; nanomedicine; nanoparticles; National
   Nanotechnology Initiative; nonexclusive licensing; patent
   classification; patent thickets; US Patent and Trademark Office
ID DRUG DEVELOPMENT; DELIVERY; NANOSUSPENSIONS; NANOTECHNOLOGY; TECHNOLOGY
AB Big pharma's business model, which relies on a few blockbusters to
   generate profits, is clearly broken. Patent expiration on numerous
   blockbusters in recent years is already altering the drug landscape.
   Drug companies are also facing other challenges that necessitate
   development and implementation of novel R&D strategies, including those
   that focus on nanotechnology and miniaturization. Clearly, there is
   enormous excitement and expectation regarding nanomedicine's potential
   impact. However, securing valid and defensible patent protection will be
   critical. Although early forecasts for nanomedicine commercialization
   are encouraging, there are numerous bottlenecks as well. One of the
   major hurdles is an emerging thicket of patent claims, resulting
   primarily from patent proliferation as well as continued issuance of
   surprisingly broad patents by the US Patent and Trademark Office (PTO).
   Adding to this confusion is the fact that the US National Nanotechnology
   Initiative's widely cited definition of nanotechnology is inaccurate and
   irrelevant from a nanomedicine perspective. It is also the cause of the
   inadequate patent classification system that was recently unveiled by
   the PTO. All of this is creating a chaotic, tangled patent landscape in
   various sectors of nanomedicine where the competing players are unsure
   of the validity and enforceability of numerous issued patents. If this
   trend continues, it could stifle competition and limit access to some
   inventions. Therefore, reforms are urgently needed at the PTO to address
   problems ranging from poor patent quality and questionable examination
   practices to inadequate search capabilities, rising attrition, poor
   employee morale and a skyrocketing patent application backlog. Only a
   robust patent system will stimulate the development of commercially
   viable nanomedicine products that can drastically improve a patient's
   quality of life and reduce healthcare costs.
C1 Bawa Biotechnol Consulting LLC, Ashburn, VA USA.
   Rensselaer Polytech Inst, Troy, NY USA.
RP Bawa, R (reprint author), Bawa Biotechnol Consulting LLC, 21005 Starflower Way, Ashburn, VA USA
EM bawabio@aol.com
CR BAWA R, 2008, IN PRESS NANOETHICS
   Reisch MS, 2007, CHEM ENG NEWS, V85, P22
   Tremblay JF, 2007, CHEM ENG NEWS, V85, P11
   Schulz W, 2007, CHEM ENG NEWS, V85, P13
   Saini A, 2007, NEW SCI, V193, P20
   Marasco CA, 2007, CHEM ENG NEWS, V85, P47
   2007, NAN BIOL MED METH, P1
   THASSU D, 2007, NANOPARTICULATE DRUG
   BAWA R, 2007, IN PRESS CLIN N AM
   MORROW KL, 2007, IN PRESS CLIN N AM
   BAWA R, 2007, IN PRESS HOPES VISIO
   BAWA R, 2007, IN PRESS INT J NANOM
   ONEILL S, 2007, NANOTECHNOLOGY LAW B, V4, P595
   2007, NEWSCIENTIST, V194, P23
   *FREED GROUP INC, 2007, NAN HEALTHC
   OWENS J, 2007, NAT REV DRUG DISCOV, V6, P104
   BREEN P, 2007, PHARMA, V3, P22
   HULTQUIST S, 2007, INTELLECT PROP TODAY, V14, P48
   MCDONALD D, 2007, INTELLECTUAL PROPERT, V14, P7
   SHAW G, 2007, DRUG DISCOV DEV, V10, P45
   FARRELL C, 2007, BUSINESS WEEK   0108, P78
   WEINTRAUB A, 2007, BUSINESS WEEK    FEB, P48
   Erickson J, 2006, SCIENCE, V312, P997
   Adams CP, 2006, HEALTH AFFAIR, V25, P420, DOI 10.1377/hlthaff.25.2.420
   *LUX RES INC, 2006, NAN REP
   QUILLEN CD, 2006, FED CIRCUIT BAR J, V15, P635
   JAIN KK, 2006, NANOTECHNOLOGY LAW B, V3, P411
   2006, FED REG, V71, P61
   EDWARDS SA, 2006, NANOTECH PIONEERS WH
   2006, FED REG, V71, P48
   BAWA R, 2006, BIOMEDICAL ENG HDB
   2006, NAT NANOTECHNOL, V1, P8
   EBERT LB, 2006, J PAT TRADEMARK OFF, V88, P1068
   VANLENTE MA, 2006, CASE W RES J INT LAW, V38, P173
   PETHERBRIDGE L, 2006, IDEA J LAW TECHNOL, V173, P182
   OAS B, 2006, TABLET CAPSULES  OCT, P12
   BAWA R, 2005, J INTELLECTUAL PROPE, V10, P426
   FREITAS RA, 2005, NANOMEDICINE, V1, P2
   BAWA R, 2005, NANOMED-NANOTECHNOL, V1, P150
   *ETC GROUP, 2005, NAN 2 NAT PAT IMP GL
   *NAT AC PUBL ADM, 2005, US PAT TRAD OFF TRAN
   MITTAL AK, 2005, GAO051008T
   BAWA R, 2005, SMALL TIMES, V5, P16
   JAFFE AB, 2005, IEEE SPECTRUM, V42, P38
   BAWA R, 2005, NANOMEDICINE NANOTEC, V1, P346
   BAWA R, 2005, FORESIGHT INNOVATION, P31
   Rabinow BE, 2004, NAT REV DRUG DISCOV, V3, P785, DOI 10.1038/nrd1494
   Patravale VB, 2004, J PHARM PHARMACOL, V56, P827, DOI 10.1211/0022357023691
   NIEMEYER CM, 2004, NANOBIOTECHNOLOGY CO
   BAWA R, 2004, NANOTECHNOLOGY LAW B, V1, P31
   JAFFE AB, 2004, INNOVATIONS ITS DISC
   MERRILL SA, 2004, PATENT SYSTEM 21 CEN
   HARRIS D, 2004, NANOTECHNOLOGY LAW B, V1, P101
   REGALANDO A, 2004, WALL STREET J   0618
   *EMRC, 2004, NAN ESF EUR MED RES
   SHAPIRO C, 2004, BERKELEY TECHNOLOGY, V19, P1017
   BAWA R, 2004, SMALL TIMES, V4, pIP8
   SABETY T, 2004, NANOTECHNOLOGY LAW B, V1, P262
   HUNT WH, 2004, J MAT, P13
   FORMAN D, 2004, SMALL TIMES      MAY, P21
   Mazzola L, 2003, NAT BIOTECHNOL, V21, P1137, DOI 10.1038/nbt1003-1137
   Paull R, 2003, NAT BIOTECHNOL, V21, P1144, DOI 10.1038/nbt1003-1144
   Huang Z, 2003, J NANOPART RES, V5, P333
   DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1
   *FTC, 2003, PROM INN PROP BAL CO
   *FRONT LIN STRAT C, 2003, NANOBIOTECHNOLOGY OP
   RISINGER D, 2003, US MAJOR PHARM MODE
   SUSSMAN NL, 2003, BUSINESS BRIEFING FU, P46
   Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1
   LAWRENCE S, 2002, RED HERRING     1120
   *CMR I, 2002, PHARM REPRESENTA MAY, P42
   SHAPIRO C, 2001, INNOVATION POLICY EC, V1, P119
   ANON R, 1999, HEALTHCARE REPORTS
NR 73
TC 14
Z9 14
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD JUN
PY 2007
VL 2
IS 3
BP 351
EP 374
DI 10.2217/17435889.2.3.351
PG 24
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 193CE
UT WOS:000248250400013
ER
PT J
AU Daim, TU
   Rueda, G
   Martin, H
   Gerdsri, P
AF Daim, Tugrul U.
   Rueda, Guillenno
   Martin, Hilary
   Gerdsri, Pisek
TI Forecasting emerging technologies: Use of bibliometrics and patent
   analysis
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
ID MODELS
AB It is rather difficult to forecast emerging technologies as there is no
   historical data available. In such cases, the use of bibliometrics and
   patent analysis have provided useful data. This paper presents the
   forecasts for three emerging technology areas by integrating the use of
   bibliometrics and patent analysis into well-known technology forecasting
   tools such as scenario planning, growth curves and analogies. System
   dynamics is also used to be able to model the dynamic ecosystem of the
   technologies and their diffusion. Technologies being forecasted are fuel
   cell, food safety and optical storage technologies. Results from these
   three applications help us to validate the proposed methods as
   appropriate tools to forecast emerging technologies. (c) 2006 Elsevier
   Inc. All rights reserved.
C1 Portland State Univ, Maseeh Coll Engn & Comp Sci, Dept Engn & Technol Management, Portland, OR 97207 USA.
RP Daim, TU (reprint author), Portland State Univ, Maseeh Coll Engn & Comp Sci, Dept Engn & Technol Management, POB 751, Portland, OR 97207 USA
EM tugrul@etm.pdx.edu
CR WAKELAND W, 2006, WEBCT SYSTEM DYNAMIC
   Demos T, 2005, FORTUNE, V152, P32
   Lashinsky A, 2005, FORTUNE, V151, P36
   ASSICIATION CE, 2005, FACTORY SALES DVD PL
   PORTER AL, 2005, PORTL INT C MAN ENG
   *EIA, 2004, ANN EN REV
   KAPLAN J, 2004, PC MAGAZINE, V23, P109
   LABRIOLA D, 2004, PC MAGAZINE, V23, P30
   ALAN SWC, 2004, EXAMPLE PROCESS TECH, P321
   Silberglitt R, 2003, TECHNOL FORECAST SOC, V70, P297, DOI 10.1016/S0040-1625(02)00254-8
   PILKINGTON A, 2003, PICMET 03 PORTLNS
   PORTER AL, 2003, MINING PICMET 1997 2
   BRINN M, 2003, P 2003 SYST INF ENG
   RUEDA G, 2003, PORTL INT C MAN ENG
   PORTER A, 2003, TI MIN C P CORP TECH
   *EIA, 2003, ANN EN REV
   SAGER B, 2003, TECHNOL FORECAST SOC, P109
   WINEBRAKE JJ, 2003, TECHNOL FORECAST SOC, P359
   MARTINO J, 2003, TECHNOL FORECAST SOC, P719
   Morris S, 2002, COMPUT IND ENG, V43, P841
   Mishra S, 2002, TECHNOL FORECAST SOC, V69, P1
   MEAD P, 2002, FOOD RELATED ILLNESS
   CARRILLO M, 2002, TECHNOL FORECAST SOC, P69
   Kostoff RN, 2001, TECHNOL FORECAST SOC, V68, P223
   Abraham BP, 2001, TECHNOVATION, V21, P245
   *CEC, 2001, PROJ AUT FUEL CELL U
   NORTON MJ, 2001, INTRO CONCEPTS INFOR
   WANTANABE C, 2001, TECHNOVATION, V21, P783
   STERMAN J, 2000, BUSINESS DYNAMICS SY
   PILKINGTON A, 2000, PICMET 05 PORTL OR
   *FDA, 2000, HLTH PEOPL 2000 STAT
   LINSTONE H, 1999, DECISION MAKING TECH
   MODIS T, 1999, TECHNOL FORECAST SOC, P173
   Meade N, 1998, MANAGE SCI, V44, P1115
   PORTER A, 1998, INNOVATION FORECAST
   LEVIN C, 1998, PC MAGAZINE, V17, P10
   Wang YX, 1998, INORG CHEM COMMUN, V1, P27
   Watts RJ, 1997, TECHNOL FORECAST SOC, V56, P25
   Liu SJ, 1997, INT J TECHNOL MANAGE, V13, P661
   SCHAEFFER G, 1996, FUEL CELLS FUTURE CO
   GILLEN MA, 1995, BILLBOARD, V107, P107
   YOUNG P, 1993, TECHNOL FORECAST SOC, V44, P375
   MARTINO JP, 1993, TECHNOLOGICAL FORECA
   PORTER AL, 1991, FORECASTING MANAGEME
   MILLETT SM, 1991, MANAGERS GUIDE TECHN
   KAPSTEIN J, 1990, BUS WEEK, P44
   ASHTON WB, 1988, RES TECHNOL MANAGE, V32, P36
   BASBERG BL, 1987, RES POLICY, V16, P131
   LINSTONE HA, 1984, MULTIPLE PERSPECTIVE
   MARTINO JP, 1983, TECHNOLOGICAL FORECA
   RICHARDSON GP, 1981, INTRO SYSTEM DYNAMIC
   SHARPLEY AM, 1981, COLLECTED ORIGINAL R, V5, P7
   FORRESTER JW, 1961, IND DYNAMICS
   VEZIROGLU N, PICMET 05 HYDR CIV P
   BENGISU M, IN PRESS TECHNOL FOR
   WARR B, IN PRESS REXS FORECA
   EISENMANN T, FUEL CELLS HYDROGEN, P18
NR 57
TC 64
Z9 66
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD OCT
PY 2006
VL 73
IS 8
BP 981
EP 1012
DI 10.1016/j.techfore.2006.04.004
PG 32
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 089ES
UT WOS:000240863700006
ER
PT J
AU Bengisu, M
   Nekhili, R
AF Bengisu, Murat
   Nekhili, Ramzi
TI Forecasting emerging technologies with the aid of science and technology
   databases
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE forecasting; S-curves; foresight; emerging technologies
AB Short term forecasting was applied to 20 emerging technologies under the
   "Machine and Materials" category based on the Vision 2023 foresight
   study previously conducted for Turkey. This scientometric approach uses
   the most suitable keywords linked to the technology in question and
   determines the number of publications and patents in those fields for a
   given year. Database analysis of publications and patents in the
   previous 11 years indicates that while the majority of the top 20
   technologies identified by the experts are indeed emerging (i.e. the
   number of research and/or patenting in these technologies is
   increasing), some of them have not actually attracted too much interest
   in the science and technology (S&T) community. Forecasts based on
   S-curves indicate steady growth in some of the selected technologies.
   There is a high correlation between the number of scientific
   publications and patents in most of the technologies investigated. The
   method is proposed as a simple and efficient tool to link national
   foresight efforts to international S&T activities and to obtain
   quantitative information for prioritized technologies that could be used
   for technology management and decision making for research funding and
   technology investment. (c) 2005 Elsevier Inc. All rights reserved.
C1 Eastern Mediterranean Univ, Dept Ind Engn, TR-10 Mersin, Turkey.
RP Bengisu, M (reprint author), Eastern Mediterranean Univ, Dept Ind Engn, TR-10 Mersin, Turkey
EM murat.bengisu@emu.edu.tr
CR *TUBITAK, 2004, VIS 2023 TECHN FOR D
   Martino JP, 2003, TECHNOL FORECAST SOC, V70, P719, DOI 10.1016/S0040-1625(02)00375-X
   Bengisu M, 2003, SCIENTOMETRICS, V58, P473
   *TUBITAK, 2003, VIS 2023 PROJ MACH M
   *TUBITAK, 2001, 0103 TUBITAK BTP
   LIM K, 2000, RELATIONSHIP PUBLICA, V4120
   DELURGIO SA, 1998, FORECASTING PRINCIPL
   BURGELMAN RA, 1996, STRATEGIC MANAGEMENT
   PATEL P, 1994, RES POLICY, V23, P533
   FRANSES PH, 1994, TECHNOL FORECAST SOC, V46, P45
NR 10
TC 38
Z9 38
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD SEP
PY 2006
VL 73
IS 7
BP 835
EP 844
DI 10.1016/j.techfore.2005.09.001
PG 10
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 076TP
UT WOS:000239981000005
ER
PT J
AU McAleer, M
   Chan, F
AF McAleer, Michael
   Chan, Felix
TI Modelling trends and volatility in atmospheric carbon dioxide
   concentrations
RID A-2407-2008
SO ENVIRONMENTAL MODELLING & SOFTWARE
LA English
DT Article; Proceedings Paper
CT 15th Biannual Congress on Modelling and Simulation
CY 2003
CL Townsville, AUSTRALIA
DE atmospheric carbon dioxide concentration; conditional volatility;
   forecasting; GARCH; GJR; EGARCH
ID TIME-SERIES MODELS; CONDITIONAL HETEROSCEDASTICITY; ECOLOGICAL PATENTS;
   GARCH MODEL; HETEROSKEDASTICITY; STATIONARITY; USA
AB Atmospheric carbon dioxide concentration (ACDC) is a crucial variable
   for many environmental simulation models, and is regarded as an
   important factor for predicting temperature and climate changes.
   However, the conditional variance of ACDC levels has not previously been
   examined. This paper analyses the trends and volatility in ACDC levels
   using monthly data from January 1965 to December 2002. The data are a
   subset of the well known Mauna Loa atmosphere carbon dioxide record
   obtained through the Carbon Dioxide Information Analysis Center. The
   conditional variance of ACDC levels is modelled using the generalised
   autoregressive conditional heteroscedasticity (GARCH) model and its
   asymmetric variations, namely the GJR and EGARCH models. These models
   are shown to be able to capture the dynamics in the conditional variance
   in ACDC levels and to improve the out-of-sample forecast accuracy of
   ACDC. (c) 2005 Published by Elsevier Ltd.
C1 Univ Western Australia, Sch Econ & Commerce, Crawley, WA 6009, Australia.
RP McAleer, M (reprint author), Univ Western Australia, Sch Econ & Commerce, 35 Stirling Highway, Crawley, WA 6009, Australia
EM michael.mcaleer@uwa.edu.au
CR Marinova D, 2006, ENVIRON MODELL SOFTW, V21, P1257, DOI [10.1016/j.envsoft.2005.04.025, 10.1016/j.envsoft]
   Chan F, 2005, ENVIRON MODELL SOFTW, V20, P1369, DOI 10.1016/j.envsoft.2004.09.017
   Hoti S, 2005, ENVIRON MODELL SOFTW, V20, P1289, DOI 10.1016/j.envsoft.2004.08.010
   Wise R, 2005, ENVIRON MODELL SOFTW, V20, P1139, DOI 10.1016/j.envsoft.2004.08.001
   Liu H, 2005, ENVIRON MODELL SOFTW, V20, P761, DOI 10.1016/j.envsoft.2004.03.017
   McAleer M, 2005, ECONOMET THEOR, V21, P232, DOI 10.1017/S0266466605050140
   Chan F, 2004, SCIENTOMETRICS, V59, P179, DOI 10.1023/B:SCIE.0000018527.22276.10
   Ling SQ, 2003, ECONOMET THEOR, V19, P280, DOI 10.1017/S0266466603192092
   Marinova D, 2003, ENVIRON MODELL SOFTW, V18, P195, DOI 10.1016/S1364-8152(02)00079-8
   Li WK, 2002, J ECON SURV, V16, P245
   Ling SQ, 2002, ECONOMET THEOR, V18, P722, DOI 10.1017/S0266466602183071
   Ling SQ, 2002, J ECONOMETRICS, V106, P109
   CHAN F, 2002, AUSTR M EC SOC BRISB
   MCALEER M, 2002, IN PRESS J ECONOMETR
   Boussama F, 2000, CR ACAD SCI I-MATH, V331, P81
   LING S, 2000, STAT FINANCE INTERFA, P226
   GLASER K, 2000, GLOBAL WARMING CORRE
   Phillips OL, 1998, SCIENCE, V282, P439
   Jones TH, 1998, SCIENCE, V280, P441
   Jeantheau T, 1998, ECONOMET THEOR, V14, P70
   Ling SQ, 1997, J AM STAT ASSOC, V92, P1184
   Wong H, 1997, BIOMETRIKA, V84, P111
   SHEPHARD N, 1996, STAT MODELS ECONOMET, P1
   BOLLERSLEV T, 1992, ECONOMET REV, V11, P143
   GLOSTEN L, 1992, J FINANC, V46, P1779
   NELSON DB, 1991, ECONOMETRICA, V59, P347
   NELSON DB, 1990, ECONOMET THEOR, V6, P318
   PHILLIPS PCB, 1988, BIOMETRIKA, V75, P335
   BOLLERSLEV T, 1986, J ECONOMETRICS, V31, P307
   ENGLE RF, 1982, ECONOMETRICA, V50, P987
   KEELING CD, 1982, CARBON DIOXIDE REV
   HILL MJ, IN PRESS ENV MODELLI
NR 32
TC 5
Z9 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1364-8152
J9 ENVIRON MODELL SOFTW
JI Environ. Modell. Softw.
PD SEP
PY 2006
VL 21
IS 9
BP 1273
EP 1279
DI 10.1016/j.envsoft.2005.04.023
PG 7
WC Computer Science, Interdisciplinary Applications; Engineering,
   Environmental; Environmental Sciences
SC Computer Science; Engineering; Environmental Sciences & Ecology
GA 060JE
UT WOS:000238797700006
ER
PT J
AU Radalj, KF
AF Radalj, K. F.
TI Hedgers, speculators and forward markets: Evidence from currency markets
SO ENVIRONMENTAL MODELLING & SOFTWARE
LA English
DT Article; Proceedings Paper
CT 15th Biannual Congress on Modelling and Simulation
CY 2003
CL Townsville, AUSTRALIA
DE speculators; normal backwardation; foreign exchange risk; hedgers;
   insurance premium
ID NORMAL BACKWARDATION; HEDGING PRESSURE; FUTURES MARKETS; ECOLOGICAL
   PATENTS; RISK PREMIA; VOLATILITY
AB Since Keynes [Keynes, J.M., 1930. A Treatise on Money, vol. II.
   Macmillan, London.] and Hicks [Hicks, J.R., 1939. Value and Capital.
   Oxford University Press, Cambridge.] propounded their theory of normal
   backwardation, the issue of whether hedgers must pay speculators an
   insurance premium has remained controversial. Recent theoretical
   developments incorporating the existence of market imperfections have
   validated the existence of an insurance premium charged to hedgers by
   speculators. Owing to differences in data sets and econometric methods,
   a consensus has not yet been reached. Drawing inspiration from asset
   pricing theory a model of currency returns is used, similar to that in
   Mark [Mark, N.C., 1988. Time-varying beta and risk premia in the pricing
   of forward foreign exchange contracts. Journal of Financial Economics
   22, 335-354.] and the importance of speculative influences is tested.
   The purpose of the paper is to highlight the theoretical and statistical
   deficiencies of the extant literature and to examine the robustness of
   previous empirical results to changes in specification. Applications to
   risk management and forecasting are immediate, as knowledge of any
   insurance premium is crucial in formulating an optimal hedging strategy
   and an optimal forecasting model. (c) 2005 Published by Elsevier Ltd.
C1 Univ Western Australia, Dept Econ, Nedlands, WA 6009, Australia.
RP Radalj, KF (reprint author), Univ Western Australia, Dept Econ, 35 Stirling Highway, Nedlands, WA 6009, Australia
EM kfr@azurecapital.com.au
CR Chan F, 2005, ENVIRON MODELL SOFTW, V20, P1369, DOI 10.1016/j.envsoft.2004.09.017
   Marinova D, 2003, ENVIRON MODELL SOFTW, V18, P195, DOI 10.1016/S1364-8152(02)00079-8
   de Roon FA, 2000, J FINANC, V55, P1437
   Chatrath A, 1997, J FUTURES MARKETS, V17, P707
   ENGEL C, 1996, J EMPIR FINANC, V3, P123
   KOLB RW, 1992, J FUTURES MARKETS, V12, P75
   BESSEMBINDER H, 1992, REV FINANC STUD, V5, P637
   HIRSHLEIFER D, 1990, ECONOMETRICA, V58, P411
   BAILLIE RT, 1989, J BUS ECON STAT, V7, P297
   MARK NC, 1988, J FINANC ECON, V22, P335
   CHANG EC, 1985, J FINANC, V40, P193
   CARTER CA, 1983, J POLIT ECON, V91, P319
   HICKS JR, 1939, VALUE CAPITAL
   KEYNES JM, 1930, TREATISE MONEY, V2
NR 14
TC 1
Z9 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1364-8152
J9 ENVIRON MODELL SOFTW
JI Environ. Modell. Softw.
PD SEP
PY 2006
VL 21
IS 9
BP 1381
EP 1386
DI 10.1016/j.envsoft.2005.04.014
PG 6
WC Computer Science, Interdisciplinary Applications; Engineering,
   Environmental; Environmental Sciences
SC Computer Science; Engineering; Environmental Sciences & Ecology
GA 060JE
UT WOS:000238797700018
ER
PT J
AU Hoffman, JM
   Shah, ND
   Vermeulen, LC
   Schumock, GT
   Grim, P
   Hunkler, RJ
   Hontz, KM
AF Hoffman, JM
   Shah, ND
   Vermeulen, LC
   Schumock, GT
   Grim, P
   Hunkler, RJ
   Hontz, KM
TI Projecting future drug expenditures - 2006
SO AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
LA English
DT Article
DE administration; budgets; control; costs; drug use; drugs; economics;
   patents; pharmacy, institutional, hospital; prescriptions; pricing;
   product development; rational therapy; toxicity
ID PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; DECOMPENSATED HEART-FAILURE;
   PHARMACEUTICAL SUPPLY CHAIN; CROHNS-DISEASE; NATALIZUMAB; NESIRITIDE;
   INHIBITORS; THERAPY; CANCER; RISK
AB Purpose. Drug expenditure trends in 2004 and 2005, projected drug
   expenditures for 2006, and factors likely to influence drug costs are
   discussed.
   Summary. Various factors are likely to affect drug costs, including drug
   prices, drugs in development, and generic drugs. In 2004 there was a
   continued moderation of the increase in drug expenditures. Drug
   expenditures increased by 8.7% from 2003 to 2004. Through the first nine
   months of 2005, expenditures increased by only 8.1% compared with 2004.
   This moderation can be attributed to several factors, including the
   continued trend toward higher prescription drug cost sharing for insured
   consumers, growing availability of generic drugs, and lack of
   "blockbuster" new drugs in recent years. Drug expenditures in 2006 will
   likely be influenced by similar factors, with few costly new products
   reaching the market, increased concern over product safety slowing the
   diffusion of those new agents that do reach the market, and several
   important patent expirations, leading to slower growth in expenditures.
   Conclusion. Forecasting and managing rising drug expenditures remains a
   challenge. Pharmacy managers must remain vigilant in monitoring drug
   costs in their health system and take a proactive role in pursuing
   efficient drug utilization. The dynamic health policy environment
   further complicates drug budgeting and must be considered, especially in
   integrated health systems responsible for managing inpatient,
   outpatient, and clinic drug costs. The comparison of
   health-system-specific data and trends with the national information
   presented in this article may provide a useful context when presenting
   institutional drug costs to senior management.
C1 Univ Wisconsin Hosp & Clin, Ctr Drug Policy, Madison, WI 53792 USA.
   St Jude Childrens Hosp, Dept Pharmaceut, Memphis, TN 38105 USA.
   Mayo Clin, Div Hlth Care Policy & Res, Rochester, MN USA.
   Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA.
   Univ Illinois, Coll Pharm, Ctr Pharmacoecon Res, Chicago, IL USA.
   IMS Hlth, Mkt, Plymouth Meeting, PA USA.
RP Vermeulen, LC (reprint author), Univ Wisconsin Hosp & Clin, Ctr Drug Policy, 600 Highland Dr,M-C 9475, Madison, WI 53792 USA
EM lc.vermeulen@hosp.wisc.edu
CR Di Nisio M, 2005, NEW ENGL J MED, V353, P1028
   Jayaraman KS, 2005, NAT REV DRUG DISCOV, V4, P616, DOI 10.1038/nrd1815
   Van Assche G, 2005, NEW ENGL J MED, V353, P362
   Langer-Gould A, 2005, NEW ENGL J MED, V353, P375
   Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369
   Topol EJ, 2005, NEW ENGL J MED, V353, P113
   Haas JS, 2005, ANN INTERN MED, V142, P891
   Melnikova I, 2005, NAT REV DRUG DISCOV, V4, P453, DOI 10.1038/nrd1755
   Sackner-Bernstein JD, 2005, JAMA-J AM MED ASSOC, V293, P1900
   Sackner-Bernstein JD, 2005, CIRCULATION, V111, P1487, DOI 10.1161/01.CIR.0000159340.93220.E4
   Okie S, 2005, NEW ENGL J MED, V352, P1063
   Yost RD, 2005, AM J HEALTH-SYST PH, V62, P525
   Dunehew A, 2005, AM J HEALTH-SYST PH, V62, P527
   Mayer SA, 2005, NEW ENGL J MED, V352, P777
   Vogel CL, 2005, J CLIN ONCOL, V23, P1178, DOI 10.1200/JCO.2005.09.102
   Hoffman JM, 2005, AM J HEALTH-SYST PH, V62, P149
   KAUFMAN M, 2005, WASH POST       0820, pA1
   SCHMIT J, 2005, USA TODAY       0627, pB1
   HARRIS G, 2005, NY TIMES        0225, pA1
   SAUL S, 2005, NY TIMES        0606, pC1
   2005, FDC REP PINK SHEET, V67, P23
   2005, FDC REP PINK SHEET, V67, P4
   2005, WALL ST J       0720, pD5
   2005, FDC REP PINK SHEET, V67, P3
   2005, FDC REP PINK SHEET, V67, P6
   2005, CHICAGO TRIBUNE 0924, P2
   2005, NY TIMES        0810, pC3
   2005, FDC REP PINK SHEET, V67, P12
   2005, FDC REP PINK SHEET, V67, P24
   2005, FEC REP PINK SHEET, V67, P19
   HEFFLER S, 2005, HLTH AFFAIRS W, V5, P74
   PEAR R, 2005, NY TIMES        1020, pA1
   CONNOLLY C, 2005, WASHINGTON POST 0603, pA1
   *CDR DEP, 2005, FDC REP PINK SHEET, V67, P12
   *NDA, 2005, FDC REP PINK SHEET, V67, P14
   *FDA COMM, 2005, FDC REP PINK SHEET, V67, P3
   *IND FIL, 2005, FDC REP PINK SHEET, V67, P9
   STRUNK BC, 2005, HLTH AFF, V5, P286
   CONMY D, 2005, MED MARK MEDIA, V40, P36
   GEBHART F, 2005, DRUG TOPICS     0822, P18
   SIPKOFF M, 2005, DRUG TOPICS S    AUG, pS11
   SIPKOFF M, 2005, DRUG TOPICS S    AUG, pS4
   BAYOT J, 2005, NY TIMES        0726, pC5
   JONES D, 2005, USA TODAY       0822, pB3
   KAUFMAN M, 2005, WASHINGTON POST 0719, pA19
   Meyer BM, 2004, AM J HEALTH-SYST PH, V61, P1042
   Hoffman JM, 2004, AM J HEALTH-SYST PH, V61, P145
   Lee TH, 2004, NEW ENGL J MED, V350, P211
   *KAIS FAM FDN, 2004, 2004 EMPL HLTH BEN 2
   LEE TH, 2004, NEW ENGL J MED, V350, P1586
   RAPP RP, 2004, AM J HLTH SYSTE PHAR, V61, P1556
   JOHNSON K, 2004, MANAG HEALTHC E 0201, P46
   RAPP RP, 2004, AM J HEALTH-SYST PH, V61, P1554
   Seltzer E, 2003, CLIN INFECT DIS, V37, P1298
   Shactman D, 2003, HEALTH AFFAIR, V22, P12, DOI 10.1377/hlthaff.22.6.12
   Weir HK, 2003, J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040
   Ghosh S, 2003, NEW ENGL J MED, V348, P24
   WEIR HK, 2003, J NATL CANCER I, V95, P1641
   HESSELGRAVE BL, 2003, MANAG CARE Q, V11, P1
   Boulis A, 2002, J HEALTH POLIT POLIC, V27, P977
   ROGERS EM, 1995, DIFFUSION INNOVATION
   *NAT COMPR CANC NE, MYEL GROWTH FACT CAN
   *CTR MED MED SERV, HLTH ACC
   *FOOD DRUG ADM, CDER APPR TIM PRIOR
   *FOOD DRUG ADM, CDER DRUG BIOL REP
   *KAIS FAM FDN, 2005 EMPL HLTH BEN 2
   *FOOD DRUG ADM, CDER NME APPR CAL YE
   *MEDC, DRUG TREND REP MAN G
   *FOOD DRUG ADM, CDER NEW MOL ENT NME
   *FOOD DRUG ADM, CDER NUMB NDAS REC C
   *CTR DRUG EV RES, CDER REP NAT 2004
   *FOOD DRUG ADM, NUMB ACT INDS CLOS C
   *FOOD DRUG ADM, OR INDS REC CAL YEAR
   *KAIS FAM FDN, MED DRUG BEN BEN PER
   *BIOT HEALTHC, PEGF IND EXT INCL 1
   *AM HOSP ASS, TRENDS AFF HOSP HLTH
   *GEN PHARM ASS, GPHA PAT REF THOUGHT
NR 77
TC 17
Z9 17
PU AMER SOC HEALTH-SYSTEM PHARMACISTS
PI BETHESDA
PA 7272 WISCONSIN AVE, BETHESDA, MD 20814 USA
SN 1079-2082
J9 AM J HEALTH-SYST PH
JI Am. J. Health-Syst. Pharm.
PD JAN 15
PY 2006
VL 63
IS 2
BP 123
EP 138
DI 10.2146/ajhp050446
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 006MN
UT WOS:000234901700005
ER
PT J
AU Gardner, ES
   Koehler, AB
AF Gardner, ES
   Koehler, AB
TI Comments on a patented bootstrapping method for forecasting intermittent
   demand
SO INTERNATIONAL JOURNAL OF FORECASTING
LA English
DT Letter
ID LEAD-TIME DEMAND; INVENTORY CONTROL; PARTS
C1 Miami Univ, Dept Decis Sci, Oxford, OH 45056 USA.
   Miami Univ, Management Informat Syst, Oxford, OH 45056 USA.
   Univ Houston, Bauer Coll Business, Houston, TX 77204 USA.
RP Gardner, ES (reprint author), Miami Univ, Dept Decis Sci, Oxford, OH 45056 USA
EM evgardner@uh.edu
   koehleab@muohio.edu
CR Syntetos AA, 2005, INT J FORECASTING, V21, P303, DOI 10.1016/j.ijforecast.2004.10.001
   Willemain TR, 2004, INT J FORECASTING, V20, P375, DOI 10.1016/S0169-2070(03)00013-X
   Eaves AHC, 2004, J OPER RES SOC, V55, P431, DOI 10.1057/palgrave.jors.2601697
   Snyder R, 2002, EUR J OPER RES, V140, P684, DOI 10.1016/S0377-2217(01)00231-4
   Snyder RD, 2002, INT J FORECASTING, V18, P5
   HYNDMAN RJ, 2002, INT J FORECASTING, P269
   Syntetos AA, 2001, INT J PROD ECON, V71, P457
   Snyder RD, 1999, J OPER RES SOC, V50, P1079
   Sani B, 1997, J OPER RES SOC, V48, P700
   Johnston FR, 1996, J OPER RES SOC, V47, P113
   JOHNSTON FR, 1986, J OPER RES SOC, V37, P303
   CROSTON JD, 1972, OPER RES QUART, V23, P289
   BROWN RG, 1959, STAT FORECASTING INV
NR 13
TC 9
Z9 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-2070
J9 INT J FORECASTING
JI Int. J. Forecast.
PD JUL-SEP
PY 2005
VL 21
IS 3
BP 617
EP 618
DI 10.1016/j.ijforecast.2005.04.021
PG 2
WC Economics; Management
SC Business & Economics
GA 949PN
UT WOS:000230800700016
ER
PT J
AU Lai, KK
   Wu, SJ
AF Lai, KK
   Wu, SJ
TI Using the patent co-citation approach to establish a new patent
   classification system
SO INFORMATION PROCESSING & MANAGEMENT
LA English
DT Article
DE patent management; patent classification system; co-citation;
   bibliometrics
ID INTELLECTUAL STRUCTURE; AUTHOR COCITATION
AB The paper proposes a new approach to create a patent classification
   system to replace the IPC or UPC system for conducting patent analysis
   and management. The new approach is based on co-citation analysis of
   bibliometrics. The traditional approach for management of patents, which
   is based on either the IPC or UPC, is too general to meet the needs of
   specific industries. In addition, some patents are placed in incorrect
   categories, making it difficult for enterprises to carry out R&D
   planning, technology positioning, patent strategy-making and technology
   forecasting. Therefore, it is essential to develop a patent
   classification system that is adaptive to the characteristics of a
   specific industry. The analysis of this approach is divided into three
   phases. Phase I selects appropriate databases to conduct patent searches
   according to the subject and objective of this study and then select
   basic patents. Phase II uses the co-cited frequency of the basic patent
   pairs to assess their similarity. Phase III uses factor analysis to
   establish a classification system and assess the efficiency of the
   proposed approach. The main contribution of this approach is to develop
   a patent classification system based on patent similarities to assist
   patent manager in understanding the basic patents for a specific
   industry, the relationships among categories of technologies and the
   evolution of a technology category. (C) 2003 Elsevier Ltd. All rights
   reserved.
C1 Natl Yunlin Univ Sci & Technol, Dept Business Adm, Touliu 640, Yunlin, Taiwan.
   Natl Yunlin Univ Sci & Technol, Grad Sch Management, Yunlin, Taiwan.
RP Lai, KK (reprint author), Natl Yunlin Univ Sci & Technol, Dept Business Adm, Touliu 640, Yunlin, Taiwan
EM laikk@yuntech.edu.tw
CR YULAN H, 2002, INFORMATION PROCESSI, V38, P491
   *USPTO, 2001, MAN PAT EX PROC  AUG
   RIVITTE KR, 2000, REMNANTS ATTIC UNLOC
   HALL BH, 2000, W7435 NBER
   Harhoff D, 1999, REV ECON STAT, V81, P511
   Akin L, 1998, LIBR INFORM SCI RES, V20, P251
   Ernst H, 1997, SMALL BUS ECON, V9, P361
   MOGEE ME, 1997, TECHN TRANSF SOC ANN
   Archibugi D, 1996, TECHNOVATION, V16, P451
   Stuart TE, 1996, STRATEGIC MANAGE J, V17, P21
   Eom SB, 1996, DECIS SUPPORT SYST, V16, P315
   HOLSAPPLE CW, 1995, DECIS SUPPORT SYST, V14, P359
   HUFKER T, 1994, J PRODUCT BRAND MANA, V3, P44
   HOFFMAN DL, 1993, J CONSUM RES, V19, P505
   MCCAIN KW, 1991, J AM SOC INFORM SCI, V42, P290
   MCCAIN KW, 1990, J AM SOC INFORM SCI, V41, P433
   CULNAN MJ, 1990, J AM SOC INFORM SCI, V41, P453
   TRAJTENBERG M, 1990, RAND J ECON, V21, P172
   CULNAN MJ, 1987, MIS QUART, V11, P341
   NARIN F, 1987, RES POLICY, V16, P143
   DASGUPTA P, 1987, ARROW ASCENT MODERN
   MCCAIN KW, 1986, J AM SOC INFORM SCI, V37, P111
   HAYES RM, 1983, J EDUC LIBRARIANSHIP, V23, P151
   WHITE HD, 1981, J AM SOC INFORM SCI, V32, P163
   SMALL H, 1973, J AM SOC INFORM SCI, V24, P265
   KESSLER MM, 1963, IEEE T INFORMATION T, V49
NR 26
TC 31
Z9 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4573
J9 INFORM PROCESS MANAG
JI Inf. Process. Manage.
PD MAR
PY 2005
VL 41
IS 2
BP 313
EP 330
DI 10.1016/j.ipm.2003.11.004
PG 18
WC Computer Science, Information Systems; Information Science & Library
   Science
SC Computer Science; Information Science & Library Science
GA 874AK
UT WOS:000225323100009
ER
PT J
AU Yoon, B
   Park, Y
AF Yoon, B
   Park, Y
TI A systematic approach for identifying technology opportunities:
   Keyword-based morphology analysis
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article
DE morphology analysis; technology opportunity analysis; text mining;
   technology dictionary
ID VISUALIZATION
AB Morphology analysis (MA), a representative qualitative technique in
   technology forecasting (TF), has been utilized to identify technology
   opportunities. However, conventional MA is subject to limitations in
   that there is no scientific or systematic way in establishing the
   morphology of technology, and it is difficult to prioritize the
   alternatives. As a remedy, we propose a keyword-based MA that is
   supported by a systematic procedure and quantitative data for concluding
   the morphology of technology. To this end, a technology dictionary is
   developed by factor analysis for keywords that are extracted from patent
   documents through text mining. Then, the morphology of patents is
   identified based on the technology dictionary. By listing the occupied
   configurations of collected patents, the unoccupied territory of
   configurations are suggested as technology opportunities. Moreover, the
   priority of alternatives is concluded, and similar and substitutive
   technologies can be analyzed for the purpose of extending morphology
   structure. Technical and managerial strategy for in-house R&D or
   cross-licensing can also be supported by examining the morphology
   portfolio of technologies. A thin film transistor-liquid crystal display
   (TFT-LCD) case is exemplified to illustrate the detailed procedure of
   this brand-new MA. (C) 2004 Elsevier Inc. All rights reserved.
C1 Seoul Natl Univ, Sch Engn, Dept Ind Engn, Seoul, South Korea.
RP Park, Y (reprint author), Seoul Natl Univ, Sch Engn, Dept Ind Engn, San 56-1,Shillim Dong, Seoul, South Korea
EM parkyt@cybernet.snu.ac.kr
CR YOON B, 2004, J HIGH TECHNOLOGY MA, V15, P37
   YOON BU, 2004, P 33 INT C COMPUT IN
   PELT JV, 2004, MATH BIOSCI, V188, P147
   Mann DL, 2003, TECHNOL FORECAST SOC, V70, P779, DOI 10.1016/S0040-1625(02)00357-8
   LOVERIDGE D, 2003, SHORT GUIDE TECHNOLO, V35
   PORTER A, 2003, FUTURES RES METHODOL
   GLENN JC, 2003, FUTURES RES METHODOL
   Morris S, 2002, COMPUT IND ENG, V43, P841
   Zhu DH, 2002, TECHNOL FORECAST SOC, V69, P495
   Huckvale M, 2002, COMPUT SPEECH LANG, V16, P165, DOI 10.1006/csla.2001.0187
   ERIKSSON T, 2002, SWEDISH MORPHOLOGICA
   RITCHEY T, 2002, P 4 INT C LOC AUTH S
   TRAJTENBERG M, 2002, PATENTS CITATIONS IN
   YOON BU, 2002, R&D MANAGE, V34, P291
   Coates V, 2001, TECHNOL FORECAST SOC, V67, P1
   Belaziz M, 2000, COMPUT AIDED DESIGN, V32, P377
   *UNCTAD, 1999, TECH CH OPP DEV MOV
   ZHU D, 1999, CIENC INF, V28, P7
   FELDMAN R, 1998, P 2 INT C PRACT ASP
   Watts RJ, 1997, TECHNOL FORECAST SOC, V56, P25
   PIDD M, 1996, TOOLS THINKING MODEL
   BARKER D, 1995, LONG RANGE PLANN, V28, P21
   KLEVORICK AK, 1995, RES POLICY, V24, P185
   COYLE RG, 1995, FUTURES, V28, P269
   RHYNE R, 1995, FUTURES, V27, P659
   MOGEE ME, 1991, RES TECHNOL MANAGE, V34, P43
   GRILICHES Z, 1990, J ECON LIT, V28, P1661
   WISSEMA JG, 1976, TF INVESTIGATION FUT, V8, P146
   ZWICKY F, 1969, DISCOVERY INVENTION
   PENROSE E, 1951, ECONOMICS INTERNATIO
NR 30
TC 23
Z9 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD FEB
PY 2005
VL 72
IS 2
BP 145
EP 160
DI 10.1016/j.techfore.2004.08.011
PG 16
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 893KU
UT WOS:000226718600002
ER
PT J
AU Cramer, RD
   Jilek, RJ
   Guessregen, S
   Clark, SJ
   Wendt, B
   Clark, RD
AF Cramer, RD
   Jilek, RJ
   Guessregen, S
   Clark, SJ
   Wendt, B
   Clark, RD
TI "Lead hopping". Validation of topomer similarity as a superior predictor
   of similar biological activities
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID PHARMACOPHORE MODEL; STRUCTURE DATABASES; INHIBITORS; DESIGN; DISCOVERY;
   RECEPTOR; IDENTIFICATION; DESCRIPTORS; ANTAGONISTS; GENERATION
AB Two extensive studies quantifying the ability of topomer shape
   similarity to forecast a variety of biological similarities are
   described. In a prospective trial of "lead hopping", using topomer
   similarity for virtual screening and queries from the patent literature,
   biological assays of 308 selected compounds (representing 0.03% of those
   available, per assay type) yielded 11 successful "lead hops" in the 13
   assays attempted. The hit rate averaged over all assays was 39%
   ("activity" defined as inhibition greater than or equal to 20% at 10
   muM), significantly greater than an unexpectedly high negative control
   hit rate of 15%. The average "Tanimoto 2D fingerprint similarity"
   between query and "lead hop" structures (0.36) was little more than the
   Tanimoto similarity between random drug-like structures. Topomer shape
   and Tammoto 2D fingerprint similarities were also compared
   retrospectively, in their tendencies to concentrate together potential
   and actual drugs reported to belong to the same "activity class", for
   twenty classes. Among the most similar 3% of structures (corresponding
   to "greater than or equal to 0.85 Tanimoto" for these structures), an
   average of 62% of the topomer similar selection possessed a near
   neighbor belonging to the same activity class, roughly a one-third
   superiority over the "Tanimoto greater than or equal to 0.85" selection
   containing 48% actives in avoiding false positives. Conversely, the
   least similar 75% of structures contained 0.3% actives for topomer
   similarity vs 1.0% actives for Tanimoto 2D fingerprint similarity, a
   3-fold superiority for topomers in avoiding false negatives.
C1 Tripos Discovery Res, Bude EX23 8LY, Cornwall, England.
   Tripos Inc, St Louis, MO 63144 USA.
RP Cramer, RD (reprint author), CO Natl Ctr Genome Resources, Tripos Associates Inc, 2935 Rodeo Pk Dr E, Santa Fe, NM 87505 USA
EM cramer@tripos.com
CR Jilek RJ, 2004, J CHEM INF COMP SCI, V44, P1221, DOI 10.1021/ci049961d
   Shen M, 2004, J MED CHEM, V47, P2356, DOI 10.1021/jm030584q
   Jain AN, 2004, J MED CHEM, V47, P947, DOI 10.1021/jm030520f
   LYNN PD, 2004, J MED CHEM, V47, P1962
   Vinkers HM, 2003, J MED CHEM, V46, P2765, DOI 10.1021/jm030809x
   Brenk R, 2003, J MED CHEM, V46, P1133, DOI 10.1021/jm0209937
   Abrahamian E, 2003, J CHEM INF COMP SCI, V43, P458, DOI 10.1021/ci025595r
   Cramer RD, 2003, J MED CHEM, V46, P374, DOI 10.1021/jm020194o
   Khatuya H, 2002, BIOORG MED CHEM LETT, V12, P2145
   Enyedy IJ, 2002, BIOORG MED CHEM LETT, V12, P1775
   Dumas J, 2002, BIOORG MED CHEM LETT, V12, P1559
   Cramer RD, 2002, J MOL GRAPH MODEL, V20, P447, DOI 10.1016/S1093-3263(01)00146-2
   Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w
   Grzybowski BA, 2002, P NATL ACAD SCI USA, V99, P1270
   MARTIN YC, 2002, J MED CHEM, V47, P4350
   Finke PE, 2001, BIOORG MED CHEM LETT, V11, P2475
   Habeeb AG, 2001, J MED CHEM, V44, P2921
   Lober S, 2001, J MED CHEM, V44, P2691
   Van der Mey M, 2001, J MED CHEM, V44, P2511, DOI 10.1021/jm010837k
   Weber B, 2001, BRIT J PHARMACOL, V133, P1243
   Kuroda S, 2001, CHEM PHARM BULL, V49, P988
   Paiva AM, 2001, BBA-PROTEIN STRUCT M, V1545, P67
   Gruneberg S, 2001, ANGEW CHEM INT EDIT, V40, P389
   Carlson HA, 2000, J MED CHEM, V43, P2100
   Andrews KM, 2000, J MED CHEM, V43, P1723
   Wang SM, 2000, J MED CHEM, V43, P351
   HOLLIDAY JD, 2000, J CHEM INF COMP SCI, V40, P163
   Cramer RD, 1999, J MED CHEM, V42, P3919
   Cramer RD, 1998, J CHEM INF COMP SCI, V38, P1010
   Matter H, 1997, J MED CHEM, V40, P1219
   DOWNING D, 1997, STAT EASY WAY BARRON, P208
   Patterson DE, 1996, J MED CHEM, V39, P3049
   Cramer RD, 1996, J MED CHEM, V39, P3060
   Wang SM, 1996, J MED CHEM, V39, P2047
   BROWN RD, 1995, SIMILARITY CLUSTERIN, V209
   SNEDECOR GW, 1989, STAT METHODS, P117
   CRAMER RD, 1974, J MED CHEM, V17, P533
   BENDER SL
   KORNBERG BE
   NIETO JCD
   NISHIYAMA A
NR 41
TC 51
Z9 54
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
J9 J MED CHEM
JI J. Med. Chem.
PD DEC 30
PY 2004
VL 47
IS 27
BP 6777
EP 6791
DI 10.1021/jm049501b
PG 15
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 882QC
UT WOS:000225952400017
ER
PT J
AU Alameddine, F
   Block, PC
AF Alameddine, F
   Block, PC
TI Transcatheter patent foramen ovale closure for secondary prevention of
   paradoxical embolic events: Acute results from the FORECAST registry
SO CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
LA English
DT Article
DE occluder; atrial septal aneurysm; percutaneous; shunt
ID PFO CLOSURE; TERM RISK; STROKE
AB Patients with patent foramen ovale (PFO) and paradoxical embolism are at
   increased risk for recurrent events. Percutaneous PFO closure is a new
   treatment modality aimed at secondary prevention. We report the
   multicenter experience of interventional closure of PFO using two
   different devices in 272 patients. The mean age was 51 +/- 14.2 years
   and 52.9% were males. The implantation procedure resulted in an initial
   complete shunt closure rate of 74.3% with a periprocedural complication
   rate of 6.6%. There were no deaths or pericardial tamponade. The mean
   procedure time was less than 44 min under either conscious sedation,
   local or general anesthesia. This is the largest report to date
   demonstrating the procedural safety, reliability, and feasibility of the
   transcatheter PFO closure technique with the STARFlex and CardioSEAL
   septal implants. Randomized clinical trials are currently in progress to
   identify patients most likely to benefit from this intervention. (C)
   2004 Wiley-Liss, Inc.
C1 Emory Univ Hosp, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.
RP Block, PC (reprint author), Emory Univ Hosp, Dept Med, Div Cardiol, 1364 Clifton Rd,Suite F 606, Atlanta, GA 30322 USA
EM peter_block@emoryhealthcare.org
CR Block PC, 2002, CIRCULATION, V106, P514
   Sievert H, 2002, CIRCULATION, V106, P619
   Martin F, 2002, CIRCULATION, V106, P1121, DOI 10.1161/01.CIR.0000027819.19722.EE
   Braun MU, 2002, J AM COLL CARDIOL, V39, P2019
   Bruch L, 2002, CIRCULATION, V105, P2845, DOI 10.1161/01.CIR.0000019069.32964.0E
   WAHL A, 2001, J INTERV CARDIOL, V14, P203
   Overell JR, 2000, NEUROLOGY, V55, P1172
   Hung J, 2000, J AM COLL CARDIOL, V35, P1311
   Windecker S, 2000, CIRCULATION, V101, P893
   Grabitz RG, 1997, INVEST RADIOL, V32, P523
   Falk V, 1997, THORAC CARDIOV SURG, V45, P90
   Bogousslavsky J, 1996, NEUROLOGY, V46, P1301
   MAS JL, 1995, AM HEART J, V130, P1083
   BRIDGES ND, 1992, CIRCULATION, V86, P1902
   LECHAT P, 1988, NEW ENGL J MED, V318, P1148
   HAGEN PT, 1984, MAYO CLIN PROC, V59, P17
   KING TD, 1976, JAMA-J AM MED ASSOC, V235, P2506
NR 17
TC 17
Z9 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1522-1946
J9 CATHETER CARDIO INTE
JI Catheter. Cardiovasc. Interv.
PD AUG
PY 2004
VL 62
IS 4
BP 512
EP 516
DI 10.1002/ccd.20108
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 844SX
UT WOS:000223181400016
ER
PT J
AU Alameddine, F
   Block, PC
AF Alameddine, F
   Block, PC
TI International FORECAST(SM) registry demonstrates safety and efficacy of
   transcatheter patent foramen ovale closure
SO STROKE
LA English
DT Meeting Abstract
CT 29th International Stroke Conference
CY FEB 05-07, 2004
CL SAN DIEGO, CALIFORNIA
SP Amer Heart Assoc
C1 Emory Univ Hosp, Atlanta, GA 30322 USA.
NR 0
TC 0
Z9 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0039-2499
J9 STROKE
JI Stroke
PD JAN
PY 2004
VL 35
IS 1
BP 254
EP 254
PG 1
WC Clinical Neurology; Peripheral Vascular Disease
SC Neurosciences & Neurology; Cardiovascular System & Cardiology
GA 758JH
UT WOS:000187630500148
ER
PT J
AU Mann, DL
AF Mann, DL
TI Better technology forecasting using systematic innovation methods
SO TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE
LA English
DT Article; Proceedings Paper
CT International Symposium on Forecasting (ISF)
CY JUN, 2002
CL DUBLIN, IRELAND
DE TRIZ; design; trends
AB An evolved version of the Soviet-originated Theory of Inventive Problem
   Solving, TRIZ, contains a series of generically predictable technology
   and business evolution trends uncovered from the systematic analysis of
   over 2 million patents, academic journals and business texts. The
   current state of the art-recorded for the first time together in this
   paper-now bring the total number of generic technical trends to over 30,
   and the number of business trends to over 20. The paper describes some
   of the newly discovered trends, and their incorporation into a design
   method that allows individuals and businesses to first establish the
   relative maturity of their current systems, and then, more importantly,
   to identify areas where 'evolutionary potential' exists. The paper
   introduces this concept of evolutionary potential-defined as the
   difference between the relative maturity of the current system, and the
   point where it has reached the limits of each of the evolution
   trends-through a number of case study examples focused on the design and
   evolution of complex systems. (C) 2002 Elsevier Science Inc. All rights
   reserved.
C1 CREAX, Clevedon BS21 7SU, N Somerset, England.
RP Mann, DL (reprint author), CREAX, POB 93, Clevedon BS21 7SU, N Somerset, England
CR MANN D, 2002, HANDS SYSTEMATIC INN
   2000, CREATRIZ MANAGERS BU
   MANN DL, 2000, DESIGN COMPROMISE DE
   PINE BJ, 1999, EXPERIENCE EC
   SALAMATOV Y, 1999, TRIZ RIGHT SOLUTION
   UTTERBACK J, 1995, MASTERING DYNAMICS E
   ALTSHULLER G, 1984, CREATIVITY EXACT SCI
NR 7
TC 15
Z9 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0040-1625
J9 TECHNOL FORECAST SOC
JI Technol. Forecast. Soc. Chang.
PD OCT
PY 2003
VL 70
IS 8
BP 779
EP 795
DI 10.1016/S0040-1625(02)00357-8
PG 17
WC Business; Planning & Development
SC Business & Economics; Public Administration
GA 719QW
UT WOS:000185216500005
ER
PT J
AU Morris, S
   DeYong, C
   Wu, Z
   Salman, S
   Yemenu, D
AF Morris, S
   DeYong, C
   Wu, Z
   Salman, S
   Yemenu, D
TI DIVA: a visualization system for exploring document databases for
   technology forecasting
SO COMPUTERS & INDUSTRIAL ENGINEERING
LA English
DT Article
DE technology forecasting; information visualization; knowledge discovery
   in databases; KDD; data mining; citation analysis; document mapping;
   bibliometrics; scientometrics
ID DISCOVERY
AB Database Information Visualization and Analysis system (DIVA) is a
   computer program that helps perform bibliometric analysis of collections
   of scientific literature and patents for technology forecasting.
   Documents, drawn from the technological field of interest, are
   visualized as clusters on a two dimensional map, permitting exploration
   of the relationships among the documents and document clusters and also
   permitting derivation of summary data about each document cluster. Such
   information, when provided to subject matter experts performing a
   technology forecast, can yield insight into trends in the technological
   field of interest. This paper discusses the document visualization and
   analysis process: acquisition of documents, mapping documents,
   clustering, exploration of relationships, and generation of summary and
   trend information. Detailed discussion of DIVA exploration functions is
   presented and followed by an example of visualization and analysis of a
   set of documents about chemical sensors. (C) 2002 Published by Elsevier
   Science Ltd.
C1 Oklahoma State Univ, Sch Elect & Comp Engn, Stillwater, OK 74078 USA.
   Oklahoma State Univ, Sch Ind Engn & Management, Stillwater, OK 74078 USA.
RP Morris, S (reprint author), Oklahoma State Univ, Sch Elect & Comp Engn, 202 Engn S, Stillwater, OK 74078 USA
CR MORRIS SA, 2001, P IEEE INT JOINT C N
   *MATHW INC, 1999, DAT TOOLB
   LAWRENCE S, 1999, IEEE COMPUT, V32, P67
   Davidson GS, 1998, J INTELL INF SYST, V11, P259
   McCain KW, 1998, SCIENTOMETRICS, V41, P389
   Spasser MA, 1997, SCIENTOMETRICS, V39, P77
   Swanson DR, 1997, ARTIF INTELL, V91, P183
   Small H, 1997, SCIENTOMETRICS, V38, P275
   MOGEE ME, 1997, KEEPING ABREAST SCI
   KOSTOFF RN, 1997, HDB RES IMPACT ASSES
   GARFIELD E, 1994, CURRENT CONTENT 0103
   MOGEE ME, 1991, RES TECHNOL MANAGE, V34, P43
   SALTON G, 1989, AUTOMATIC TEXT PROCE
NR 13
TC 26
Z9 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-8352
J9 COMPUT IND ENG
JI Comput. Ind. Eng.
PD SEP
PY 2002
VL 43
IS 4
BP 841
EP 862
DI 10.1016/S0360-8352(02)00143-2
PG 22
WC Computer Science, Interdisciplinary Applications; Engineering,
   Industrial
SC Computer Science; Engineering
GA 596FE
UT WOS:000178152900014
ER
PT J
AU Litt, B
   Echauz, J
AF Litt, B
   Echauz, J
TI Prediction of epileptic seizures
SO LANCET NEUROLOGY
LA English
DT Review
ID TEMPORAL-LOBE EPILEPSY; NEURONAL COMPLEXITY LOSS; INDUCED INTERICTAL
   DISCHARGES; PRIMARY EPILEPTOGENIC AREA; BRAIN ELECTRICAL-ACTIVITY;
   TIME-SERIES ANALYSIS; CEREBRAL-BLOOD-FLOW; STATISTICAL-ANALYSIS;
   NONLINEAR-ANALYSIS; CAT HIPPOCAMPUS
AB For almost 40 years, neuroscientists thought that epileptic seizures
   began abruptly, just a few seconds before clinical attacks. There is now
   mounting evidence that seizures develop minutes to hours before clinical
   onset. This change in thinking is based on quantitative studies of long
   digital intracranial electroencephalographic (EEG) recordings from
   patients being evaluated for epilepsy surgery. Evidence that seizures
   can be predicted is spread over diverse sources in medical, engineering,
   and patent publications. Techniques used to forecast seizures include
   frequency-based methods, statistical analysis of EEG signals, non-linear
   dynamics (chaos), and intelligent engineered systems. Advances in
   seizure prediction promise to give rise to implantable devices able to
   warn of impending seizures and to trigger therapy to prevent clinical
   epileptic attacks. Treatments such as electrical stimulation or focal
   drug infusion could be given on demand and might eliminate side-effects
   in some patients taking antiepileptic drugs long term. Whether
   closed-loop seizure-prediction and treatment devices will have the
   profound clinical effect of their cardiological predecessors will depend
   on our ability to perfect these techniques. Their clinical efficacy must
   be validated in large-scale, prospective, controlled trials.
C1 Hosp Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Biomed Engn, Philadelphia, PA 19104 USA.
   NeuroPace Inc, Sunnyvale, CA USA.
   Univ Puerto Rico, Mayaguez, PR USA.
RP Litt, B (reprint author), Hosp Univ Penn, Dept Neurol, 3400 Spruce St,3 West Gates, Philadelphia, PA 19104 USA
EM littb@mail.med.upenn.edu
CR Lehnertz K, 2001, J CLIN NEUROPHYSIOL, V18, P209
   Protopopescu VA, 2001, J CLIN NEUROPHYSIOL, V18, P223
   Sunderam S, 2001, J CLIN NEUROPHYSIOL, V18, P275
   Litt B, 2001, NEURON, V30, P51
   Iasemidis LD, 2001, J COMB OPTIM, V5, P9
   Lian J, 2001, BRAIN RES, V890, P246
   Le Van Quyen M, 2001, LANCET, V357, P183
   SACKELLARES JC, 2001, EPILEPSIA, V42, P40
   DALESSANDRO M, 2001, IEEE INT M ENG MED B
   DALESSANDRO M, 2001, THESIS GEORGIA I TEC
   LEVANQUYEN M, 2001, EPILEPSIA, V42, P98
   Widman G, 2000, EPILEPSIA, V41, P811
   Le Van Quyen M, 2000, EUR J NEUROSCI, V12, P2124
   Schiff SJ, 2000, CLIN NEUROPHYSIOL, V111, P953
   SHIAU DS, 2000, EPILEPSIA, V41, P208
   IASEMIDIS LD, 2000, DISCRETE PROBLEMS ME, V55, P55
   MORMANN F, 2000, PHYSICA D, V144, P359
   VELIS DN, 2000, EPILIPSIA, V41, P205
   MORMANN F, 2000, EPILEPSIA, V41, P167
   Towle VL, 1999, J CLIN NEUROPHYSIOL, V16, P528
   Novak V, 1999, J AUTONOM NERV SYST, V77, P195
   Widman G, 1999, BRAIN RES, V836, P156
   Lehnertz K, 1999, REV NEUROL, V155, P454
   Strong V, 1999, SEIZURE-EUR J EPILEP, V8, P62
   BROWN S, 1999, 23 INT EP C SEPT 17
   IASEMIDIS L, 1999
   ESTELLER R, 1999, IEEE INT C AC SPEE S, P2343
   Martinerie J, 1998, NAT MED, V4, P1173
   Geva AB, 1998, IEEE T BIO-MED ENG, V45, P1205, DOI 10.1109/10.720198
   Salant Y, 1998, MED BIOL ENG COMPUT, V36, P549
   Weber B, 1998, EPILEPSIA, V39, P922
   Lehnertz K, 1998, PHYS REV LETT, V80, P5019
   Baumgartner C, 1998, J NUCL MED, V39, P978
   Elger CE, 1998, EUR J NEUROSCI, V10, P786
   LITT B, 1998
   Rajna P, 1997, SEIZURE, V6, P361
   Lehnertz K, 1997, ELECTROEN CLIN NEURO, V103, P376
   Weinand ME, 1997, J NEUROSURG, V86, P226
   IASEMIDIS LD, 1997, FR ART INT, V37, P81
   WALSH M, 1997, GLOBAL NEWS
   Iasemidis LD, 1996, NEUROSCIENTIST, V2, P118
   IASEMIDIS LD, 1996, EPILEPSIA S, V37, P90
   Scott DA, 1995, BIOPHYS J, V69, P1748
   LEHNERTZ K, 1995, ELECTROEN CLIN NEURO, V95, P108
   ECHAUZ JR, 1995, THESIS I TECHNOLOGY
   HILBORN RC, 1994, CHAOS NONLINEAR DYNA
   IASEMIDIS LD, 1994, EPILEPSY RES, V17, P81
   ELGER CE, 1994, EPILEPTIC SEIZURES S, P541
   DUCKROW RB, 1992, ELECTROEN CLIN NEURO, V82, P415
   PEITGEN HO, 1992, FRACTALS CLASSROOM 2
   BALISH M, 1991, EPILEPSIA, V32, P642
   KATZ A, 1991, ELECTROEN CLIN NEURO, V79, P153
   IASEMIDIS LD, 1991, MEASURING CHAOS HUMA, P49
   IASEMIDIS LD, 1990, BRAIN TOPOGRAPHY, V2, P187
   RISINGER MW, 1989, NEUROLOGY, V39, P1288
   WIESER HG, 1989, EPILEPSIA, V30, P669
   IASEMIDIS LD, 1988, IEEE ENG MED BIOL SO, P1201
   IASEMIDIS L, 1988, ELECTROENCEPHALOGR C, V5, P339
   MILTON JG, 1987, EPILEPSIA, V28, P471
   LANGE HH, 1983, ELECTROEN CLIN NEURO, V56, P543
   GOTMAN J, 1982, EPILEPSIA, V23, P432
   ROGOWSKI Z, 1981, BIOL CYBERN, V42, P9
   TAKENS F, 1981, WARWICK 1980 LECT NO, V898, P366
   SHERWIN I, 1978, ELECTROEN CLIN NEURO, V45, P525
   VIGLIONE SS, 1975, ELECTROENCEPHALOGR C, V39, P435
   VIGLIONE S, 1973
   LISS S, 1973
   ROSS S, 1972
   CRICHTON M, 1972, TERMINAL MAN
   VIGLIONE SS, 1970, 21 W I EP FEB 27 28
   DICHTER M, 1969, J NEUROPHYSIOL, V32, P649
   DICHTER M, 1969, J NEUROPHYSIOL, V32, P663
   RALSTON BL, 1958, ELECTROEN CLIN NEURO, V10, P217
NR 73
TC 123
Z9 131
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1474-4422
J9 LANCET NEUROL
JI Lancet Neurol.
PD MAY
PY 2002
VL 1
IS 1
BP 22
EP 30
DI 10.1016/S1474-4422(02)00003-0
PG 9
WC Clinical Neurology
SC Neurosciences & Neurology
GA 588GQ
UT WOS:000177694100017
ER
PT J
AU Kurokawa, S
   Tong-Ngok, W
   Yamada, H
AF Kurokawa, S
   Tong-Ngok, W
   Yamada, H
TI Determinants of organisational R&D persistence: a case of semiconductor
   laser diodes in the USA and Japan
SO INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT
LA English
DT Article
DE technology forecasting; technology diffusion; technology policy; R&D
   management; persistence; R&D community; semiconductor laser diodes
ID TECHNOLOGICAL COMPETENCES; INDUSTRIAL-INNOVATION; CORE COMPETENCES;
   COMMUNITIES; MANAGEMENT; ALLIANCES; PATTERNS; PROGRESS; FIRMS
AB This paper examines the factors affecting organisational R&D persistence
   from 1966 to 1998 in the field of semiconductor laser diodes. We
   constructed several hypotheses based on the relevant literature and
   tested these hypotheses with 922 US and 366 Japanese organisations
   (firms, universities and government labs), by using their published
   papers and patents. We found: (1) the more papers and patents an
   organisation has, the more likely it is to persists (2) universities are
   more persistent than other organisations (3) sales expectation
   contributes significantly to corporate RD persistence; (4) Japanese
   firms are more likely to persist than US firms; and (5) US government
   labs are more likely to persist than Japanese government labs, By our
   interviews and further quantitative analyses, we also found that the
   technology diffusion in Japan seemed to be more pervasive than that in
   the USA.
C1 Drexel Univ, Coll Business, Philadelphia, PA 19104 USA.
   Chiang Mai Univ, Sch Engn, Chiang Mai 50200, Thailand.
   Int Univ Japan, Ctr Global Commun, Tokyo 1060032, Japan.
RP Kurokawa, S (reprint author), Drexel Univ, Coll Business, Philadelphia, PA 19104 USA
CR Howells J, 1999, TECHNOL ANAL STRATEG, V11, P17
   BROWN RH, 1999, US IND OUTLOOK 1999
   YAMADA H, 1999, GIUJUTU KYOSOUTO SEK
   ROBERTS EB, 1999, MIT S STRAT MAN TECH
   AFUAH A, 1998, INNOVATION MANAGEMEN
   SHAPIRO C, 1998, INFORMATION RULES ST
   Chen JC, 1998, INT J TECHNOL MANAGE, V15, P761
   Sakakibara M, 1997, RES POLICY, V26, P447
   Malerba F, 1997, INT J IND ORGAN, V15, P801
   Granstrand O, 1997, CALIF MANAGE REV, V39, P8
   Patel P, 1997, RES POLICY, V26, P141
   Kurokawa S, 1997, IEEE T ENG MANAGE, V44, P124, DOI 10.1109/17.584921
   Prencipe A, 1997, RES POLICY, V25, P1261
   Liu SJ, 1997, INT J TECHNOL MANAGE, V13, P661
   Reid DT, 1997, IEEE J QUANTUM ELECT, V33, P1, DOI 10.1109/3.554854
   Teece DJ, 1996, J ECON BEHAV ORGAN, V31, P193
   Mansfield E, 1996, RES POLICY, V25, P1047
   Coombs R, 1996, R&D MANAGE, V26, P345
   BABCOCK DL, 1996, MANAGING ENG TECHNOL
   KRICKX GA, 1995, J ECON BEHAV ORGAN, V26, P75
   *HIK SANG SHINK, 1995, 25 HIK SANG SHINK
   KODAMA F, 1995, EMERGING PATTERNS IN
   BATES KA, 1995, BEST PAPER P AM ACAD, V55, P235
   DEBACKERE K, 1995, BEST PAPER P AM ACAD, V55, P417
   RAPPA MA, 1995, R&D MANAGE, V25, P209
   SAVIOTTI PP, 1995, INT J TECHNOL MANAGE, P407
   RAPPA MA, 1994, R&D MANAGE, V24, P183
   UTTERBACK J, 1994, MASTERING DYNAMICS I
   AMSDEN AH, 1994, EUROPEAN EC REV, V38, P94
   BURGERS WP, 1993, STRATEGIC MANAGE J, V14, P419
   WOLEK FW, 1993, SRA-J SOC RES ADMIN, V24, P27
   LYNN LH, 1993, J ENG TECHNOL MANAGE, V10, P53
   DIXIT A, 1993, THINKING STRATEGICAL
   SAKAKIBARA K, 1993, J ENG TECHNOL MANAGE, V10, P393
   RAPPA MA, 1992, TECHNOL FORECAST SOC, V42, P133
   RAPPA MA, 1992, R&D MANAGE, V22, P209
   ECCLES RG, 1992, HYPE REDISCOVERING E
   DEBACKERE K, 1992, SURVIVAL NETWORK PER
   RAPPA MA, 1992, USING LIT STUDY EMER
   BLEEKE J, 1991, HARVARD BUS REV, V69, P127
   POLLEY DE, 1991, THESIS GRADUATE SCH
   OKUMURA H, 1991, HOUJIN SGHIHON SHUGI
   PRAHALAD CK, 1990, HARVARD BUS REV, V68, P79
   WOMACK JP, 1990, MACHINE CHANGED WORL
   PORTER M, 1990, COMPETITIVE ADV NATI
   YAMADA H, 1990, THESIS MIT
   LIEVROUW LA, 1989, COMMUN RES, V16, P615
   KOTTE E, 1989, TECHNOLOGIES LIGHT
   DERTOUZOS ML, 1989, MADE AM
   AYRES RU, 1988, TECHNOVATION, V7, P87
   VONHIPPEL E, 1988, SOURCES INNOVATION
   YAMAMURA K, 1988, STRATEGIC TRADE POLI
   ALLEN TJ, 1988, MANAGING PROFESSIONA, P3
   BOWEN MG, 1987, ACAD MANAGE REV, V12, P52
   ZIMAN J, 1987, KNOWING EVERYTHING N
   FARRELL F, 1987, PRODUCT STANDARDIZAT
   STAW BM, 1987, RES ORG BEHAV, V9
   KATZ ML, 1986, J POLIT ECON, V94, P822
   VANDEVEN AH, 1986, MANAGE SCI, V32, P590
   CULNAN MJ, 1986, MANAGE SCI, V32, P156
   ABERNATHY WJ, 1985, RES POLICY, V14, P3
   HARRIGAN KR, 1985, STRATEGIES JOINT VEN
   CUSUMANO M, 1985, JAPANESE AUTOMOBILE
   ABEGGLEN JC, 1985, KAISHA JAPANESE CORP
   KAGONO T, 1985, STRATEGIC VS EVOLUTI
   FUSFELD HI, 1985, HARVARD BUSINESS NOV, P60
   LINK A, 1983, DECISION SCI, V14, P46
   FREEMAN C, 1982, EC IND INNOVATION
   HECHT J, 1982, LASER SUPERTOOL 1980
   BROCKNER J, 1981, J EXP SOC PSYCHOL, V17, P68
   OUCHI WG, 1980, ADMIN SCI QUART, V25, P129
   KILLING JP, 1980, COLUMBIA J WORLD BUS, V15, P125
   ABERNATHY WJ, 1978, TECHNOL REV, V80, P40
   ALLEN TJ, 1977, MANAGING FLOW TECHNO, P8
   PRICE DJD, 1956, DISCOVERY, V17, P240
NR 75
TC 1
Z9 1
PU INDERSCIENCE ENTERPRISES LTD
PI GENEVA AEROPORT
PA WORLD TRADE CENTER BLDG 110 AVE LOUSIS CASAI CP 306, CH-1215 GENEVA
   AEROPORT, SWITZERLAND
SN 0267-5730
J9 INT J TECHNOL MANAGE
JI Int. J. Technol. Manage.
PY 2002
VL 23
IS 7-8
BP 813
EP 835
DI 10.1504/IJTM.2002.003039
PG 23
WC Engineering, Multidisciplinary; Management; Operations Research &
   Management Science
SC Engineering; Business & Economics; Operations Research & Management
   Science
GA 561FZ
UT WOS:000176130700009
ER
nullPT J
AU TERAPANE, JF
AF TERAPANE, JF
TI PATENT FILE AND PATENT-AND-TRADEMARK-OFFICE TECHNOLOGY-ASSESSMENT AND
   FORECAST PROGRAM
SO JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES
LA English
DT Article
C1 US PATENT & TRADEMARK OFF,OFF TECHNOL ASSESSMENT & FORECAST,WASHINGTON,DC 20231.
CR SCHMOOKLER J, 1966, INVENTION EC GROWTH, pCH2
   LAWSON WS, COMMUNICATION
NR 2
TC 1
Z9 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036
SN 0095-2338
J9 J CHEM INF COMP SCI
JI J. Chem. Inf. Comput. Sci.
PY 1977
VL 17
IS 3
BP 130
EP 133
DI 10.1021/ci60011a005
PG 4
WC Chemistry, Multidisciplinary; Computer Science, Information Systems;
   Computer Science, Interdisciplinary Applications
SC Chemistry; Computer Science
GA DS289
UT WOS:A1977DS28900004
ER
EF